text,title,id,project_number,terms,administration,organization,mechanism,year,award_amount,cong_dist,score
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers    DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. PUBLIC HEALTH RELEVANCE: The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.           Project Narrative The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,7843531,R01CA132065,"['Alu Elements ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Lung Neoplasms ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Gene Targeting ', ' Methylation ', ' Protein Methylation ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Biological Process ', ' Biological Function ', ' CpG Islands ', ' CpG-Rich Islands ', ' Transgenes ', ' Play ', ' Shapes ', ' Promoter Regions (Genetics) ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' cancer cell ', ' Malignant Cell ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' gene product ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' Repression ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' sound ', ' Employee Strikes ', ' Strikes ', ' Testing ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' carcinogenesis ', ' Cancer Induction ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Gene Silencing ', ' Gene Inactivation ', ' treatment planning ', ' Primary Neoplasm ', ' Primary Tumor ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cell Culture Techniques ', ' cell culture ', ' Generations ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Code ', ' Coding System ', ' Polycomb ', ' Mediating ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' cancer diagnosis ', ' Cancer cell line ', ' Resistance ', ' resistant ', ' tumor ', ' overexpression ', ' overexpress ', ' public health relevance ', ' biomarker ', ' genome-wide ', ' genomewide ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Cytosine ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' histone modification ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Modification Methylases ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' prevent ', ' preventing ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' Fibrinogen ', ' Factor One ', ' Factor I ', ' Coagulation Factor One ', ' Coagulation Factor I ', ' Blood Factor One ', ' Blood Coagulation Factor One ', ' Blood Coagulation Factor I ', ' DNA Sequence ', ' Affect ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Human Genome ', ' human whole genome ', ' base ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Histones ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Site ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' ']",NCI,EMORY UNIVERSITY,R01,2010,315601,GA-05,0.2289628245880875
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers    DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. PUBLIC HEALTH RELEVANCE: The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.           Project Narrative The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8069622,R01CA132065,"['carcinogenesis ', ' Cancer Induction ', ' DNA Methyltransferase ', ' histone modification ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' DNA Methylation ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' cancer diagnosis ', ' sound ', ' Cancer cell line ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Transgenes ', ' Employee Strikes ', ' Strikes ', ' genome-wide ', ' genomewide ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' Repression ', ' Code ', ' Coding System ', ' cancer cell ', ' Malignant Cell ', ' DNA Sequence ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' novel ', ' Gene Silencing ', ' Gene Inactivation ', ' Primary Neoplasm ', ' Primary Tumor ', ' Algorithms ', ' Recruitment Activity ', ' recruit ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Genomics ', ' Histones ', ' Gene Expression ', ' Shapes ', ' Molecular Target ', ' Gene Targeting ', ' Modeling ', ' Biological Process ', ' Biological Function ', ' prevent ', ' preventing ', ' Cell Culture Techniques ', ' cell culture ', ' DNA ', ' Deoxyribonucleic Acid ', ' Classification ', ' Systematics ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Testing ', ' Molecular ', ' Methylation ', ' Protein Methylation ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Role ', ' social role ', ' Event ', ' Genome ', ' Research ', ' Play ', ' Genes ', ' Defect ', ' Process ', ' tumor ', ' Complex ', ' Risk ', ' biomarker ', ' Affect ', ' Goals ', ' Human Genome ', ' human whole genome ', ' base ', ' Resistance ', ' resistant ', ' Tumor-Suppressor Gene Inactivation ', ' Publishing ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Site ', ' Data ', ' Training ', ' treatment planning ', ' in vivo ', ' Predisposition ', ' Susceptibility ', ' overexpression ', ' overexpress ', ' CpG Islands ', ' CpG-Rich Islands ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Resources ', ' Research Resources ', ' Work ', ' Health ', ' Generations ', ' improved ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Proteins ', ' gene product ', ' Techniques ', ' Pattern ', ' Mediating ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Frequencies (time pattern) ', ' Frequency ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Aberrant DNA Methylation ', ' Hypermethylation ', ' Polycomb ', ' Deletion Mutation ', ' DNA Modification Methylases ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' Alu Elements ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Chromatin Structure ', ' Cytosine ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Pattern Recognition ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Lung Neoplasms ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Ectopic Expression ', ' Promoter Regions (Genetics) ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' ']",NCI,EMORY UNIVERSITY,R01,2011,306133,GA-05,0.2289628245880875
"Statistical Methods for Correlated and High-Dimensional Biomedical Data We propose in the renewal of this MERIT award application to continue developing advanced statistical and computational methods for analysis of correlated and high-dimensional data, which arise frequently in health science research, especially in cancer research. Correlated data are often observed in observational studies and clinical trials, such as longitudinal studies and familial studies. High-dimensional data have emerged rapidly in recent years due to the advance of high-throughput 'omics technologies, e.g, in Genome- Wide Association Studies (GWAS), and genome-wide epigenetic (DNA methylation) studies. Massive next generation sequencing data are soon available. There is an urgent need to develop advanced stati stical and computational methods for analyzing such high throughput 'omics data in observational studies and clinical trials. We propose to develop statistical and computational methods for analysis of (1) genome-wide association studies; (2) sequencing data for studying rare variant effects; (3) genome-wide DNA methylation studies; (4) gene-gene and gene-environment interactions. We will develop methods for both case-control studies and cohort studies, such as longitudinal studies and survival studies. We will study the theoretical properties of the proposed methods and evaluate the finite s ample performance using simulation studies. We will develop efficient numerical algorithms and user-friendly statistical software, and disseminate these tools to health sciences researchers. In collaboration with biomedical investigators, we will apply the proposed models methods to data from several genome-wide epidemiological studies in cancer and other chronic diseases. RELEVANCE (See instructions):  Development of new statistical methods for analysis of correlated and high-dimensional data will provide  powerful analytic tools to advance 'omics research in observational studies and clinical trials and to help  understand the roles of genes, gene products, and the environment in causing human diseases.",Statistical Methods for Correlated and High-Dimensional Biomedical Data,8117858,R37CA076404,"['Statistical Methods ', ' human whole genome ', ' Human Genome ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Genome ', ' genomewide ', ' genome-wide ', ' Goals ', ' Environment ', ' cancer research ', ' anticancer research ', ' environment effect on gene ', ' gene environment interaction ', ' clinical investigation ', ' Clinical Trials ', ' gene product ', ' Proteins ', ' Algorithms ', ' Technology ', ' mRNA ', ' Messenger RNA ', ' DNA Methylation ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' human disease ', ' Genetic ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Knowledge ', ' computer program/software ', ' Software ', ' Computer software ', ' gene interaction ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Dimensions ', ' Biomedical Research ', ' long-term study ', ' Longitudinal Studies ', ' case control ', ' developmental ', ' Development ', ' Collaborations ', ' Investigation ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Genes ', ' Research ', ' Modeling ', ' disease/disorder ', ' Disorder ', ' Disease ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Preventive strategy ', ' Prevention strategy ', ' next generation ', ' Award ', ' Genomics ', ' Health Sciences ', ' Variation ', ' Variant ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' user-friendly ', ' Data ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' LOINC Axis 2 Property ', ' Property ', ' Performance ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Aging ', ' Testing ', ' Techniques ', ' tool ', ' pediatric ', ' Childhood ', ' Scientist ', ' Measures ', ' Methods ', ' programs ', ' Advanced Development ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' novel technologies ', ' new technology ', ' simulation ', ' cancer risk ', ' Concurrent Studies ', ' Cohort Studies ', ' Instruction ', ' epigenome ', ' epigenomics ', ' Statistical Computing ', ' social role ', ' Role ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' novel ', ' Genotype ', ' high throughput analysis ', ' computer science ', ' Explosion ', ' Public Health Schools ', ' Theoretical Studies ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Observational Study ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' health science research ', ' signal processing ', ' data processing ', ' computerized data processing ', ' ']",NCI,HARVARD SCHOOL OF PUBLIC HEALTH,R37,2011,308344,MA-07,0.05490639645225228
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.      PUBLIC HEALTH RELEVANCE:  There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.            There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8181076,R01NS076465,"['Food Supply ', ' mate ', ' Partner in relationship ', ' chromatin remodeling ', ' RNA Sequences ', ' Genetic Models ', ' Nucleic Acids ', ' Strikes ', ' Employee Strikes ', ' DNA Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' loss of function ', ' neonate ', ' in utero ', ' chromatin modification ', ' Pregnant Women ', ' C element ', ' Carbon ', ' Spottings ', "" man's "", ' man ', ' Emergent Technologies ', ' Emerging Technologies ', ' Human Genetics ', ' Pattern ', ' Body Tissues ', ' Tissues ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' Translating ', ' Investigation ', ' Life ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Outcome ', ' Embryonic ', ' Embryo ', ' Animals ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Clinical ', ' Genome ', ' pathway ', ' Pathway interactions ', ' Event ', ' Mediating ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Genomics ', ' Testing ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Patients ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' Modification ', ' Risk ', ' gene product ', ' Proteins ', ' Blood Reticuloendothelial System ', ' Blood ', ' Data ', ' Parturition ', ' Birth ', ' Age ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' Receptor Protein ', ' receptor ', ' Variation ', ' Variant ', ' mouse model ', ' Population ', ' Cells ', ' Sampling ', ' epigenome ', ' epigenomics ', ' Individual ', ' Detection ', ' Staging ', ' Biological ', ' Affect ', ' Survey Instrument ', ' Surveys ', ' human disease ', ' Prevention ', ' developmental ', ' Development ', ' response ', ' Family ', ' cohort ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Molecular ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' social role ', ' Role ', ' base ', ' Gene Expression ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Phenotype ', ' Deoxyribonucleic Acid ', ' DNA ', ' unborn ', ' prenatal ', ' innovative ', ' innovate ', ' innovation ', ' Source ', ' Complex ', ' Process ', ' Infant ', ' Work ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Lipids ', ' Genetic ', ' Genes ', ' Cancer Biology ', ' Intake ', ' peripheral blood ', ' genomewide ', ' genome-wide ', ' Dependence ', ' major depression ', ' Major Depressive Disorder ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Recommendation ', ' Nucleotides ', ' Splicing ', ' RNA Splicing ', ' arm ', ' dietary ', ' Diet ', ' Algorithms ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' standard of care ', ' Neonatal ', ' Protein Methylation ', ' Methylation ', ' Route ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Chromatin ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Histones ', ' Metabolic ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Genotype ', ' Preventive strategy ', ' Prevention strategy ', ' Metabolic Pathway ', ' Clinical Data ', ' Supplementation ', ' stem ', ' Ensure ', ' Neural tube ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Embryonic Tissue ', ' embryo tissue ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' Neural Tube Closure ', ' Enriched Food ', ' Fortified Food ', ' epigenetic variation ', ' neurogenetics ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Genetic Code ', ' fortification ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' Folate ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2011,1186731,NY-12,0.17896194406950683
"Point Impact and Sparsity in Functional Data Analysis.    DESCRIPTION (provided by applicant): This is a project to develop new methods of functional data analysis directed towards important public health applications in genomics and life course epidemiology. In genome-wide expression and DNA methylation studies, it is of interest to locate genes showing activity that is associated with clinical outcomes, e.g., to use gene expression profiles from the tumors of breast cancer patients to predict estrogen receptor protein concentration, an important prognostic marker for breast tumors. In such studies, the gene expression profile across a chromosome can be regarded a functional predictor, and a gene associated with the clinical outcome is identified by its base pair position along the chromosome. The key aim of the project is to develop new methods of statisti- cal inference for finding such genetic loci, leading to the identification of chromosomal regions that are potentially useful for diagnosis and therapy. Although there is extensive statistical literature on gene expression data, it is almost exclusively concerned with multiple testing procedures for detecting the presence of differentially expressed genes, and statistical methods for locating such genes based on expression profiles (interpreted as functional predictors) are not well developed. Although functional data analysis has reached a mature stage of development over the last ten years, serious problems can arise when the currently available methods are applied in situations involving functional predictors (or trajectories) that have point impact effects (as with gene expression), or in situations in which there is only sparse temporal resolution in the observation of the trajectories. The broad objectives of the project are to exploit fractal behavior in the trajectories to improve statistical learning methodology in functional data analysis. The project will have important implications for understanding a wide variety of complex adaptive systems having fractal behavior. Studies of calorie-intake trajectories and DNA methylation profiles related to cardiovascular risk outcomes, and growth rate trajectories related to neuropsychological outcomes, will be developed as applications of the new methodology. The first specific problem to be addressed is to show that the rates of learning in systems involving trajectories with fractal characteristics are determined by the Hurst parameter (i.e., the exponent of self-similarity scaling) and to show that a type of bootstrap learning can adapt to the full range of fractal behavior. The second specific problem to be addressed is to develop an imputation method for generating missing values of trajectories that have fractal properties (e.g., growth rate curves), and to find a way to carry out functional regression modeling based on the imputed trajectories. 1      PUBLIC HEALTH RELEVANCE: The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.            The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.          ",Point Impact and Sparsity in Functional Data Analysis.,8023927,R01GM095722,"['Perinatal ', ' Famines ', ' estrophile ', ' estrogen receptor protein ', ' estrophilin ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Base Pairing ', ' Fractals ', ' Procedures ', ' Learning ', ' Data Analysis ', ' Data Analyses ', ' Clinical ', ' Genetic ', ' Collaborations ', ' Data ', ' genomewide ', ' genome-wide ', ' interest ', ' developmental ', ' Development ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Time ', ' Methods ', ' novel ', ' Testing ', ' Measurement ', ' base ', ' Outcome ', ' Public Health ', ' public health medicine (field) ', ' Articulation ', ' Joints ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Dataset ', ' Data Set ', ' Genomics ', ' Genes ', ' Goals ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Collection ', ' Affect ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Chromosomes ', ' Resolution ', ' Characteristics ', ' Address ', ' Work ', ' LOINC Axis 2 Property ', ' Property ', ' Accounting ', ' Method LOINC Axis 6 ', ' Methodology ', ' Gene Expression ', ' epidemiology study ', ' Modeling ', ' Diagnosis ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' data modeling ', ' Staging ', ' tumor ', ' Statistical Methods ', ' indexing ', ' LOINC Axis 4 System ', ' System ', ' improved ', ' response ', ' Literature ', ' Complex ', ' Position ', ' Positioning Attribute ', ' Behavior ', ' insight ', ' flexible ', ' flexibility ', ' Cancer Patient ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Public Health Applications ', ' Public Health Applications Research ', ' mammary tumor ', ' Mammary Cancer ', ' Breast Tumors ', ' Breast Neoplasms ', ' Mammary Neoplasms ', ' theories ', ' Linear Regressions ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Intake ', ' Students ', ' Disease Outcome ', ' DNA Methylation ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' neuropsychological ', ' Equation ', ' ']",NIGMS,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2011,180612,NY-13,0.055516099402627944
"A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS    DESCRIPTION (provided by applicant): Epigenetic regulation of gene expression through variation in DNA methylation plays a critical role in a range of biological processes including cellular differentiation, human disease and cancer. New methods for determining the fine structure of methylation patterns genome-wide have led to an explosion of research in this field. Methylation near the gene promoter is correlated with gene silencing, while unmethylated promoters are potentially active. Current computational methods classify genes as either methylated and silenced or unmethylated and potentially active based on a coarse calculation of CpG methylation state across a window of a few hundred base pairs around the transcription start site. The detailed spatial pattern of methylation across the promoter may be an important determinant of gene expression, but current computational methods ignore this valuable information. Recent work has found regions proximal to CpG island promoters, dubbed ""CpG island shores"", whose methylation state correlates with transcription. CpG island shores are loosely defined, however, and this concept is difficult to apply in practice. While other methylation signatures are also likely to correlate with gene expression, a general framework to identify and study them has not been established. New computational tools for identification and correlation of detailed methylation patterns with gene expression are critical for advancing our understanding of the epigenetics of gene regulation. We propose to develop software tools to detect new methylation signatures at gene promoters that correlate with expression. This will be done within a formal framework so that these signatures can be used to determine differentially methylated genes in a variety of study designs. Taking advantage of the fact  that methylation over short ranges are highly correlated, we will interpolate methylation data at individual  CpG sites in a 10 kb window around the TSS to yield a methylation signature at each promoter that is  independent of primary sequence features. We will then use a metric from topology, the discrete Frechet distance, to calculate the similarity between methylation signatures, and apply this metric to cluster signatures of similar type. We will then determine clusters with methylation signatures that correlate with expression.  Clusters that contain both silenced and expressed genes will be examined to see if other local primary sequence features can be used to discriminate the genes based on expression. This approach will be used to detect methylation changes in case-control studies and in pairwise comparisons, such as needed for timecourse analysis or for the detection of different states of differentiation. The general framework developed here can be expanded in the future to examine methylation signatures at enhancers and gene bodies, as well as to histone marks or other genomic signals that carry detailed spatial information.          Narrative  DNA methylation, the addition of a methyl group to the cytosine in CpG dinucleotides, is an important  epigenetic regulator of gene expression in cells. DNA methylation has been implicated in a large number of  biological processes including cellular differentiation and cancer. We will develop software tools to analyze  data from new techniques for mapping DNA methylation genome-wide to discover new methylation signatures  that are associated with silenced and active genes. These will include tools to use these signatures to  determine what genes are differentially regulated in different cell types and in human disease.",A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS,8229567,R21LM011199,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cells ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Explosion ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Histones ', ' In Vitro ', ' Learning ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Play ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Time ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Enhancers ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Individual ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cell type ', ' Pattern ', ' Techniques ', ' methyl group ', ' Gene Inactivation ', ' Gene Silencing ', ' Base Pairing ', ' Structure ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Metric ', ' Reporting ', ' Sampling ', ' spatial neglect ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Transcription Start Site ', ' Transcription Initiation Site ', ' Data ', ' Detection ', ' Resolution ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Process ', ' computational tools ', ' computerized tools ', ' human disease ', ' genomewide ', ' genome-wide ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2012,152000,MO-01,0.18066893328693762
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.         There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8507299,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Folate ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' Chip sequencing ', ' Chip seq ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2012,79369,NY-12,0.18616312619879408
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.         There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8326618,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Folate ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' Chip sequencing ', ' Chip seq ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2012,1219985,NY-12,0.18616312619879408
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. Project Narrative  The overarching goal of this research is to better understand the mechanisms by which  important growth regulatory genes are targeted for epigenetic silencing in human cancers.  Although the consequences of this event are the same as a mutation, there is no molecular  defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the  DNA and the histone proteins it is wrapped around that render certain genes abnormally and  permanently silent. We plan to use a computational approach to identify DNA features that put  certain genes at risk of aberrant methylation. Because genes that are silenced by methylation  are otherwise structurally sound, the potential for reactivating these genes by blocking or  reversing the methylation process represents an exciting molecular target for chemotherapeutic  intervention. A better understanding of the factors that contribute to aberrant methylation,  including the identification of sequence features that attract or repel DNA methylation, will be an  important step in achieving this long-term goal. Moreover, the ability to identify those genes at  risk of epigenetic silencing will provide novel molecular targets for further study as potential  biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8246510,R01CA132065,"['Affect ', ' Algorithms ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Alu Elements ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' cell culture ', ' Cell Culture Techniques ', ' Systematics ', ' Classification ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Deoxyribonucleic Acid ', ' DNA ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' DNA Modification Methylases ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Protein Methylation ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Play ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' Promoter Regions (Genetics) ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Publishing ', ' recruit ', ' Recruitment Activity ', ' Repression ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' sound ', ' Strikes ', ' Employee Strikes ', ' Testing ', ' Work ', ' Generations ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' Polycomb ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Susceptibility ', ' Predisposition ', ' Training ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' Transgenes ', ' Shapes ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' Cancer Induction ', ' carcinogenesis ', ' tumor suppressor ', ' Tumor Suppressor Proteins ', ' Gene Inactivation ', ' Gene Silencing ', ' treatment planning ', ' Primary Tumor ', ' Primary Neoplasm ', ' novel ', ' Coding System ', ' Code ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' cancer diagnosis ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Cancer cell line ', ' resistant ', ' Resistance ', ' tumor ', ' overexpress ', ' overexpression ', ' biomarker ', ' genomewide ', ' genome-wide ', ' Chip Chip ', ' Chip on Chip ', ' ']",NCI,EMORY UNIVERSITY,R01,2012,306133,GA-05,0.2129208956533475
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.         There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8538214,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Folate ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' Chip sequencing ', ' Chip seq ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2012,49798,NY-12,0.18616312619879408
"Point Impact and Sparsity in Functional Data Analysis.    DESCRIPTION (provided by applicant): This is a project to develop new methods of functional data analysis directed towards important public health applications in genomics and life course epidemiology. In genome-wide expression and DNA methylation studies, it is of interest to locate genes showing activity that is associated with clinical outcomes, e.g., to use gene expression profiles from the tumors of breast cancer patients to predict estrogen receptor protein concentration, an important prognostic marker for breast tumors. In such studies, the gene expression profile across a chromosome can be regarded a functional predictor, and a gene associated with the clinical outcome is identified by its base pair position along the chromosome. The key aim of the project is to develop new methods of statisti- cal inference for finding such genetic loci, leading to the identification of chromosomal regions that are potentially useful for diagnosis and therapy. Although there is extensive statistical literature on gene expression data, it is almost exclusively concerned with multiple testing procedures for detecting the presence of differentially expressed genes, and statistical methods for locating such genes based on expression profiles (interpreted as functional predictors) are not well developed. Although functional data analysis has reached a mature stage of development over the last ten years, serious problems can arise when the currently available methods are applied in situations involving functional predictors (or trajectories) that have point impact effects (as with gene expression), or in situations in which there is only sparse temporal resolution in the observation of the trajectories. The broad objectives of the project are to exploit fractal behavior in the trajectories to improve statistical learning methodology in functional data analysis. The project will have important implications for understanding a wide variety of complex adaptive systems having fractal behavior. Studies of calorie-intake trajectories and DNA methylation profiles related to cardiovascular risk outcomes, and growth rate trajectories related to neuropsychological outcomes, will be developed as applications of the new methodology. The first specific problem to be addressed is to show that the rates of learning in systems involving trajectories with fractal characteristics are determined by the Hurst parameter (i.e., the exponent of self-similarity scaling) and to show that a type of bootstrap learning can adapt to the full range of fractal behavior. The second specific problem to be addressed is to develop an imputation method for generating missing values of trajectories that have fractal properties (e.g., growth rate curves), and to find a way to carry out functional regression modeling based on the imputed trajectories. 1        The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.          ",Point Impact and Sparsity in Functional Data Analysis.,8324206,R01GM095722,"['Accounting ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Behavior ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' Chromosomes ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Famines ', ' Gene Expression ', ' Genes ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' indexing ', ' Articulation ', ' Joints ', ' Learning ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Linear Regressions ', ' Literature ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Public Health ', ' public health medicine (field) ', ' Students ', ' Testing ', ' Time ', ' Work ', ' estrophile ', ' estrogen receptor protein ', ' estrophilin ', ' Dataset ', ' Data Set ', ' base ', ' Perinatal ', ' improved ', ' Procedures ', ' Clinical ', ' Fractals ', ' insight ', ' Measurement ', ' Collaborations ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Equation ', ' Base Pairing ', ' Disease Outcome ', ' novel ', ' epidemiology study ', ' Position ', ' Positioning Attribute ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' theories ', ' Genomics ', ' Address ', ' mammary tumor ', ' Mammary Cancer ', ' Breast Tumors ', ' Breast Neoplasms ', ' Mammary Neoplasms ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Intake ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Public Health Applications ', ' Public Health Applications Research ', ' Resolution ', ' Cancer Patient ', ' Collection ', ' Characteristics ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' data modeling ', ' Outcome ', ' neuropsychological ', ' tumor ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ']",NIGMS,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2012,180612,NY-13,0.03908971408728192
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.         There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8478222,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Folate ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' deep sequencing ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' Chip sequencing ', ' Chip seq ', ' genomewide methylation ', ' genome wide methylation ', ' epigenome ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2013,1301838,NY-12,0.18616312619879408
"A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS    DESCRIPTION (provided by applicant): Epigenetic regulation of gene expression through variation in DNA methylation plays a critical role in a range of biological processes including cellular differentiation, human disease and cancer. New methods for determining the fine structure of methylation patterns genome-wide have led to an explosion of research in this field. Methylation near the gene promoter is correlated with gene silencing, while unmethylated promoters are potentially active. Current computational methods classify genes as either methylated and silenced or unmethylated and potentially active based on a coarse calculation of CpG methylation state across a window of a few hundred base pairs around the transcription start site. The detailed spatial pattern of methylation across the promoter may be an important determinant of gene expression, but current computational methods ignore this valuable information. Recent work has found regions proximal to CpG island promoters, dubbed ""CpG island shores"", whose methylation state correlates with transcription. CpG island shores are loosely defined, however, and this concept is difficult to apply in practice. While other methylation signatures are also likely to correlate with gene expression, a general framework to identify and study them has not been established. New computational tools for identification and correlation of detailed methylation patterns with gene expression are critical for advancing our understanding of the epigenetics of gene regulation. We propose to develop software tools to detect new methylation signatures at gene promoters that correlate with expression. This will be done within a formal framework so that these signatures can be used to determine differentially methylated genes in a variety of study designs. Taking advantage of the fact  that methylation over short ranges are highly correlated, we will interpolate methylation data at individual  CpG sites in a 10 kb window around the TSS to yield a methylation signature at each promoter that is  independent of primary sequence features. We will then use a metric from topology, the discrete Frechet distance, to calculate the similarity between methylation signatures, and apply this metric to cluster signatures of similar type. We will then determine clusters with methylation signatures that correlate with expression.  Clusters that contain both silenced and expressed genes will be examined to see if other local primary sequence features can be used to discriminate the genes based on expression. This approach will be used to detect methylation changes in case-control studies and in pairwise comparisons, such as needed for timecourse analysis or for the detection of different states of differentiation. The general framework developed here can be expanded in the future to examine methylation signatures at enhancers and gene bodies, as well as to histone marks or other genomic signals that carry detailed spatial information.          Narrative  DNA methylation, the addition of a methyl group to the cytosine in CpG dinucleotides, is an important  epigenetic regulator of gene expression in cells. DNA methylation has been implicated in a large number of  biological processes including cellular differentiation and cancer. We will develop software tools to analyze  data from new techniques for mapping DNA methylation genome-wide to discover new methylation signatures  that are associated with silenced and active genes. These will include tools to use these signatures to  determine what genes are differentially regulated in different cell types and in human disease.",A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS,8500440,R21LM011199,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cells ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Explosion ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Histones ', ' In Vitro ', ' Learning ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Play ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Time ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Enhancers ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Individual ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cell type ', ' Pattern ', ' Techniques ', ' methyl group ', ' Gene Inactivation ', ' Gene Silencing ', ' Base Pairing ', ' Structure ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Metric ', ' Reporting ', ' Sampling ', ' spatial neglect ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Transcription Start Site ', ' Transcription Initiation Site ', ' Data ', ' Detection ', ' Resolution ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Process ', ' computational tools ', ' computerized tools ', ' human disease ', ' genomewide ', ' genome-wide ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2013,135645,MO-01,0.18066893328693762
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. Project Narrative  The overarching goal of this research is to better understand the mechanisms by which  important growth regulatory genes are targeted for epigenetic silencing in human cancers.  Although the consequences of this event are the same as a mutation, there is no molecular  defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the  DNA and the histone proteins it is wrapped around that render certain genes abnormally and  permanently silent. We plan to use a computational approach to identify DNA features that put  certain genes at risk of aberrant methylation. Because genes that are silenced by methylation  are otherwise structurally sound, the potential for reactivating these genes by blocking or  reversing the methylation process represents an exciting molecular target for chemotherapeutic  intervention. A better understanding of the factors that contribute to aberrant methylation,  including the identification of sequence features that attract or repel DNA methylation, will be an  important step in achieving this long-term goal. Moreover, the ability to identify those genes at  risk of epigenetic silencing will provide novel molecular targets for further study as potential  biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8459567,R01CA132065,"['Affect ', ' Algorithms ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Alu Elements ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' cell culture ', ' Cell Culture Techniques ', ' Systematics ', ' Classification ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Deoxyribonucleic Acid ', ' DNA ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' DNA Modification Methylases ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Protein Methylation ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Play ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' Promoter Regions (Genetics) ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Publishing ', ' recruit ', ' Recruitment Activity ', ' Repression ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' sound ', ' Strikes ', ' Employee Strikes ', ' Testing ', ' Work ', ' Generations ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' Polycomb ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Susceptibility ', ' Predisposition ', ' Training ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' Transgenes ', ' Shapes ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' Cancer Induction ', ' carcinogenesis ', ' tumor suppressor ', ' Tumor Suppressor Proteins ', ' Gene Inactivation ', ' Gene Silencing ', ' treatment planning ', ' Primary Tumor ', ' Primary Neoplasm ', ' novel ', ' Coding System ', ' Code ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' cancer diagnosis ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Cancer cell line ', ' resistant ', ' Resistance ', ' tumor ', ' overexpress ', ' overexpression ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' Chip Chip ', ' Chip on Chip ', ' ']",NCI,EMORY UNIVERSITY,R01,2013,287765,GA-05,0.2129208956533475
"Point Impact and Sparsity in Functional Data Analysis.    DESCRIPTION (provided by applicant): This is a project to develop new methods of functional data analysis directed towards important public health applications in genomics and life course epidemiology. In genome-wide expression and DNA methylation studies, it is of interest to locate genes showing activity that is associated with clinical outcomes, e.g., to use gene expression profiles from the tumors of breast cancer patients to predict estrogen receptor protein concentration, an important prognostic marker for breast tumors. In such studies, the gene expression profile across a chromosome can be regarded a functional predictor, and a gene associated with the clinical outcome is identified by its base pair position along the chromosome. The key aim of the project is to develop new methods of statisti- cal inference for finding such genetic loci, leading to the identification of chromosomal regions that are potentially useful for diagnosis and therapy. Although there is extensive statistical literature on gene expression data, it is almost exclusively concerned with multiple testing procedures for detecting the presence of differentially expressed genes, and statistical methods for locating such genes based on expression profiles (interpreted as functional predictors) are not well developed. Although functional data analysis has reached a mature stage of development over the last ten years, serious problems can arise when the currently available methods are applied in situations involving functional predictors (or trajectories) that have point impact effects (as with gene expression), or in situations in which there is only sparse temporal resolution in the observation of the trajectories. The broad objectives of the project are to exploit fractal behavior in the trajectories to improve statistical learning methodology in functional data analysis. The project will have important implications for understanding a wide variety of complex adaptive systems having fractal behavior. Studies of calorie-intake trajectories and DNA methylation profiles related to cardiovascular risk outcomes, and growth rate trajectories related to neuropsychological outcomes, will be developed as applications of the new methodology. The first specific problem to be addressed is to show that the rates of learning in systems involving trajectories with fractal characteristics are determined by the Hurst parameter (i.e., the exponent of self-similarity scaling) and to show that a type of bootstrap learning can adapt to the full range of fractal behavior. The second specific problem to be addressed is to develop an imputation method for generating missing values of trajectories that have fractal properties (e.g., growth rate curves), and to find a way to carry out functional regression modeling based on the imputed trajectories. 1        The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.          ",Point Impact and Sparsity in Functional Data Analysis.,8505504,R01GM095722,"['Accounting ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Behavior ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' Chromosomes ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Famines ', ' Gene Expression ', ' Genes ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' indexing ', ' Articulation ', ' Joints ', ' Learning ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Linear Regressions ', ' Literature ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Public Health ', ' public health medicine (field) ', ' Students ', ' Testing ', ' Time ', ' Work ', ' estrophile ', ' estrogen receptor protein ', ' estrophilin ', ' Dataset ', ' Data Set ', ' base ', ' Perinatal ', ' improved ', ' Procedures ', ' Clinical ', ' Fractals ', ' insight ', ' Measurement ', ' Collaborations ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Equation ', ' Base Pairing ', ' Disease Outcome ', ' novel ', ' epidemiology study ', ' Position ', ' Positioning Attribute ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' theories ', ' Genomics ', ' Address ', ' mammary tumor ', ' Mammary Cancer ', ' Breast Tumors ', ' Breast Neoplasms ', ' Mammary Neoplasms ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Intake ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Public Health Applications ', ' Public Health Applications Research ', ' Resolution ', ' Cancer Patient ', ' Collection ', ' Characteristics ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' data modeling ', ' Outcome ', ' neuropsychological ', ' tumor ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ']",NIGMS,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2013,174291,NY-13,0.03908971408728192
"Systems genetic and reverse phenotypic analysis of age and retirement     DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways.         PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.            ",Systems genetic and reverse phenotypic analysis of age and retirement,8579754,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Economics ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genetic variant ', ' designing ', ' design ', ' child depression ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' public health relevance ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2013,315700,CA-33,0.024142800674905127
"Genome analysis based on the integration of DNA sequence and shape  Title: Genome analysis based on the integration of DNA sequence and shape PI: Rohs, Remo (USC); Co-I: Noble, William Stafford (UW); Co-I: Tullius, Thomas D. (BU) PROJECT SUMMARY Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription factors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.            ",Genome analysis based on the integration of DNA sequence and shape,8632246,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Relative ', ' Relative (related person) ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' genetic evolution ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' three dimensional structure ', ' computer algorithm ', ' Computational algorithm ', ' human disease ', ' public health relevance ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' Chip sequencing ', ' Chip seq ', ' Chip Chip ', ' Chip on Chip ', ' genome analysis ', ' Geometry ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2014,334303,CA-37,0.07997397140080578
"Epigenetic Transgenerational Endocrine Disruptor Actions     DESCRIPTION (provided by applicant): A number of environmental toxicants were shown in the previous grant period to promote the epigenetic transgenerational inheritance of adult onset disease including the fungicide vinclozolin, pesticides, plastics (BPA and phthalates), dioxin, hydrocarbons, and DDT. The ability of environmental compounds (e.g. endocrine disruptors) to promote transgenerational disease phenotypes is anticipated to be a critical aspect of adult onset disease etiology. The transgenerational inheritance phenotype requires the heritable epigenetic alterations of the germline. The current proposal is designed to further investigate the molecular and developmental aspects of the epigenetic transgenerational inheritance phenomenon and assess the potential use of epigenetic biomarkers for exposure and disease. The general hypothesis tested is that ""transient fetal exposure around the period of gonadal sex determination to environmental toxicants (i.e. vinclozolin) promotes the reprogramming of the epigenome (i.e. DNA methylation) of the male germline that then transmits an imprinted-like epigenome to subsequent generations to induce the epigenetic transgenerational inheritance of adult onset disease (e.g. male infertility)"". The previous grant period focused on the analysis of the epigenetic alteration in the F3 generation sperm using promoter associated differential DNA methylation regions (epimutations), as well as documented the epigenetic and transcriptome changes in the F3 generation vinclozolin lineage primordial germ cells. The molecular etiology of somatic cell changes associated with ovary and testis disease was established. The current proposal further investigates the molecular and developmental aspects of the germline mediated epigenetic transgenerational inheritance of disease. The experimental approach to test the above hypothesis consists of the following specific aims: Aim 1) Determine the developmental and generational aspects of the genome-wide germline epimutations. Aim 2) Determine the genomic features associated with the epimutations and potential genetic alterations involved in the epigenetic transgenerational inheritance phenomenon. Aim 3) Determine the optimal exposure parameters of the environmental induced transgenerational model and correlate epigenetic biomarkers with exposure and disease. Completion of the proposed research will determine the cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The proposed research will further elucidate the molecular and developmental aspects of environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.         PUBLIC HEALTH RELEVANCE: The current proposal further investigates the molecular and developmental aspects of germline mediated epigenetic transgenerational inheritance of disease. The cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes will be determined. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The epimutations are anticipated to promote genetic alterations to contribute to the transgenerational disease phenotype. Completion of the research will elucidate the molecular etiology of the environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.                ",Epigenetic Transgenerational Endocrine Disruptor Actions,8696510,R01ES012974,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' depression ', ' Mental Depression ', ' Dioxin Compound ', ' Dioxins ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Fertility/Fertilization ', ' Fertilization ', ' Genes ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Germ Cells ', ' Grant ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hydrocarbons ', ' Inbreeding ', ' Male Infertility ', ' male ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Ovary ', ' Pesticides ', ' Phenotype ', ' Plastics ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Research ', ' Safety ', ' Spermatogenesis ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' sperm cell ', ' Testing ', ' Testicles ', ' Testis ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' 3-(3,5-dichlorophenyl)-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione ', ' 2,4-oxazolidinedione, 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl- ', ' vinclozolin ', ' Generations ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' phthalates ', ' Primordial Germ Cell ', ' Structure of primordial sex cell ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' Staging ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' fungicide ', ' fungicidal ', ' Industrial fungicide ', ' Event ', ' Sequence Alteration ', ' Genetic mutation ', ' Gene Alteration ', ' DNA mutation ', ' DNA Alteration ', ' Gene Mutation ', ' hazard ', ' Somatic Cell ', ' Modeling ', ' Genomics ', ' Genome Instability ', ' Genomic Instability ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' sex determination ', ' Dose ', ' copy number variation ', ' Copy Number Polymorphism ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' intrauterine environmental exposure ', ' intra-uterine environmental exposure ', ' in utero exposure ', ' fetal exposure ', ' Perinatal Exposure ', ' Molecular ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' disease phenotype ', ' computerized ', ' designing ', ' design ', ' endocrine disrupting compound ', ' Endocrine disrupting agent ', ' Endocrine Disrupting Chemicals ', ' Endocrine Disrupter ', ' Endocrine Disruptors ', ' imprint ', ' public health relevance ', ' genomewide ', ' genome-wide ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' ']",NIEHS,WASHINGTON STATE UNIVERSITY,R01,2014,339750,WA-05,0.1892151229488621
"Systems genetic and reverse phenotypic analysis of age and retirement     DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways.         PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.            ",Systems genetic and reverse phenotypic analysis of age and retirement,8691636,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Economics ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' pediatric depression ', ' childhood depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' public health relevance ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2014,315700,CA-33,0.024142800674905127
"Epigenome Interactions in Complex Neurogenetic Disorders    DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD.         There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.         ",Epigenome Interactions in Complex Neurogenetic Disorders,8667342,R01NS076465,"['Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP (chromatin immunoprecipitation) ', ' CHIP assay ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' deep sequencing ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' Chip sequencing ', ' Chip seq ', ' genomewide methylation ', ' genome wide methylation ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' risk variant ', ' epigenome ', ' gDNA ', ' Genomic DNA ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Folate ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2014,941819,NY-12,0.18616312619879408
"Point Impact and Sparsity in Functional Data Analysis.    DESCRIPTION (provided by applicant): This is a project to develop new methods of functional data analysis directed towards important public health applications in genomics and life course epidemiology. In genome-wide expression and DNA methylation studies, it is of interest to locate genes showing activity that is associated with clinical outcomes, e.g., to use gene expression profiles from the tumors of breast cancer patients to predict estrogen receptor protein concentration, an important prognostic marker for breast tumors. In such studies, the gene expression profile across a chromosome can be regarded a functional predictor, and a gene associated with the clinical outcome is identified by its base pair position along the chromosome. The key aim of the project is to develop new methods of statisti- cal inference for finding such genetic loci, leading to the identification of chromosomal regions that are potentially useful for diagnosis and therapy. Although there is extensive statistical literature on gene expression data, it is almost exclusively concerned with multiple testing procedures for detecting the presence of differentially expressed genes, and statistical methods for locating such genes based on expression profiles (interpreted as functional predictors) are not well developed. Although functional data analysis has reached a mature stage of development over the last ten years, serious problems can arise when the currently available methods are applied in situations involving functional predictors (or trajectories) that have point impact effects (as with gene expression), or in situations in which there is only sparse temporal resolution in the observation of the trajectories. The broad objectives of the project are to exploit fractal behavior in the trajectories to improve statistical learning methodology in functional data analysis. The project will have important implications for understanding a wide variety of complex adaptive systems having fractal behavior. Studies of calorie-intake trajectories and DNA methylation profiles related to cardiovascular risk outcomes, and growth rate trajectories related to neuropsychological outcomes, will be developed as applications of the new methodology. The first specific problem to be addressed is to show that the rates of learning in systems involving trajectories with fractal characteristics are determined by the Hurst parameter (i.e., the exponent of self-similarity scaling) and to show that a type of bootstrap learning can adapt to the full range of fractal behavior. The second specific problem to be addressed is to develop an imputation method for generating missing values of trajectories that have fractal properties (e.g., growth rate curves), and to find a way to carry out functional regression modeling based on the imputed trajectories. 1        The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.          ",Point Impact and Sparsity in Functional Data Analysis.,8669009,R01GM095722,"['Accounting ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Behavior ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' Chromosomes ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Famines ', ' Gene Expression ', ' Genes ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' indexing ', ' Articulation ', ' Joints ', ' Learning ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Linear Regressions ', ' Literature ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Public Health ', ' public health medicine (field) ', ' Students ', ' Testing ', ' Time ', ' Work ', ' estrophile ', ' estrogen receptor protein ', ' estrophilin ', ' Dataset ', ' Data Set ', ' base ', ' Perinatal ', ' improved ', ' Procedures ', ' Clinical ', ' Fractals ', ' insight ', ' Measurement ', ' Collaborations ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Equation ', ' Base Pairing ', ' Disease Outcome ', ' novel ', ' epidemiology study ', ' Position ', ' Positioning Attribute ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' theories ', ' Genomics ', ' Address ', ' mammary tumor ', ' Mammary Cancer ', ' Breast Tumors ', ' Breast Neoplasms ', ' Mammary Neoplasms ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Intake ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Public Health Applications ', ' Public Health Applications Research ', ' Resolution ', ' Cancer Patient ', ' Collection ', ' Characteristics ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' data modeling ', ' Outcome ', ' neuropsychological ', ' tumor ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ']",NIGMS,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2014,180612,NY-13,0.03908971408728192
"Epigenome Interactions in Complex Neurogenetic Disorders DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD. There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.",Epigenome Interactions in Complex Neurogenetic Disorders,8860253,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP assay ', ' ChIP (chromatin immunoprecipitation) ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' deep sequencing ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' ChIP Sequencing ', ' ChIP-seq ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' genomewide methylation ', ' genome wide methylation ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' epigenome ', ' gDNA ', ' Genomic DNA ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2015,877497,NY-12,0.18616312619879408
"Epigenome Interactions in Complex Neurogenetic Disorders DESCRIPTION (provided by applicant):  Modifications of DNA and chromatin impact the accessibility of the genetic code to the biological machinery of the cell. Relating epigenomic changes to neurodevelopmental disorders has been challenging. One obstacle is the need to study the relevant tissues at an appropriate stage of the disease process, while another is the difficulty of understanding the relationship of nucleotide and chromatin modifications to complex genetic disorders in which multiple loci interactions underlie expression of the disease. We propose to take advantage of a disorder, neural tube defects (NTDs), in which the existing mouse models closely parallel the human disease and in which several lines of evidence indicate a strong influence in both mouse and man of epigenetic modifications regulating disease expression. We will combine proof of principle studies in the mouse with investigations of human NTD cohorts to examine the relationship between DNA/chromatin methylation and the expressivity of NTDs in genetically susceptible individuals.  The study of epigenetic events contributing to NTDs has multiple distinct advantages over epigenomic investigation of other human diseases, as more than 200 genes are implicated in NTDs by human or animal studies. These provide critical clues to molecular pathways important for normal neurulation. Supporting the existing clinical data, we discovered several NTD-prone mouse mutant lines in which NTD occurrence is sensitive to folic acid supplementation. Folate metabolism is the source of al S-adenosyl methoinine (SAM), which is the primary methyl donor for methylating nucleic acids, proteins and lipids. Providing methyl donors is thought to be a major route through which folate supplementation exerts its beneficial effects on neurulation. We will use cutting edge and emerging technologies applied to mouse and human patient material to interrogate genome wide methylation and chromatin remodeling interactions, correlated with individual genotype, to examine epigenetic effects on the transcriptome and on phenotypic outcome.  This proposal tests the hypothesis that epigenetic modifications in DNA and chromatin in the setting of prenatal supplementation that modulates DNA and chromatin methylation will impact a recognizable pattern of gene expression to either favor or impair neurulation in a manner that can be predicted based on individual genotype. Moreover, we hypothesize that certain patterns will be evident not only in the developing neural tube but also in the peripheral blood and so will be useful in evaluating risk and optimal NTD prevention in a clinical setting. We predict that some DNA and chromatin methylation signatures acquired in utero wil persist postnatally, regardless of whether supplementation continues after birth. Finally, we expect that DNA methylation patterns found in mouse will be present as well-at least at the level of pathways if not individual genes-in human patients affected by an NTD. There is a critical need to identify patterns of human genetic--modified by epigenetic--variation that will allow individual risks to be accurately assessed. This would enable NTD prevention strategies to be optimized for each family, rather than basing recommendations on whole populations. With our food supply now fortified, folic acid has become the most widely administered medicinal agent in the US today. Therefore, this study will also have broad relevance to human disorders in which folate intake has an implicated role, including major depression, autism, Alzheimer's disease, among others.",Epigenome Interactions in Complex Neurogenetic Disorders,8994456,R01NS076465,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Animals ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' betaine compound ', ' Oxyneurine ', ' Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt ', ' Lycine ', ' Glycine Betaine ', ' Betaine ', ' Parturition ', ' Birth ', ' Blood Reticuloendothelial System ', ' Blood ', ' C element ', ' Carbon ', ' Cells ', ' Chromatin ', ' dietary ', ' Diet ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Embryonic ', ' Embryo ', ' Family ', ' vitamin Bc ', ' Vitamin M ', ' Pteroylglutamic Acid ', ' N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid ', ' Folic Acid ', ' Food Supply ', ' Enriched Food ', ' Fortified Food ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genetics ', ' Infant ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Lipids ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' L-Methionine ', ' L-Isomer Methionine ', ' Methionine ', ' Protein Methylation ', ' Methylation ', ' mouse mutant ', ' Mutant Strains Mice ', ' Genetic Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Neural Tube Developmental Defects ', ' Neural Tube Defects ', ' Nucleic Acids ', ' Nucleotides ', ' Patients ', ' Phenotype ', ' Pregnant Women ', ' gene product ', ' Proteins ', ' Recommendation ', ' Risk ', ' Splicing ', ' RNA Splicing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Strikes ', ' Employee Strikes ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Work ', ' methotrexate-binding protein ', ' folic acid receptor ', ' folic acid binding protein ', ' folate-methotrexate transporter ', ' folate receptor ', ' folate carrier ', ' folate-binding protein ', ' rachischisis posterior ', ' hydrocele spinalis ', ' cleft spine ', ' Spinal Dysraphia ', ' Spina Bifida ', ' Schistorrhachis ', ' Spinal Dysraphism ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' RNA Sequences ', ' base ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Ensure ', ' peripheral blood ', ' Neural tube ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' Individual ', ' Metabolic ', ' Spottings ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Investigation ', ' Complex ', ' Dependence ', ' Event ', ' Source ', ' Route ', ' Pattern ', ' neurogenetics ', ' Receptor Protein ', ' receptor ', ' cohort ', ' Long Interspersed DNA Sequence Elements ', ' LINE Repeat Sequences ', ' Long Interspersed Nucleotide Elements ', ' unborn ', ' prenatal ', ' Preventive strategy ', ' Prevention strategy ', ' mate ', ' Partner in relationship ', ' Prevention ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Embryonic Tissue ', ' embryo tissue ', ' chromatin modification ', ' chromatin remodeling ', ' Folic Acid Metabolosm ', ' Folate Metabolism ', ' folic acid metabolism ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' major depression ', ' Major Depressive Disorder ', ' Metabolic Pathway ', ' ChIP assay ', ' ChIP (chromatin immunoprecipitation) ', ' chromatin immunoprecipitation ', ' Data ', ' Detection ', ' Intake ', ' Supplementation ', ' Cancer Biology ', ' Clinical Data ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' Modification ', ' Neural Tube Closure ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' pathway ', ' Pathway interactions ', ' in utero ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' deep sequencing ', ' epigenomics ', ' neonate ', ' Outcome ', ' Neonatal ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" man's "", ' man ', ' human disease ', ' mouse model ', ' loss of function ', ' stem ', ' epigenetic variation ', ' fortification ', ' standard of care ', ' genomewide ', ' genome-wide ', ' arm ', ' ChIP Sequencing ', ' ChIP-seq ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' genomewide methylation ', ' genome wide methylation ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' epigenome ', ' gDNA ', ' Genomic DNA ', ' ']",NINDS,WEILL MEDICAL COLL OF CORNELL UNIV,R01,2015,100000,NY-12,0.18616312619879408
"Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes     DESCRIPTION (provided by applicant): Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal blood disorders characterized by ineffective hematopoiesis that can lead to bone marrow failure and progression to acute myeloid leukemia (AML). Aberrant DNA hypermethylation is characteristic of this disorder and, as such, DNA methyltransferase inhibitors (DMTis) are often used to treat MDS in lieu of conventional chemotherapies that have proven to be ineffective for this disease. However, even with DMTi therapy, only about one third of MDS patients achieve a clinical response leading to a survival benefit. Moreover, current DMTi-based regimens for MDS require a minimum of 6 months of treatment before a patient can be deemed resistant to this therapy. Given that only ~30-40% of patients respond to this treatment, the majority of patients will spend 6 months receiving a therapy to which they are unlikely to respond. Therefore, the identification of molecular differences that distinguish between sensitive and resistant patients at the time of diagnosis is critical in order to harness these differences for the development of molecular biomarkers predictive of DMTi response. These biomarkers would allow us to more accurately risk-stratify these patients and prevent unwarranted and ineffective therapy for resistant patients. Using next-generation sequencing technology we performed genome-wide DNA methylation, gene expression and mutational analysis on a cohort of patients with chronic myelomonocytic leukemia (CMML), an MDS/MPN overlap syndrome, including both sensitive and resistant patients to the DMTi Decitabine (DAC). We found that robust epigenetic and gene expression differences exist between DMTi responders and non-responders. From these differences, we were able to develop an epigenetic classifier that predicts response to decitabine therapy in these patients with 87% accuracy. Moreover, using RNA-seq we identified a gene expression signature associated with primary resistance to DAC in CMML. Based on these data, we hypothesize that comparable differences are likely to be found in MDS patients who are either sensitive or resistant to the DMTi Azacytidine (AZA), and that these too have the potential to be used as the basis of a molecular classifier of response as well as to identify mechanisms of primary resistance to the drug. We propose to perform genome-wide studies DNA methylation and expression studies in a cohort of 250 MDS patients treated with AZA in order to identify DNA methylation and expression biomarkers predictive of response to this agent in MDS. From these studies, we expect to be able to develop clinically useful biomarkers that can be translated to CLIA-compatible technologies that can be applied in molecular diagnostics labs.         PUBLIC HEALTH RELEVANCE: Myelodysplastic syndromes (MDS) are the most common hematological disorder of the elderly. To date, the only effective therapies are the DNA methyltransferase inhibitors (Azacytidine and Decitabine), but even with this therapy, approximately 60% of patients do not respond. Currently there are no accurate molecular biomarkers that may help risk-stratify patients at the time of diagnosis, and therefore a vast majority of patients are forced to receive up to 6 months of Azacytidine before they can be offered alternative therapies. Moreover, it is unclear why some patients respond while others don't. Therefore, it is of the utmost urgency that we develop more accurate ways of risk-stratifying patients at the time of diagnosis in order to prevent the unwarranted treatment of a large fraction of patients who are unlikely to ever respond to these agents as well as to identify novel alternative therapeutic targets.            ",Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,8979977,R01HL126947,"['Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Algorithms ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one ', ' Azacitidine ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Bone Marrow Reticuloendothelial System ', ' Bone Marrow ', ' Systematics ', ' Classification ', ' cytopenia ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Exons ', ' Gene Expression ', ' Genes ', ' Genome ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' Intervening Sequences ', ' Introns ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Leukemia, Myelocytic, Acute ', ' Leukemia, Myelomonocytic, Chronic ', ' myelodysplasia ', ' Smoldering Leukemia ', ' Myelodysplastic Syndromes ', ' Dysmyelopoietic Syndromes ', ' Bone marrow failure ', ' Pancytopenia ', ' Patients ', ' Play ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' Promoter Regions (Genetics) ', ' genetic regulatory element ', ' Regulatory Regions, Nucleic Acid (Genetics) ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' Risk ', ' social role ', ' Role ', ' Syndrome ', ' Technology ', ' Time ', ' Translating ', ' Dezocitidine ', ' Deoxyazacytidine ', ' 5-deoxyazacytidine ', ' 5-Azadeoxycytidine ', ' 5-Aza-2-deoxycytidine ', "" 5-Aza-2'deoxycytidine/Decitabine "", "" 2'-Deoxy-5-azacytidine "", ' Decitabine ', ' Enhancers ', ' base ', ' Distal ', ' Clinical ', ' peripheral blood ', ' CpG-Rich Islands ', ' CpG Islands ', ' Therapeutic ', ' Diagnostic ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Disorder Management ', ' Disease Management ', ' cancer chemotherapy ', ' Quimioterapia ', ' Combination Chemotherapy Regimen ', ' Chemotherapy, Cancer, General ', ' Chemotherapy Regimen ', ' Chemotherapy Protocol ', ' Chemotherapy-Oncologic Procedure ', ' cohort ', ' novel ', ' response ', ' Genomics ', ' Alternative Therapies ', ' preventing ', ' prevent ', ' Ineffective Hematopoiesis ', ' b-TG1 ', ' THBGB1 ', ' THBGB ', ' TGB1 ', ' SCYB7 ', ' NAP-2-L1 ', ' LA-PF4 ', ' CXCL7 ', ' CTAPIII ', ' CTAP3 ', ' PPBP gene ', ' DNA Methyltransferase Inhibitor ', ' Data ', ' Hypermethylation ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' in vivo ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' next generation ', ' resistant ', ' Resistance ', ' chemotherapy ', ' therapeutic target ', ' genome-wide analysis ', ' overexpress ', ' overexpression ', ' public health relevance ', ' effective treatment ', ' effective therapy ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' Regimen ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Massive Parallel Sequencing ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2015,404125,MI-12,0.16249167426461603
"Epigenetic Transgenerational Endocrine Disruptor Actions DESCRIPTION (provided by applicant): A number of environmental toxicants were shown in the previous grant period to promote the epigenetic transgenerational inheritance of adult onset disease including the fungicide vinclozolin, pesticides, plastics (BPA and phthalates), dioxin, hydrocarbons, and DDT. The ability of environmental compounds (e.g. endocrine disruptors) to promote transgenerational disease phenotypes is anticipated to be a critical aspect of adult onset disease etiology. The transgenerational inheritance phenotype requires the heritable epigenetic alterations of the germline. The current proposal is designed to further investigate the molecular and developmental aspects of the epigenetic transgenerational inheritance phenomenon and assess the potential use of epigenetic biomarkers for exposure and disease. The general hypothesis tested is that ""transient fetal exposure around the period of gonadal sex determination to environmental toxicants (i.e. vinclozolin) promotes the reprogramming of the epigenome (i.e. DNA methylation) of the male germline that then transmits an imprinted-like epigenome to subsequent generations to induce the epigenetic transgenerational inheritance of adult onset disease (e.g. male infertility)"". The previous grant period focused on the analysis of the epigenetic alteration in the F3 generation sperm using promoter associated differential DNA methylation regions (epimutations), as well as documented the epigenetic and transcriptome changes in the F3 generation vinclozolin lineage primordial germ cells. The molecular etiology of somatic cell changes associated with ovary and testis disease was established. The current proposal further investigates the molecular and developmental aspects of the germline mediated epigenetic transgenerational inheritance of disease. The experimental approach to test the above hypothesis consists of the following specific aims: Aim 1) Determine the developmental and generational aspects of the genome-wide germline epimutations. Aim 2) Determine the genomic features associated with the epimutations and potential genetic alterations involved in the epigenetic transgenerational inheritance phenomenon. Aim 3) Determine the optimal exposure parameters of the environmental induced transgenerational model and correlate epigenetic biomarkers with exposure and disease. Completion of the proposed research will determine the cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The proposed research will further elucidate the molecular and developmental aspects of environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease. PUBLIC HEALTH RELEVANCE: The current proposal further investigates the molecular and developmental aspects of germline mediated epigenetic transgenerational inheritance of disease. The cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes will be determined. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The epimutations are anticipated to promote genetic alterations to contribute to the transgenerational disease phenotype. Completion of the research will elucidate the molecular etiology of the environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.",Epigenetic Transgenerational Endocrine Disruptor Actions,8845554,R01ES012974,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' depression ', ' Mental Depression ', ' Dioxin Compound ', ' Dioxins ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Fertility/Fertilization ', ' Fertilization ', ' Genes ', ' Germ Cells ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Grant ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hydrocarbons ', ' Inbreeding ', ' Male Infertility ', ' male ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Ovary ', ' Pesticides ', ' Phenotype ', ' Plastics ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Research ', ' Safety ', ' Spermatogenesis ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' sperm cell ', ' Testing ', ' Testicles ', ' Testis ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' 3-(3,5-dichlorophenyl)-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione ', ' 2,4-oxazolidinedione, 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl- ', ' vinclozolin ', ' Generations ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' phthalates ', ' Primordial Germ Cell ', ' Structure of primordial sex cell ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' Staging ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' fungicide ', ' fungicidal ', ' Industrial fungicide ', ' Event ', ' hazard ', ' Somatic Cell ', ' Modeling ', ' Genomics ', ' Genome Instability ', ' Genomic Instability ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' sex determination ', ' Dose ', ' copy number variation ', ' Copy Number Polymorphism ', ' DNA Sequence Alteration ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' intrauterine environmental exposure ', ' intra-uterine environmental exposure ', ' in utero exposure ', ' fetal exposure ', ' Perinatal Exposure ', ' Molecular ', ' developmental ', ' Development ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' disease phenotype ', ' computerized ', ' designing ', ' design ', ' endocrine disrupting compound ', ' Endocrine disrupting agent ', ' Endocrine Disrupting Chemicals ', ' Endocrine Disrupter ', ' Endocrine Disruptors ', ' imprint ', ' genomewide ', ' genome-wide ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' ']",NIEHS,WASHINGTON STATE UNIVERSITY,R01,2015,339750,WA-05,0.1892151229488621
"Genetic and epigenetic contributions to Sjogren's syndrome     DESCRIPTION (provided by applicant): High throughput whole genome platforms to quantitatively and efficiently assay human DNA methylation provide an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). Epigenetic modifications, such as methylation of the 5' carbon of cytosine which occurs in the context of CpG dinucleotides, do not affect the genetic sequence; however, they do play a critical role in transcriptional regulation of a gene and subsequent gene expression. We have applied this technology, in conjunction with whole genome SNP genotyping to a clinically well-characterized collection of SS cases and controls developed specifically for genetic and epigenetic studies. Samples from the Sjogren's International Collaborative Clinical Alliance (SICCA) repository (total n=3,500 individuals) will b utilized, given the careful phenotype characterization and standardized collection of biospecimens that has been performed for each participant. For this proposal, we have initially obtained DNA from peripheral blood mononuclear cells (PBMCs) and sorted cell populations with high purity, including CD14+ monocytes, CD19+ B cells, CD4+ T cells, as well as labial salivary gland biopsy tissue from 120 SICCA participants (100 SS cases and 20 controls). Data collected for ~450,000 highly informative CpG sites spanning 22,000 genes across the genome will provide a comprehensive assessment of DNA methylation for each individual for our proposed study Aims. As part of Aim 1, DNA methylation profiles will be examined using three main approaches: 1) Global DNA methylation profiles will be analyzed for association with SS risk in all sample types; 2) Multidimensional scaling analysis (MDS) and principal components analysis (PCA) will be performed to determine whether SS case samples can be distinguished from control samples; and 3) Local analyses will also be performed and will focus specifically on DNA methylation changes within candidate SS genes and genes demonstrating at least 1.5 fold methylation differences between cases and controls. Our proposal will take advantage of available whole genome data for each study participant and results from the largest genome wide association study (GWAS) in SS. In Aim 2, we will utilize DNA methylation profiles and methods from Aim 1 to determine whether important SS case phenotypes can be distinguished from one another. We will identify top ranked CpG sites that are either hypo or hyper methylated in specific SS case groups or that distinguish cases from controls using supervised machine learning algorithms. We will attempt replication for all top findings in an independent dataset, followed by random effects meta-analysis to incorporate other SS risk factors. Finally, we will determine whether DNA methylation profiles of interest from Aims 1 and 2 can be detected in DNA from whole blood for potential use as a biomarker. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of different cell and tissue types and genetic background have the potential to significantly transform our understanding of SS etiology.         PUBLIC HEALTH RELEVANCE New molecular genetic assays offer an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). We propose to perform a comprehensive screen of more than 450,000 highly informative CpG sites spanning 22,000 genes across the genome using DNA derived from peripheral blood mononuclear cells (PBMCs), sorted cell populations, and labial salivary gland biopsy tissue from SS cases and control individuals to identify epigenetic profiles that are predictive of disease risk and specifi clinical phenotypes. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of several different cell and tissue types and whole genome SNP data have the potential to significantly transform our understanding of SS etiology, and may lead to more effective approaches to prevention, diagnosis and treatment.                ",Genetic and epigenetic contributions to Sjogren's syndrome,8829521,R03DE024316,"['Affect ', ' Algorithms ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' self recognition (immune) ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' Budgets ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cells ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' Patients ', ' Phenotype ', ' Play ', ' Production ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' helper T cell ', ' T4 Lymphocytes ', ' T4 Cells ', ' CD4-Positive Lymphocytes ', ' CD4+ T-Lymphocyte ', ' CD4+ T cell ', ' CD4 lymphocyte ', ' CD4 T cells ', ' CD4 Cells ', ' CD4 Positive T Lymphocytes ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' T-Cell Subsets ', ' T-Lymphocyte Subsets ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Site ', ' Clinical ', ' Individual ', ' European ', ' Sample Size ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Complex ', ' Oral ', ' cell type ', ' Country ', ' interest ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' member ', ' Study Subject ', ' disease risk ', ' disorder risk ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Labial Salivary Gland ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' CD14 ', ' CD14 gene ', ' CD19 ', ' CD19 gene ', ' Data ', ' International ', ' National Institute of Dental Research ', ' NIDR ', ' NIDCR ', ' National Institute of Dental and Craniofacial Research ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' clinical phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' SNP genotyping ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' human DNA ', ' systemic autoimmune disorder ', ' systemic autoimmune disease ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2015,236912,CA-12,0.24948135085799042
"Systems genetic and reverse phenotypic analysis of age and retirement DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways. PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.",Systems genetic and reverse phenotypic analysis of age and retirement,8882214,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Genome Scan ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' pediatric depression ', ' childhood depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2015,306229,CA-33,0.024142800674905127
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,8910299,F31DE025176,"['epigenome ', ' abstracting ', ' Affect ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' self recognition (immune) ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cells ', ' Systematics ', ' Classification ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Systemic Lupus Erythematosus ', ' Mentors ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Salivary Glands Head and Neck ', ' Salivary Glands ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Body Tissues ', ' Tissues ', ' trans acting factor (genetic) ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' transcription factor ', ' Woman ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Dataset ', ' Data Set ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Inflammatory ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Country ', ' disease severity ', ' Severity of illness ', ' QTL ', ' Quantitative Trait Loci ', ' novel ', ' Participant ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' International ', ' F31 Award ', ' Predoctoral Individual National Research Service Award ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' epigenetic variation ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' ChIP Sequencing ', ' ChIP-seq ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2015,38673,CA-13,0.25484849194085496
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,8795204,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Expression Regulation ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Genome ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Relative ', ' Relative (related person) ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Untranslated RNA ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' three dimensional structure ', ' computer algorithm ', ' Computational algorithm ', ' human disease ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ChIP Sequencing ', ' ChIP-seq ', ' ChIP-chip ', ' ChIP-on-chip ', ' genome analysis ', ' Geometry ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2015,304719,CA-37,0.08022166356058046
"DNA Sequencing Using Single Molecule Electronics PROJECT SUMMARY / ABSTRACT  Progress in DNA sequencing has occurred through multiple stages of disruptive new technologies being introduced to the field, each of which has increased sequencing capabilities by lowering costs, improving throughput, and reducing errors. The goal of this research project is to investigate a new, all-electronic sequencing method that has the potential to become the next transformative step for DNA sequencing. This new method is based on single DNA polymerase molecules bound to nanoscale electronic transistors, a hybrid device that transduces the activity of a single polymerase molecule into an electronic signal.  The goal of this research project is to determine whether these hybrid polymerase-transistors are truly applicable to DNA sequencing and the competitive environment of advanced sequencing technologies. To answer this question, the project teams the scientists who have developed the devices with Illumina, Inc., a worldwide leader in the DNA sequencing market. The experiments proposed here build on encouraging preliminary results, first to demonstrate accurate DNA sequencing and second to evaluate whether the new technique could become a competitive challenge to other sequencing methods. The interdisciplinary team will combine state-of-the-art techniques from protein engineering, nanoscale fabrication, and machine learning to customize polymerase's activity and its interactions with the electronic transistors. If successful, nanoscale solid-state devices like transistors provide one of the best opportunities for increasing sequencing capabilities while decreasing sequencing costs, so that DNA sequencing can become a standard technique in health care and disease treatment. PROJECT NARRATIVE  Over the past two decades, DNA sequencing has transformed from a heroic, nearly impossible task to a routine component of modern laboratory research. The field of DNA sequencing has improved tremendously through a strategy of modifying and monitoring polymerases, a key enzyme at the heart of many DNA sequencing technologies. This proposal is motivated by developments in the field of single-molecule electronics, which provide an entirely new mode for listening to the activity of single polymerase molecules. This electronic method is very different from the biochemical, optical, or nanopore-based techniques currently in use, and it has inherent advantages that could provide exciting possibilities for DNA sequencing. The project will tailor single-molecule electronics for the specific purpose of DNA sequencing and determine whether this strategy could lead to a new generation of sequencing technology.",DNA Sequencing Using Single Molecule Electronics,9172062,R01HG009188,"['Affect ', ' C element ', ' Carbon ', ' Charge ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Dependent DNA Polymerases ', ' DNA Polymerases ', ' DNA-Directed DNA Polymerase ', ' Single-Stranded DNA ', ' electronic device ', ' Electronics ', ' Enzyme Gene ', ' Enzymes ', ' Foundations ', ' Goals ', ' Heart ', ' Hybrids ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Marketing ', ' Methods ', ' Molecular Models ', ' Motion ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Noise ', ' Nucleotides ', ' optical ', ' Optics ', ' protein design ', ' genetic protein engineering ', ' Protein Engineering ', ' Proteins ', ' Publishing ', ' Reading ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' Temperature ', ' Transistors ', ' Work ', ' Generations ', ' Healthcare ', ' health care ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Surface ', ' Variation ', ' Variant ', ' Biochemical ', ' Individual ', ' enzyme activity ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Scientist ', ' Event ', ' Route ', ' Techniques ', ' System ', ' Performance ', ' solid state ', ' Molecular Modeling Protein/Amino Acid Biochemistry ', ' Molecular Modeling Nucleic Acid Biochemistry ', ' molecular modeling ', ' Base Pairing ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' novel technologies ', ' new technology ', ' Modality ', ' Devices ', ' response ', ' nanotechnological ', ' nanotech ', ' nano-technological ', ' nano technology ', ' nano tech ', ' Nanotechnology ', ' single molecule ', ' Molecular Interaction ', ' Binding ', ' Polymerase ', ' Data ', ' Resolution ', ' Enzyme Kinetics ', ' Monitor ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' cost ', ' nano electronics ', ' nanoelectronics ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanoscale ', ' nano pore ', ' nanopore ', ' single walled carbon nano tube ', ' SWNT ', ' single walled carbon nanotube ', ' scale up ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' collaborative environment ', ' workplace environment ', ' workplace climate ', ' work environment ', ' supportive environment ', ' peer-group environment ', ' job environment ', ' interdisciplinary environment ', ' interactive environment ', ' informal environment ', ' enthusiastic environment ', ' competitive environment ', ' business-friendly environment ', ' Health Care Research ', ' healthcare research ', ' ']",NHGRI,UNIVERSITY OF CALIFORNIA-IRVINE,R01,2016,584552,CA-45,0.06306426354659805
"Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes     DESCRIPTION (provided by applicant): Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal blood disorders characterized by ineffective hematopoiesis that can lead to bone marrow failure and progression to acute myeloid leukemia (AML). Aberrant DNA hypermethylation is characteristic of this disorder and, as such, DNA methyltransferase inhibitors (DMTis) are often used to treat MDS in lieu of conventional chemotherapies that have proven to be ineffective for this disease. However, even with DMTi therapy, only about one third of MDS patients achieve a clinical response leading to a survival benefit. Moreover, current DMTi-based regimens for MDS require a minimum of 6 months of treatment before a patient can be deemed resistant to this therapy. Given that only ~30-40% of patients respond to this treatment, the majority of patients will spend 6 months receiving a therapy to which they are unlikely to respond. Therefore, the identification of molecular differences that distinguish between sensitive and resistant patients at the time of diagnosis is critical in order to harness these differences for the development of molecular biomarkers predictive of DMTi response. These biomarkers would allow us to more accurately risk-stratify these patients and prevent unwarranted and ineffective therapy for resistant patients. Using next-generation sequencing technology we performed genome-wide DNA methylation, gene expression and mutational analysis on a cohort of patients with chronic myelomonocytic leukemia (CMML), an MDS/MPN overlap syndrome, including both sensitive and resistant patients to the DMTi Decitabine (DAC). We found that robust epigenetic and gene expression differences exist between DMTi responders and non-responders. From these differences, we were able to develop an epigenetic classifier that predicts response to decitabine therapy in these patients with 87% accuracy. Moreover, using RNA-seq we identified a gene expression signature associated with primary resistance to DAC in CMML. Based on these data, we hypothesize that comparable differences are likely to be found in MDS patients who are either sensitive or resistant to the DMTi Azacytidine (AZA), and that these too have the potential to be used as the basis of a molecular classifier of response as well as to identify mechanisms of primary resistance to the drug. We propose to perform genome-wide studies DNA methylation and expression studies in a cohort of 250 MDS patients treated with AZA in order to identify DNA methylation and expression biomarkers predictive of response to this agent in MDS. From these studies, we expect to be able to develop clinically useful biomarkers that can be translated to CLIA-compatible technologies that can be applied in molecular diagnostics labs. PUBLIC HEALTH RELEVANCE: Myelodysplastic syndromes (MDS) are the most common hematological disorder of the elderly. To date, the only effective therapies are the DNA methyltransferase inhibitors (Azacytidine and Decitabine), but even with this therapy, approximately 60% of patients do not respond. Currently there are no accurate molecular biomarkers that may help risk-stratify patients at the time of diagnosis, and therefore a vast majority of patients are forced to receive up to 6 months of Azacytidine before they can be offered alternative therapies. Moreover, it is unclear why some patients respond while others don't. Therefore, it is of the utmost urgency that we develop more accurate ways of risk-stratifying patients at the time of diagnosis in order to prevent the unwarranted treatment of a large fraction of patients who are unlikely to ever respond to these agents as well as to identify novel alternative therapeutic targets.",Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,9099915,R01HL126947,"['Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Algorithms ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' Azacitidine ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Bone Marrow Reticuloendothelial System ', ' Bone Marrow ', ' Systematics ', ' Classification ', ' cytopenia ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Exons ', ' Gene Expression ', ' Genes ', ' Genome ', ' Health ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' Intervening Sequences ', ' Introns ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myelocytic Leukemia ', ' Chronic Myelomonocytic Leukemia ', ' myelodysplasia ', ' Smoldering Leukemia ', ' Myelodysplastic Syndromes ', ' Dysmyelopoietic Syndromes ', ' Bone marrow failure ', ' Pancytopenia ', ' Patients ', ' Play ', ' genetic promoter element ', ' Promotor Regions ', ' Promoter Regions ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' Risk ', ' social role ', ' Role ', ' Syndrome ', ' Technology ', ' Time ', ' Translating ', ' Decitabine ', ' Dezocitidine ', ' Deoxyazacytidine ', ' 5-deoxyazacytidine ', ' 5-Azadeoxycytidine ', ' Enhancers ', ' base ', ' Distal ', ' Clinical ', ' peripheral blood ', ' CpG-Rich Islands ', ' CpG Islands ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Disorder Management ', ' Disease Management ', ' cancer chemotherapy ', ' Quimioterapia ', ' Combination Chemotherapy Regimen ', ' Chemotherapy, Cancer, General ', ' Chemotherapy Regimen ', ' Chemotherapy Protocol ', ' Chemotherapy-Oncologic Procedure ', ' cohort ', ' novel ', ' response ', ' Genomics ', ' Alternative Therapies ', ' preventing ', ' prevent ', ' Ineffective Hematopoiesis ', ' -Thromboglobulin ', ' -TG ', ' beta-Thromboglobulin ', ' Thromboglobulin, Beta-1 ', ' Thrombocidin 2 ', ' Thrombocidin 1 ', ' TGB1 ', ' TC2 ', ' TC1 ', ' Small Inducible Cytokine Subfamily B, Member 7 ', ' SCYB7 ', ' Pro-Platelet Basic Protein ', ' Platelet Basic Protein ', ' PPBP ', ' PBP protein ', ' PBP gene ', ' Neutrophil-Activating Peptide 2 ', ' NAP2 ', ' NAP-2 ', ' LA-PF4 ', ' Connective Tissue-Activating Peptide III ', ' CXCL7 ', ' CXC Chemokine Ligand 7 ', ' CTAPIII ', ' CTAP3 ', ' CTAP III ', ' Beta-TG ', ' PPBP gene ', ' DNA Methyltransferase Inhibitor ', ' Data ', ' Hypermethylation ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Molecular Profiling ', ' in vivo ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' Gene Expression Profile ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' next generation ', ' Resistance ', ' resistant ', ' chemotherapy ', ' therapeutic target ', ' genome-wide analysis ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide analysis ', ' overexpression ', ' overexpress ', ' over-expression ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' effective therapy ', ' effective treatment ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' Regimen ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' methylation biomarker ', ' methylation marker ', ' bisulfite sequencing ', ' bisulfite-seq ', ' BS-seq ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' patient stratification ', ' stratified patient ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' responders and non-responders ', ' responders vs non-responders ', ' responders versus non-responders ', ' responders or non-responders ', ' responders from non-responders ', ' unnecessary treatment ', ' molecular diagnostics ', ' ineffective therapies ', ' ineffective treatment ', ' ']",NHLBI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2016,390375,MI-12,0.16249167426461603
"Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood Several million units of donor platelets are transfused annually in the US and Europe to treat patients undergoing radiation treatment, chemotherapy, or organ transplant surgery. Although transfusions of donor- derived platelets are an effective way to treat thrombocytopenic patients, numerous concerns have been raised due to the increase in demand, the five-day shelf-life, and the possibilities for contamination. Platelets are produced by megakaryocytes (MKs) in the bone marrow and are derived from hematopoietic stem and progenitor cells (HSPCs). The long-term objective of this proposal is to generate platelets ex vivo from HSPC- enriched umbilical cord blood that will allow us to address a vast public need. Recent studies have shown that the addition of histone deacetylase inhibitors (HDACi) can greatly affect expansion of progenitor cells, but can reduce MK differentiation efficiency. My central hypothesis is that epigenetic and transcriptional changes prime or desensitize HSPC to MK differentiation cues. To investigate the role of epigenetic signals during HSPC-to- MK transition, I propose to perform high-throughput ChIP and RNA-sequencing to discover differentially active regulatory elements between expanded (low potential) and fresh cord blood HSPCs. This highly interdisciplinary and collaborative proposal utilizes computational biology and machine-learning to identify differentially active regulatory elements, and associate genetic features with MK fate. To validate my findings and establish a causal relationship between histone modifications of certain regions and MK potential, I will generate a dCas9-fusion protein that can directly manipulate the epigenetic marker at a targeted site. My findings will establish the mechanism of action of chromatin-modifying agents such as HDACi, and the causal relationship between the epigenome and MK differentiation. My highly collaborative proposal with the Miller, Bagheri, and Mahmud lab will substantially enhance our understanding of hematopoietic differentiation toward manufacturing platelets. Project Narrative More than two million platelet units from donors are used to treat patients undergoing surgery or chemotherapy every year, but short shelf-life, increasing demand, and risk of contamination keep platelets in strained supply. In my proposed study, I will apply a panel of small molecules to expand and differentiate hematopoietic stem and progenitor cells from umbilical cord blood into platelet-producing cells. My work will identify the role of epigenetic modifications during the culture process, and elucidate new strategies to efficiently manufacture platelets from culture.",Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood,9195237,F31HL134331,"['Acetylation ', ' Affect ', ' Algorithms ', '  Tubulin ', ' alpha Tubulin ', ' inhibitor ', ' inhibitor/antagonist ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' Azacitidine ', ' Peripheral Blood Cell ', ' Blood Cells ', ' thrombocyte/platelet ', ' Thrombocytes ', ' Platelets Reticuloendothelial System ', ' Platelets ', ' Marrow platelet ', "" Hayem's elementary corpuscle "", "" Deetjeen's body "", "" Bizzozero's corpuscle/cell "", ' Blood Platelets ', ' Bone Marrow Reticuloendothelial System ', ' Bone Marrow ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Systematics ', ' Classification ', ' Cues ', ' Elements ', ' balance function ', ' balance ', ' Equilibrium ', ' Europe ', ' Gene Expression ', ' Genes ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Histones ', ' Influentials ', ' Megalokaryocyte ', ' Blood megakaryocyte ', ' Megakaryocytes ', ' Methods ', ' Methylation ', ' Micro-tubule ', ' Microtubules ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Transplantation Surgery ', ' Organ Transplants ', ' Grafting Procedure ', ' Organ Transplantation ', ' Patients ', ' Phenotype ', ' Play ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Radiation therapy ', ' Reagent ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' Repression ', ' Risk ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Progenitor Cells ', ' Stem cells ', ' Thrombopenia ', ' Thrombocytopenia ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Tryptophan ', ' Levotryptophan ', ' L-Tryptophan ', ' Valproic Acid ', ' Divalproex ', ' Depakote ER ', ' Depakote ', ' Work ', ' histone acetyltransferase ', ' Histone Acetylase ', ' Generations ', ' forest ', ' GATA2 transcription factor ', ' transcription factor GATA-2 ', ' NF-E1b protein ', ' GATA-binding protein 2 ', ' GATA-2 protein ', ' Data Set ', ' Dataset ', ' Umbilical Cord Blood ', ' fetal cord blood ', ' Cord Blood ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Fusion Protein ', ' Chimera Protein ', ' Chimeric Proteins ', ' base ', ' improved ', ' TRNSF ', ' Transfusion ', ' Site ', ' Biological ', ' Chemicals ', ' prognostic ', ' Training ', ' Hematopoietic ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' Life ', ' Pattern ', ' Techniques ', ' System ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' novel ', ' Somatic Cell ', ' High Throughput Assay ', ' high throughput screening ', ' histone modification ', ' malignant soft tissue tumor ', ' Malignant Soft Tissue Neoplasm ', ' sarcoma ', ' small molecule ', ' HPCA1 ', ' CD34 ', ' CD34 gene ', ' transcription factor NFE-1 ', ' nuclear factor-erythroid 1 ', ' globin transcription factor 1 ', ' Transcription Factor GATA1 ', ' NFE1 protein ', ' NF-E1 erythroid-specific transcription factor ', ' GF-1 protein ', ' GATA1 transcription factor ', ' GATA1 protein ', ' GATA1 ', ' GATA-1 ', ' GATA Binding Protein 1 ', ' ERYF1 ', ' GATA1 gene ', ' histone deacetylase 6 ', ' KIAA0901 ', ' HDAC6 ', ' HDAC6 gene ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' Signaling Protein ', ' histone deacetylase 3 ', ' RPD3-2 ', ' HDAC3 enzyme ', ' HDAC3 ', ' HDAC3 gene ', ' Address ', ' Data ', ' Deacetylation ', ' Histone deacetylase inhibition ', ' HDAC inhibitor ', ' HDAC Agent ', ' Histone Deacetylase Inhibitor ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Molecular Profiling ', ' Regulatory Element ', ' Supplementation ', ' Cell Growth and Maintenance ', ' Cell Maintenance ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Process ', ' Modification ', ' stem cell differentiation ', ' epigenomics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' Population ', ' chemotherapy ', ' progenitor ', ' stem ', ' stem cell biology ', ' large scale production ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' ']",NHLBI,NORTHWESTERN UNIVERSITY,F31,2016,37571,IL-07,0.052967714558916294
"Genetic and epigenetic contributions to Sjogren's syndrome DESCRIPTION (provided by applicant): High throughput whole genome platforms to quantitatively and efficiently assay human DNA methylation provide an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). Epigenetic modifications, such as methylation of the 5' carbon of cytosine which occurs in the context of CpG dinucleotides, do not affect the genetic sequence; however, they do play a critical role in transcriptional regulation of a gene and subsequent gene expression. We have applied this technology, in conjunction with whole genome SNP genotyping to a clinically well-characterized collection of SS cases and controls developed specifically for genetic and epigenetic studies. Samples from the Sjogren's International Collaborative Clinical Alliance (SICCA) repository (total n=3,500 individuals) will b utilized, given the careful phenotype characterization and standardized collection of biospecimens that has been performed for each participant. For this proposal, we have initially obtained DNA from peripheral blood mononuclear cells (PBMCs) and sorted cell populations with high purity, including CD14+ monocytes, CD19+ B cells, CD4+ T cells, as well as labial salivary gland biopsy tissue from 120 SICCA participants (100 SS cases and 20 controls). Data collected for ~450,000 highly informative CpG sites spanning 22,000 genes across the genome will provide a comprehensive assessment of DNA methylation for each individual for our proposed study Aims. As part of Aim 1, DNA methylation profiles will be examined using three main approaches: 1) Global DNA methylation profiles will be analyzed for association with SS risk in all sample types; 2) Multidimensional scaling analysis (MDS) and principal components analysis (PCA) will be performed to determine whether SS case samples can be distinguished from control samples; and 3) Local analyses will also be performed and will focus specifically on DNA methylation changes within candidate SS genes and genes demonstrating at least 1.5 fold methylation differences between cases and controls. Our proposal will take advantage of available whole genome data for each study participant and results from the largest genome wide association study (GWAS) in SS. In Aim 2, we will utilize DNA methylation profiles and methods from Aim 1 to determine whether important SS case phenotypes can be distinguished from one another. We will identify top ranked CpG sites that are either hypo or hyper methylated in specific SS case groups or that distinguish cases from controls using supervised machine learning algorithms. We will attempt replication for all top findings in an independent dataset, followed by random effects meta-analysis to incorporate other SS risk factors. Finally, we will determine whether DNA methylation profiles of interest from Aims 1 and 2 can be detected in DNA from whole blood for potential use as a biomarker. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of different cell and tissue types and genetic background have the potential to significantly transform our understanding of SS etiology. PUBLIC HEALTH RELEVANCE New molecular genetic assays offer an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). We propose to perform a comprehensive screen of more than 450,000 highly informative CpG sites spanning 22,000 genes across the genome using DNA derived from peripheral blood mononuclear cells (PBMCs), sorted cell populations, and labial salivary gland biopsy tissue from SS cases and control individuals to identify epigenetic profiles that are predictive of disease risk and specifi clinical phenotypes. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of several different cell and tissue types and whole genome SNP data have the potential to significantly transform our understanding of SS etiology, and may lead to more effective approaches to prevention, diagnosis and treatment.",Genetic and epigenetic contributions to Sjogren's syndrome,8991063,R03DE024316,"['Affect ', ' Algorithms ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' Budgets ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cell Body ', ' Cells ', ' Cytosine ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Health ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Modern Man ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Methodology ', ' Methylation ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' Patients ', ' Phenotype ', ' Play ', ' Production ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' helper T cell ', ' T4 Lymphocytes ', ' T4 Cells ', ' CD4-Positive Lymphocytes ', ' CD4+ T-Lymphocyte ', ' CD4+ T cell ', ' CD4 lymphocyte ', ' CD4 T cells ', ' CD4 Cells ', ' CD4 Positive T Lymphocytes ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' T-Lymphocyte Subsets ', ' T-Cell Subsets ', ' Molecular Genetics ', ' Data Set ', ' Dataset ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Site ', ' Clinical ', ' Individual ', ' European ', ' Sample Size ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Complex ', ' Oral ', ' cell type ', ' Country ', ' interest ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' member ', ' Study Subject ', ' disease risk ', ' disorder risk ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Labial Salivary Gland ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' CD14 ', ' CD14 gene ', ' CD19 ', ' CD19 gene ', ' Data ', ' International ', ' National Institute of Dental Research ', ' NIDR ', ' NIDCR ', ' National Institute of Dental and Craniofacial Research ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' clinical phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' SNP genotyping ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' human DNA ', ' systemic autoimmune disease ', ' systemic autoimmune disorder ', ' whole genome ', ' entire genome ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2016,237102,CA-12,0.24948135085799042
"Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data     DESCRIPTION (provided by applicant): This project involves the development of new statistical methodologies and computational tools for network-based integrative analysis of epigenetic risk factors of cardiovascular diseases (CVD). While the advent of omics data from new technologies has facilitated the study of epigenetic factors, existing methodologies often do not account for complexities of biological data  such as correlations due to interactions of genes/proteins as part of biological pathways  and fail to eciently integrate diverse omics data sets  for instance genetic variation, DNA methylation and gene expression. The methodologies proposed in this project, and the software tools that will be developed to implement them, address these shortcomings, and facilitate further research by the biomedical community to gain a better understanding of the underlying biology of CVD, and to develop new diagnostic biomarkers and potential targets for therapies. The proposed methodologies are motivated by the study of epigenetic data from the Multi-Ethnic Study of Atherosclerosis (MESA), and include (i) a network-based pathway enrichment analysis method that incorporates available knowledge of interactions among genes and proteins while complementing and rening such information (Aim 1A), as well as its extension for analysis of multiple types of omics data (Aim 1B), and (ii) an integrative analysis framework to identify associations among gene expression levels and DNA methylation (Aim 2A) and identify common epigenetic factors of multiple CVD phenotypes through integrated analysis of DNA methylation and mRNA expression data (Aim 2B). We will develop ecient and user-friendly software tools for the proposed methods (Aim 3), which will be made freely available to the public after extensive tests using both simulated data, as well as real data from MESA. PUBLIC HEALTH RELEVANCE: The proposed research addresses the need for development of new statistical machine learning methods for analysis of diverse epigenetic data from multiple cardiovascular disease outcomes. The proposed training activities are designed to enhance the applicant's knowledge of epigenetics and physiology of cardiovascular diseases (CVD), and to further his career as an independent investigator in the area of computational epigenetics for CVD.",Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data,9032704,K01HL124050,"['Accounting ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' Biology ', ' Biomedical Research ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Gene Expression ', ' Genes ', ' Histones ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Information Networks ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Methodology ', ' Methylation ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Phenotype ', ' Physiology ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk Factors ', ' Computer Software Tools ', ' Software Tools ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Testing ', ' training module ', ' Training Activity ', ' Variation (Genetics) ', ' Genetic Variation ', ' Genetic Diversity ', ' Data Set ', ' Dataset ', ' base ', ' career ', ' improved ', ' Area ', ' Biological ', ' Individual ', ' Dyslipidemias ', ' Measurement ', ' Genetic ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' Complex ', ' Source ', ' System ', ' user friendly computer software ', ' user friendly software ', ' Structure ', ' Disease Outcome ', ' novel ', ' member ', ' novel technologies ', ' new technology ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Protein Gene Products ', ' Gene Proteins ', ' inherited factor ', ' genetic risk factor ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' response ', ' Genomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' Address ', ' Data ', ' Post-Transcriptional Regulation Process ', ' Post-Transcriptional Control ', ' Post-Transcriptional Regulation ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' mRNA Expression ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Exogenous Factors ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Outcome ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' therapeutic target ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' epigenetic marker ', ' epigenetic biomarker ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning network ', ' learning strategy ', ' learning method ', ' learning activity ', ' training opportunity ', ' multiple omics ', ' diagnostic biomarker ', ' diagnostic marker ', ' whole genome ', ' entire genome ', ' ']",NHLBI,UNIVERSITY OF WASHINGTON,K01,2016,142841,WA-07,0.16987156479436125
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,9038173,F31DE025176,"['abstracting ', ' Affect ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cell Body ', ' Cells ', ' Systematics ', ' Classification ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Systemic Lupus Erythematosus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Salivary Glands Head and Neck ', ' Salivary Glands ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Woman ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Data Set ', ' Dataset ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Inflammatory ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' System ', ' Country ', ' disease severity ', ' Severity of illness ', ' QTL ', ' Quantitative Trait Loci ', ' novel ', ' Participant ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' Molecular Interaction ', ' Binding ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' NIH National Research Service Award for Individual ', ' Individual National Research Service Award ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' epigenetic variation ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' epigenome ', ' methylation pattern ', ' bead chip ', ' BeadChip ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' disease heterogeneity ', ' whole genome ', ' entire genome ', ' genomic data ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2016,39129,CA-13,0.25484849194085496
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,8998963,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl Radical ', ' Hydroxyl ', ' Measures ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' NMR Spectroscopy ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Untranslated RNA ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' Computational algorithm ', ' computer algorithm ', ' human disease ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-on-chip ', ' ChIP-chip ', ' genome analysis ', ' Geometry ', ' whole genome ', ' entire genome ', ' predictive tools ', ' genome browser ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2016,306949,CA-37,0.08022166356058046
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9183143,R24DK106766,"['Accounting ', ' Dorsum ', ' Back ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Biology ', ' Blood Reticuloendothelial System ', ' Blood ', ' Peripheral Blood Cell ', ' Blood Cells ', ' Cataloging ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Chromosomes ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Engineering ', ' Evolution ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Health ', ' Heart ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Production ', ' Proteins ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Science ', ' Progenitor Cells ', ' Stem cells ', ' Technology ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' falls ', ' Experimental Models ', ' Data Set ', ' Dataset ', ' DNA Sequence ', ' improved ', ' Area ', ' Training ', ' Hematopoietic ', ' insight ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Gene Targeting ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' Monoclonal Antibody R24 ', ' Collaborations ', ' Genetic ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Catalogs ', ' Frequencies ', ' cell type ', ' Pattern ', ' System ', ' transdisciplinary collaboration ', ' interdisciplinary collaboration ', ' gene conservation ', ' cell damage ', ' Cellular injury ', ' cell injury ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Basic Research ', ' Basic Science ', ' Categories ', ' personnel ', ' Manpower ', ' Human Resources ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' response ', ' Erythroid Cells ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Transcript ', ' Monitor ', ' Knockout ', ' Knock-out ', ' Modification ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' feeding ', ' data acquisition ', ' clinically significant ', ' clinical significance ', ' mouse model ', ' murine model ', ' loss of function ', ' stem ', ' prototype ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epigenome ', ' precision medicine ', ' genome editing ', ' genomic editing ', ' transcriptome ', ' chromosome conformation capture ', ' chromosome capture ', ' 3C-based technology ', ' 3C-based technique ', ' 3C-based strategy ', ' 3C-based method ', ' 3C-based assay ', ' 3C-based approach ', ' genome browser ', ' ']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2016,1324873,PA-12,0.05593076744399231
"Systems genetic and reverse phenotypic analysis of age and retirement DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways. PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.",Systems genetic and reverse phenotypic analysis of age and retirement,9015301,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Methodology ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' youth depression ', ' pediatric depression ', ' depression in adolescence ', ' depressed adolescents ', ' childhood onset depression ', ' childhood depression ', ' adolescents with depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' social implication ', ' economic implication ', ' exome ', ' exomes ', ' health data ', ' behavioral economics ', ' reverse genetics ', ' bead chip ', ' BeadChip ', ' learning strategy ', ' learning method ', ' learning activity ', ' genomic platform ', ' phenotypic data ', ' genomic data ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2016,315700,CA-33,0.024142800674905127
"Epigenetic Transgenerational Endocrine Disruptor Actions DESCRIPTION (provided by applicant): A number of environmental toxicants were shown in the previous grant period to promote the epigenetic transgenerational inheritance of adult onset disease including the fungicide vinclozolin, pesticides, plastics (BPA and phthalates), dioxin, hydrocarbons, and DDT. The ability of environmental compounds (e.g. endocrine disruptors) to promote transgenerational disease phenotypes is anticipated to be a critical aspect of adult onset disease etiology. The transgenerational inheritance phenotype requires the heritable epigenetic alterations of the germline. The current proposal is designed to further investigate the molecular and developmental aspects of the epigenetic transgenerational inheritance phenomenon and assess the potential use of epigenetic biomarkers for exposure and disease. The general hypothesis tested is that ""transient fetal exposure around the period of gonadal sex determination to environmental toxicants (i.e. vinclozolin) promotes the reprogramming of the epigenome (i.e. DNA methylation) of the male germline that then transmits an imprinted-like epigenome to subsequent generations to induce the epigenetic transgenerational inheritance of adult onset disease (e.g. male infertility)"". The previous grant period focused on the analysis of the epigenetic alteration in the F3 generation sperm using promoter associated differential DNA methylation regions (epimutations), as well as documented the epigenetic and transcriptome changes in the F3 generation vinclozolin lineage primordial germ cells. The molecular etiology of somatic cell changes associated with ovary and testis disease was established. The current proposal further investigates the molecular and developmental aspects of the germline mediated epigenetic transgenerational inheritance of disease. The experimental approach to test the above hypothesis consists of the following specific aims: Aim 1) Determine the developmental and generational aspects of the genome-wide germline epimutations. Aim 2) Determine the genomic features associated with the epimutations and potential genetic alterations involved in the epigenetic transgenerational inheritance phenomenon. Aim 3) Determine the optimal exposure parameters of the environmental induced transgenerational model and correlate epigenetic biomarkers with exposure and disease. Completion of the proposed research will determine the cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The proposed research will further elucidate the molecular and developmental aspects of environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease. PUBLIC HEALTH RELEVANCE: The current proposal further investigates the molecular and developmental aspects of germline mediated epigenetic transgenerational inheritance of disease. The cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes will be determined. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The epimutations are anticipated to promote genetic alterations to contribute to the transgenerational disease phenotype. Completion of the research will elucidate the molecular etiology of the environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.",Epigenetic Transgenerational Endocrine Disruptor Actions,9042364,R01ES012974,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' depression ', ' Mental Depression ', ' Dioxin Compound ', ' Dioxins ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Fertility/Fertilization ', ' Fertilization ', ' Genes ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Germ Cells ', ' Grant ', ' Health ', ' Modern Man ', ' Human ', ' Hydrocarbons ', ' Inbreeding ', ' Male Infertility ', ' male ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Ovary ', ' Pesticides ', ' Phenotype ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Research ', ' Safety ', ' Spermatogenesis ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' sperm cell ', ' Testing ', ' Testicles ', ' Testis ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' vinclozolin ', ' Generations ', ' Mediating ', ' promoter ', ' promotor ', ' phthalates ', ' Primordial Germ Cell ', ' Structure of primordial sex cell ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' Staging ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' fungicide ', ' fungicidal ', ' Industrial fungicide ', ' Event ', ' hazard ', ' Somatic Cell ', ' Modeling ', ' Genomics ', ' Genome Instability ', ' Genomic Instability ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' sex determination ', ' Dose ', ' copy number variation ', ' copy number variant ', ' Copy Number Polymorphism ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' DNA Sequence Alteration ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' intrauterine environmental exposure ', ' intra-uterine environmental exposure ', ' in utero exposure ', ' fetal exposure ', ' exposed in utero ', ' Perinatal Exposure ', ' Molecular ', ' developmental ', ' Development ', ' disease phenotype ', ' computerized ', ' designing ', ' design ', ' endocrine disrupting compound ', ' Endocrine disrupting agent ', ' Endocrine Disrupting Chemicals ', ' Endocrine Disrupter ', ' Endocrine Disruptors ', ' imprint ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' transgenerational epigenetic inheritance ', ' transgenerational inheritance ', ' transcriptome ', ' ']",NIEHS,WASHINGTON STATE UNIVERSITY,R01,2016,339750,WA-05,0.1892151229488621
"Epigenetic Transgenerational Endocrine Disruptor Actions DESCRIPTION (provided by applicant): A number of environmental toxicants were shown in the previous grant period to promote the epigenetic transgenerational inheritance of adult onset disease including the fungicide vinclozolin, pesticides, plastics (BPA and phthalates), dioxin, hydrocarbons, and DDT. The ability of environmental compounds (e.g. endocrine disruptors) to promote transgenerational disease phenotypes is anticipated to be a critical aspect of adult onset disease etiology. The transgenerational inheritance phenotype requires the heritable epigenetic alterations of the germline. The current proposal is designed to further investigate the molecular and developmental aspects of the epigenetic transgenerational inheritance phenomenon and assess the potential use of epigenetic biomarkers for exposure and disease. The general hypothesis tested is that ""transient fetal exposure around the period of gonadal sex determination to environmental toxicants (i.e. vinclozolin) promotes the reprogramming of the epigenome (i.e. DNA methylation) of the male germline that then transmits an imprinted-like epigenome to subsequent generations to induce the epigenetic transgenerational inheritance of adult onset disease (e.g. male infertility)"". The previous grant period focused on the analysis of the epigenetic alteration in the F3 generation sperm using promoter associated differential DNA methylation regions (epimutations), as well as documented the epigenetic and transcriptome changes in the F3 generation vinclozolin lineage primordial germ cells. The molecular etiology of somatic cell changes associated with ovary and testis disease was established. The current proposal further investigates the molecular and developmental aspects of the germline mediated epigenetic transgenerational inheritance of disease. The experimental approach to test the above hypothesis consists of the following specific aims: Aim 1) Determine the developmental and generational aspects of the genome-wide germline epimutations. Aim 2) Determine the genomic features associated with the epimutations and potential genetic alterations involved in the epigenetic transgenerational inheritance phenomenon. Aim 3) Determine the optimal exposure parameters of the environmental induced transgenerational model and correlate epigenetic biomarkers with exposure and disease. Completion of the proposed research will determine the cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The proposed research will further elucidate the molecular and developmental aspects of environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease. PUBLIC HEALTH RELEVANCE: The current proposal further investigates the molecular and developmental aspects of germline mediated epigenetic transgenerational inheritance of disease. The cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes will be determined. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The epimutations are anticipated to promote genetic alterations to contribute to the transgenerational disease phenotype. Completion of the research will elucidate the molecular etiology of the environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.",Epigenetic Transgenerational Endocrine Disruptor Actions,9247187,R01ES012974,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' depression ', ' Mental Depression ', ' Dioxin Compound ', ' Dioxins ', ' Disorder ', ' Disease ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Fertility/Fertilization ', ' Fertilization ', ' Genes ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Germ Cells ', ' Grant ', ' Modern Man ', ' Human ', ' Hydrocarbons ', ' Inbreeding ', ' Male Infertility ', ' male ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Ovary ', ' Pesticides ', ' Phenotype ', ' Plasticizers ', ' Plastics ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Research ', ' Safety ', ' Spermatogenesis ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Testing ', ' Testis ', ' Testicles ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' Toxic Environmental Substances ', ' vinclozolin ', ' Generations ', ' Mediating ', ' promotor ', ' promoter ', ' phthalates ', ' Primordial Germ Cell ', ' Structure of primordial sex cell ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Industrial fungicide ', ' fungicide ', ' fungicidal ', ' Event ', ' hazard ', ' Somatic Cell ', ' Modeling ', ' prenatal exposure ', ' prenatally exposed ', ' intrauterine environmental exposure ', ' intra-uterine environmental exposure ', ' in utero exposure ', ' fetal exposure ', ' exposed in utero ', ' Genomics ', ' Genomic Instability ', ' Genome Instability ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' sex determination ', ' Dose ', ' Copy Number Polymorphism ', ' copy number variation ', ' copy number variant ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' developmental ', ' Development ', ' disease phenotype ', ' computerized ', ' designing ', ' design ', ' endocrine disrupting compound ', ' Endocrine disrupting agent ', ' Endocrine Disrupting Chemicals ', ' Endocrine Disrupter ', ' Endocrine Disruptors ', ' Heritability ', ' imprint ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' transgenerational epigenetic inheritance ', ' transgenerational inheritance ', ' transcriptome ', ' ']",NIEHS,WASHINGTON STATE UNIVERSITY,R01,2017,339750,WA-05,0.1892151229488621
"Using epigenomic subtyping to understand the racial differences in lymphoma PROJECT SUMMARY Diffuse large B-cell lymphoma (DLBCL), the most common aggressive type of lymphomas, is characterized by marked clinical and pathological heterogeneity that is reflected at the molecular level. It is well known that although the incidence rates for DLBCL were lower for African Americans (AA) than for European Americans (EA), AA patients were diagnosed at a significantly younger age and have worse 5-year survival compared with EA patients. The reason for this apparent racial/ethnic difference is unclear and cannot be fully explained by social stressors or access to care. We speculate that epigenetic variations could underlie the racial/ethnic differences because the pathogenesis of DLBCL is strongly linked to perturbation of epigenetic mechanisms, and population-specific cytosine modifications are a fundamental feature between human populations. In addition, greater epigenetic heterogeneity is linked with more aggressive DLBCL and poorer survival outcomes. Most prior studies of DLBCL epigenetics have assessed 5-methylcytosines (5mC) in predominantly EA patients. No studies have evaluated 5-hydroxymethylcytosines (5hmC), an emerging stable and abundant modification with distinct gene regulatory and cellular functions, due mainly to technical limitations. Most importantly, no studies have assessed concurrently 5mC and 5hmC in both EA and AA DLBCL patients. Without an effective technique to obtain the complete landscape of modified cytosines, development of targeted epigenetic approaches to improve DLBCL disparities is unlikely. The objective of this Exploratory/Developmental study is to distinguish 5hmC from 5mC at the time of DLBCL diagnosis between AA and EA patients and evaluate their clinical significance. Our hypothesis is that the 5mC/5hmC signatures in tumor tissues differ between AA and EA patients and that these differences contribute to the well-known racial/ethnic differences in DLBCL risk and outcomes. The Specific Aims are to 1) distinguish 5hmC from 5mC in EA and AA patients and evaluate population-specific 5mC/5hmC loci; and 2) determine therapeutic response-associated 5hmC/5mC loci. Specifically, we will obtain tissues for 120 patients with DLBCL (60 AA and 60 EA) from the University of Chicago Lymphoma Biobank. We will combine an innovative technique, the Tet-assisted Bisulfite Sequencing (TAB-Seq) and the new Illumina EPIC array to accurately distinguish 5hmC from 5mC. We will perform an epigenome-wide scan to assess differences in 5hmC/5mC modification levels between AA and EA patients at presentation and also integrate both modifications to predict therapeutic response, defined as relapse within 24 months after treatment. This proposal addresses a critical research question in a highly innovative, cost-efficient, and timely manner, providing important data for the first time on the complete landscape of modified cytosines for racial/ethnic differences in DLBCL. The results are expected to have positive impact because it is possible that the identified epigenetic loci/biomarkers will provide new targets for individualized preventive and therapeutic interventions to decrease mortality and burden of DLBCL. PROJECT NARRATIVE PUBLIC HEALTH RELEVANCE: African Americans were diagnosed of diffuse large B-cell lymphoma (DLBCL), the most aggressive lymphoma in adults, at a significantly younger age (54 years vs. 65 years) and have worse 5-year survival (45% vs. 54%) compared with European American patients. This work seeks to understand the biological bases of the racial/ethnic differences by identifying complete DNA methylation and hydroxymethylation signatures at the time of diagnosis between African American and European American patients with DLBCL. Successful completion of this study will lead to a much better understanding of epigenetic factors that underlie the apparent racial/ethnic differences in DLBCL, which should accelerate the development of race-based individualized preventive and therapeutic interventions to substantially reduce the disparities observed in DLBCL among patients from different ethnic groups.",Using epigenomic subtyping to understand the racial differences in lymphoma,9455051,R21MD011439,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Aftercare ', ' ages ', ' Age ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Breast ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Chicago ', ' Colon ', ' Cytosine ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Endometrium ', ' ethnicity group ', ' Ethnic group ', ' Gene Expression ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Incidence ', ' indexing ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Lymphoma ', ' Reticulolymphosarcoma ', ' Malignant Lymphoma ', ' Germinoblastoma ', ' Germinoblastic Sarcoma ', ' mortality ', ' Patients ', ' Prostate ', ' Prostatic Gland ', ' Prostate Gland ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Relapse ', ' Research ', ' Risk ', ' Specificity ', ' Time ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Work ', ' Treatment outcome ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Enhancers ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Link ', ' Individual ', ' African ', ' European ', ' Ethnicity ', ' Ethnic Origin ', ' Biological Function ', ' Biological Process ', ' Solid Tumor ', ' Solid Neoplasm ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Tumor Tissue ', ' American ', ' stressor ', ' tumor initiation ', ' novel ', ' member ', ' racial difference ', ' race differences ', ' ethnic difference ', ' ethnicity difference ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' social ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' health disparity ', ' disparity in health ', ' Address ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Regulatory Element ', ' Tetanus Helper Peptide ', ' Tet ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' exploratory developmental study ', ' R21 Program ', ' R21 Mechanism ', ' Exploratory/Developmental Grant ', ' Pathologic ', ' Molecular ', ' Modification ', ' developmental ', ' Development ', ' epigenomics ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' cost efficient ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' clinically significant ', ' clinical significance ', ' racial and ethnic ', ' epigenetic variation ', ' tumor ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biobank ', ' biorepository ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' bisulfite sequencing ', ' bisulfite-seq ', ' BS-seq ', ' survival outcome ', ' disparity reduction ', ' reduce disparity ', ' ']",NIMHD,UNIVERSITY OF CHICAGO,R21,2017,254325,IL-01,0.1061240681329216
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9316617,R24DK106766,"['Dorsum ', ' Back ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Biology ', ' Blood Reticuloendothelial System ', ' Blood ', ' Peripheral Blood Cell ', ' Blood Cells ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Chromosomes ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Engineering ', ' Evolution ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Health ', ' Heart ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' hematopoietic stem progenitor cell ', ' hematopoietic progenitor ', ' Hematopoietic Progenitor Cells ', ' Blood Precursor Cell ', ' Hematopoietic stem cells ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Maps ', ' Methods ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Production ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Science ', ' Stem cells ', ' Progenitor Cells ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' falls ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Custom ', ' improved ', ' Area ', ' Training ', ' Hematopoietic ', ' insight ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Gene Targeting ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' Monoclonal Antibody R24 ', ' Collaborations ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Catalogs ', ' Dimensions ', ' Frequencies ', ' cell type ', ' Pattern ', ' System ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' gene conservation ', ' cell injury ', ' cell damage ', ' Cellular injury ', ' novel ', ' Basic Science ', ' Basic Research ', ' Categories ', ' Human Resources ', ' personnel ', ' Manpower ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' response ', ' Erythroid Cells ', ' CISH gene ', ' Suppressor of Cytokine Signaling Gene ', ' Suppressor of Cytokine Signaling ', ' SOCS Gene ', ' G18 Gene ', ' G18 ', ' Cytokine-Inducible SH2-Containing Protein Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B ', ' Cytokine Inducible SH2-Containing Protein ', ' CISH Protein ', ' CIS-1 Protein ', ' CIS-1 Gene ', ' CIS protein ', ' CIS Gene ', ' Address ', ' Data ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Transcript ', ' Pathologic ', ' Monitor ', ' Knockout ', ' Knock-out ', ' Modification ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' data acquisition ', ' clinically significant ', ' clinical significance ', ' mouse model ', ' murine model ', ' loss of function ', ' prototype ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epigenome ', ' precision medicine ', ' genome editing ', ' genomic editing ', ' transcriptome ', ' chromosome conformation capture ', ' chromosome capture ', ' 3C-based technology ', ' 3C-based technique ', ' 3C-based strategy ', ' 3C-based method ', ' 3C-based assay ', ' 3C-based approach ', ' genome browser ', ' experimental study ', ' experimental research ', ' experiment ', ' annotation  system ', ' annotation tool ', ' annotation framework ', ' ']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2017,1232180,PA-12,0.05593076744399231
"Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes     DESCRIPTION (provided by applicant): Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal blood disorders characterized by ineffective hematopoiesis that can lead to bone marrow failure and progression to acute myeloid leukemia (AML). Aberrant DNA hypermethylation is characteristic of this disorder and, as such, DNA methyltransferase inhibitors (DMTis) are often used to treat MDS in lieu of conventional chemotherapies that have proven to be ineffective for this disease. However, even with DMTi therapy, only about one third of MDS patients achieve a clinical response leading to a survival benefit. Moreover, current DMTi-based regimens for MDS require a minimum of 6 months of treatment before a patient can be deemed resistant to this therapy. Given that only ~30-40% of patients respond to this treatment, the majority of patients will spend 6 months receiving a therapy to which they are unlikely to respond. Therefore, the identification of molecular differences that distinguish between sensitive and resistant patients at the time of diagnosis is critical in order to harness these differences for the development of molecular biomarkers predictive of DMTi response. These biomarkers would allow us to more accurately risk-stratify these patients and prevent unwarranted and ineffective therapy for resistant patients. Using next-generation sequencing technology we performed genome-wide DNA methylation, gene expression and mutational analysis on a cohort of patients with chronic myelomonocytic leukemia (CMML), an MDS/MPN overlap syndrome, including both sensitive and resistant patients to the DMTi Decitabine (DAC). We found that robust epigenetic and gene expression differences exist between DMTi responders and non-responders. From these differences, we were able to develop an epigenetic classifier that predicts response to decitabine therapy in these patients with 87% accuracy. Moreover, using RNA-seq we identified a gene expression signature associated with primary resistance to DAC in CMML. Based on these data, we hypothesize that comparable differences are likely to be found in MDS patients who are either sensitive or resistant to the DMTi Azacytidine (AZA), and that these too have the potential to be used as the basis of a molecular classifier of response as well as to identify mechanisms of primary resistance to the drug. We propose to perform genome-wide studies DNA methylation and expression studies in a cohort of 250 MDS patients treated with AZA in order to identify DNA methylation and expression biomarkers predictive of response to this agent in MDS. From these studies, we expect to be able to develop clinically useful biomarkers that can be translated to CLIA-compatible technologies that can be applied in molecular diagnostics labs. PUBLIC HEALTH RELEVANCE: Myelodysplastic syndromes (MDS) are the most common hematological disorder of the elderly. To date, the only effective therapies are the DNA methyltransferase inhibitors (Azacytidine and Decitabine), but even with this therapy, approximately 60% of patients do not respond. Currently there are no accurate molecular biomarkers that may help risk-stratify patients at the time of diagnosis, and therefore a vast majority of patients are forced to receive up to 6 months of Azacytidine before they can be offered alternative therapies. Moreover, it is unclear why some patients respond while others don't. Therefore, it is of the utmost urgency that we develop more accurate ways of risk-stratifying patients at the time of diagnosis in order to prevent the unwarranted treatment of a large fraction of patients who are unlikely to ever respond to these agents as well as to identify novel alternative therapeutic targets.",Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,9268794,R01HL126947,"['ages ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Algorithms ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' Azacitidine ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Bone Marrow Reticuloendothelial System ', ' Bone Marrow ', ' Systematics ', ' Classification ', ' cytopenia ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' Exons ', ' Gene Expression ', ' Genome ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' Introns ', ' Intervening Sequences ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Acute Myelocytic Leukemia ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Chronic Myelomonocytic Leukemia ', ' Dysmyelopoietic Syndromes ', ' myelodysplasia ', ' Smoldering Leukemia ', ' Myelodysplastic Syndromes ', ' Pancytopenia ', ' Bone marrow failure ', ' Patients ', ' Play ', ' Promoter Regions ', ' genetic promoter element ', ' Promotor Regions ', ' Nucleic Acid Regulatory Sequences ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Risk ', ' Role ', ' social role ', ' Syndrome ', ' Technology ', ' Time ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Dezocitidine ', ' Deoxyazacytidine ', ' 5-deoxyazacytidine ', ' 5-Azadeoxycytidine ', ' Decitabine ', ' Enhancers ', ' base ', ' Distal ', ' Clinical ', ' Biological ', ' peripheral blood ', ' CpG-Rich Islands ', ' CpG Islands ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Disease Management ', ' Disorder Management ', ' Chemotherapy-Oncologic Procedure ', ' cancer chemotherapy ', ' Quimioterapia ', ' Combination Chemotherapy Regimen ', ' Chemotherapy, Cancer, General ', ' Chemotherapy Regimen ', ' Chemotherapy Protocol ', ' Gene Mutation ', ' Gene Alteration ', ' cohort ', ' novel ', ' Mutation Analysis ', ' response ', ' Genomics ', ' Alternative Therapies ', ' prevent ', ' preventing ', ' Hypercellular Bone Marrow ', ' Ineffective Hematopoiesis ', ' PPBP gene ', ' -Thromboglobulin ', ' -TG ', ' beta-Thromboglobulin ', ' Thromboglobulin, Beta-1 ', ' Thrombocidin 2 ', ' Thrombocidin 1 ', ' TGB1 ', ' TC2 ', ' TC1 ', ' Small Inducible Cytokine Subfamily B, Member 7 ', ' SCYB7 ', ' Pro-Platelet Basic Protein ', ' Platelet Basic Protein ', ' PPBP ', ' PBP protein ', ' PBP gene ', ' Neutrophil-Activating Peptide 2 ', ' NAP2 ', ' NAP-2 ', ' LA-PF4 ', ' Connective Tissue-Activating Peptide III ', ' CXCL7 ', ' CXC Chemokine Ligand 7 ', ' CTAPIII ', ' CTAP3 ', ' CTAP III ', ' Beta-TG ', ' ITGB3 gene ', ' Platelet Fibrinogen Receptor, Beta Subunit ', ' PTP gene ', ' NAIT ', ' Integrin Beta 3 ', ' ITGB3 ', ' GP3A ', ' GP IIIa ', ' CD61 ', ' DNA Methyltransferase Inhibitor ', ' Data ', ' Hypermethylation ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' in vivo ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' Gene Expression Profile ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' next generation ', ' Resistance ', ' resistant ', ' chemotherapy ', ' therapeutic target ', ' genome-wide analysis ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide analysis ', ' overexpression ', ' overexpress ', ' over-expression ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' effective therapy ', ' effective treatment ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' Regimen ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' bisulfite sequencing ', ' bisulfite-seq ', ' BS-seq ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' patient stratification ', ' stratified patient ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' response biomarker ', ' response markers ', ' responders and non-responders ', ' responders vs non-responders ', ' responders versus non-responders ', ' responders or non-responders ', ' responders from non-responders ', ' unnecessary treatment ', ' molecular diagnostics ', ' ineffective therapies ', ' ineffective treatment ', ' ']",NHLBI,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2017,390375,FL-27,0.16249167426461603
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,9203633,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Modern Man ', ' Human ', ' Hybrids ', ' In Vitro ', ' Linear Regressions ', ' Methods ', ' Methylation ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Nucleotides ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Proteins ', ' Publishing ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Specificity ', ' Technology ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Dimensions ', ' Scanning ', ' Techniques ', ' System ', ' Width ', ' Benchmarking ', ' Best Practice Analysis ', ' Quantitative Trait Loci ', ' QTL ', ' homeodomain ', ' Homeo Domain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Modeling ', ' Property ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Untranslated RNA ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Guanine + Cytosine Composition ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Gene Components ', ' DNA Integration ', ' Binding ', ' Molecular Interaction ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' Computational algorithm ', ' computer algorithm ', ' human disease ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-on-chip ', ' ChIP-chip ', ' genome analysis ', ' Geometry ', ' Gaussian model ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' whole genome ', ' entire genome ', ' predictive tools ', ' genome browser ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2017,309913,CA-37,0.08022166356058046
"Inferring gene regulatory circuitry from functional genomics data PROJECT SUMMARY It has long been known that methylation of genomic DNA correlates with gene expression. However, the structural mechanisms that underlie these observations remain obscure. In this project, we will pursue several innovative strategies for studying how methylation affects transcription factor (TF) binding. First, we will use Methyl-SELEX-seq  a novel experimental method developed in the previous cycle of this grant that uses barcoded mixtures of methylated and unmethylated DNA ligands  to create detailed maps of the effect of methylation on binding affinity for a broad panel of human transcription factors from various structural families. Second, we will perform detailed computational analyses and follow-up experiments to test the hypothesis that methylation causes local changes in DNA shape, which in turn modify TF binding affinity. We have shown that adding a methyl group in the major groove changes the geometry of the minor groove and enhances the electrostatic interaction between negative charges in the DNA minor groove and positively charged amino- acids in the TF. We will extend these analyses to other DNA modifications, as well as a wider range of DNA shape parameters and associated flexibility parameters. By building interpretable TF-DNA recognition models that integrate base, shape, and flexibility features using a powerful new machine learning framework developed in the previous funding cycle, we will make specific predictions regarding sequence and methylation readout mechanisms, and validate these using SELEX experiments with mutated TFs. To assess to what extent our quantitative models for binding to naked DNA built from SELEX data are predictive of binding to genomic DNA in the context of the living cell, we will perform detailed parallel analyses of SELEX and ChIP- seq data for Hox proteins and other TFs. Finally, to study the relationship between DNA binding and gene expression control in human cell lines, we will exploit Survey of Regulatory Elements (SuRE-seq), a novel massively parallel reporter assay that provides unique information about the autonomous transcriptional activity for each of >108 overlapping genomic fragments. PROJECT NARRATIVE Epigenetic modifications of the human genome are known to play a key role in development and disease, but the underlying molecular mechanisms are largely unknown. The main goal of this proposal is to develop and apply new experimental and computational tools for analyzing how the binding of regulatory proteins to DNA is influenced by cytosine methylation. This will help us better understand its impact on gene expression and disease.",Inferring gene regulatory circuitry from functional genomics data,9239323,R01HG003008,"['Affect ', ' protein sequence ', ' Primary Protein Structure ', ' Amino Acid Sequence ', ' aminoacid ', ' Amino Acids ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Biophysics ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' Charge ', ' Communities ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Gene Expression ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' human whole genome ', ' Human Genome ', ' Goals ', ' Grant ', ' Modern Man ', ' Human ', ' In Vitro ', ' Laboratories ', ' Ligands ', ' Maps ', ' Methods ', ' Methylation ', ' Names ', ' Play ', ' Proteins ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' DNA Sequence ', ' base ', ' DNA analysis ', ' Variation ', ' Variant ', ' Biological ', ' Funding ', ' Shapes ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Electrostatics ', ' Hyperactive behavior ', ' Motor Hyperactivity ', ' Hyperkinetic Movements ', ' Hyperkinesis ', ' Hyperkinesia ', ' Hyperactivity ', ' Dependence ', ' Protocols documentation ', ' Protocol ', ' preference ', ' methyl group ', ' HOX protein ', ' Free Energy ', ' novel ', ' Human Cell Line ', ' Positioning Attribute ', ' Position ', ' genetic regulatory protein ', ' regulatory gene product ', ' Regulatory Protein ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' functional genomics ', ' Genomics ', ' DNA Binding ', ' DNA bound ', ' DNA Binding Interaction ', ' DNA Modification Process ', ' DNA Modification ', ' Binding ', ' Molecular Interaction ', ' Address ', ' Affinity ', ' Data ', ' Minor Groove ', ' Mutate ', ' Regulatory Element ', ' Chromatin Structure ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Computer Analysis ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Major Groove ', ' Molecular ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' deep sequencing ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' comparative ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' methylome ', ' High-Throughput Nucleotide Sequencing ', ' High-Throughput Sequencing ', ' Geometry ', ' Genomic DNA ', ' gDNA ', ' genomic data ', ' genomic predictors ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NHGRI,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2017,560259,NY-13,0.11482425156446867
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,9240483,F31DE025176,"['Affect ', ' ages ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' auto-immune disorder ', ' auto-immune disease ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Carbon ', ' Cell Body ', ' Cells ', ' Systematics ', ' Classification ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Systemic Lupus Erythematosus ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Resources ', ' Research Resources ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Role ', ' social role ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Supervision ', ' T-Lymphocyte ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Woman ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Dataset ', ' Data Set ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Dimensions ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' Country ', ' Severity of illness ', ' disease severity ', ' Quantitative Trait Loci ', ' QTL ', ' novel ', ' Participant ', ' disorder risk ', ' disease risk ', ' Pathogenesis ', ' genetic risk factor ', ' inherited factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Binding ', ' Molecular Interaction ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' Individual National Research Service Award ', ' NIH National Research Service Award for Individual ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' epigenetic variation ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' epigenome ', ' methylation pattern ', ' bead chip ', ' BeadChip ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' disease heterogeneity ', ' whole genome ', ' entire genome ', ' genomic data ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2017,39597,CA-13,0.25484849194085496
"Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood Several million units of donor platelets are transfused annually in the US and Europe to treat patients undergoing radiation treatment, chemotherapy, or organ transplant surgery. Although transfusions of donor- derived platelets are an effective way to treat thrombocytopenic patients, numerous concerns have been raised due to the increase in demand, the five-day shelf-life, and the possibilities for contamination. Platelets are produced by megakaryocytes (MKs) in the bone marrow and are derived from hematopoietic stem and progenitor cells (HSPCs). The long-term objective of this proposal is to generate platelets ex vivo from HSPC- enriched umbilical cord blood that will allow us to address a vast public need. Recent studies have shown that the addition of histone deacetylase inhibitors (HDACi) can greatly affect expansion of progenitor cells, but can reduce MK differentiation efficiency. My central hypothesis is that epigenetic and transcriptional changes prime or desensitize HSPC to MK differentiation cues. To investigate the role of epigenetic signals during HSPC-to- MK transition, I propose to perform high-throughput ChIP and RNA-sequencing to discover differentially active regulatory elements between expanded (low potential) and fresh cord blood HSPCs. This highly interdisciplinary and collaborative proposal utilizes computational biology and machine-learning to identify differentially active regulatory elements, and associate genetic features with MK fate. To validate my findings and establish a causal relationship between histone modifications of certain regions and MK potential, I will generate a dCas9-fusion protein that can directly manipulate the epigenetic marker at a targeted site. My findings will establish the mechanism of action of chromatin-modifying agents such as HDACi, and the causal relationship between the epigenome and MK differentiation. My highly collaborative proposal with the Miller, Bagheri, and Mahmud lab will substantially enhance our understanding of hematopoietic differentiation toward manufacturing platelets. Project Narrative More than two million platelet units from donors are used to treat patients undergoing surgery or chemotherapy every year, but short shelf-life, increasing demand, and risk of contamination keep platelets in strained supply. In my proposed study, I will apply a panel of small molecules to expand and differentiate hematopoietic stem and progenitor cells from umbilical cord blood into platelet-producing cells. My work will identify the role of epigenetic modifications during the culture process, and elucidate new strategies to efficiently manufacture platelets from culture.",Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood,9345356,F31HL134331,"['Acetylation ', ' Affect ', ' Algorithms ', '  Tubulin ', ' alpha Tubulin ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' Azacitidine ', ' Peripheral Blood Cell ', ' Blood Cells ', ' thrombocyte/platelet ', ' Thrombocytes ', ' Platelets Reticuloendothelial System ', ' Platelets ', ' Marrow platelet ', "" Hayem's elementary corpuscle "", "" Deetjeen's body "", "" Bizzozero's corpuscle/cell "", ' Blood Platelets ', ' Bone Marrow Reticuloendothelial System ', ' Bone Marrow ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Systematics ', ' Classification ', ' Cues ', ' Elements ', ' balance function ', ' balance ', ' Equilibrium ', ' Europe ', ' Gene Expression ', ' Genes ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' hematopoietic stem progenitor cell ', ' hematopoietic progenitor ', ' Hematopoietic Progenitor Cells ', ' Blood Precursor Cell ', ' Hematopoietic stem cells ', ' Histones ', ' Influentials ', ' Megakaryocytes ', ' Megalokaryocyte ', ' Blood megakaryocyte ', ' Methods ', ' Methylation ', ' Microtubules ', ' Micro-tubule ', ' Organ Transplantation ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Transplantation Surgery ', ' Organ Transplants ', ' Grafting Procedure ', ' Patients ', ' Phenotype ', ' Play ', ' Radiation therapy ', ' treatment with radiation ', ' radio-therapy ', ' radiation treatment ', ' Radiotherapy ', ' Radiotherapeutics ', ' Reagent ', ' Nucleic Acid Regulatory Sequences ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Repression ', ' Risk ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Specificity ', ' Stem cells ', ' Progenitor Cells ', ' Supervision ', ' Thrombocytopenia ', ' Thrombopenia ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Levotryptophan ', ' L-Tryptophan ', ' Tryptophan ', ' Divalproex ', ' Depakote ER ', ' Depakote ', ' Valproic Acid ', ' Work ', ' Histone Acetylase ', ' histone acetyltransferase ', ' Generations ', ' forest ', ' transcription factor GATA-2 ', ' NF-E1b protein ', ' GATA-binding protein 2 ', ' GATA-2 protein ', ' GATA2 transcription factor ', ' Dataset ', ' Data Set ', ' fetal cord blood ', ' Cord Blood ', ' Umbilical Cord Blood ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' Fusion Protein ', ' Chimera Protein ', ' Chimeric Proteins ', ' base ', ' improved ', ' TRNSF ', ' Transfusion ', ' Site ', ' Biological ', ' Chemicals ', ' prognostic ', ' Training ', ' Hematopoietic ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Computational Biology ', ' computer biology ', ' Life ', ' Pattern ', ' Techniques ', ' System ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' novel ', ' Somatic Cell ', ' high throughput screening ', ' High Throughput Assay ', ' histone modification ', ' sarcoma ', ' malignant soft tissue tumor ', ' Malignant Soft Tissue Neoplasm ', ' small molecule ', ' CD34 gene ', ' HPCA1 ', ' CD34 ', ' Deacetylase ', ' GATA1 gene ', ' transcription factor NFE-1 ', ' nuclear factor-erythroid 1 ', ' globin transcription factor 1 ', ' Transcription Factor GATA1 ', ' NFE1 protein ', ' NF-E1 erythroid-specific transcription factor ', ' GF-1 protein ', ' GATA1 transcription factor ', ' GATA1 protein ', ' GATA1 ', ' GATA-1 ', ' GATA Binding Protein 1 ', ' ERYF1 ', ' HDAC6 gene ', ' histone deacetylase 6 ', ' KIAA0901 ', ' HDAC6 ', ' Signaling Protein ', ' Signaling Pathway Gene ', ' Signaling Factor Proto-Oncogene ', ' HDAC3 gene ', ' histone deacetylase 3 ', ' RPD3-2 ', ' HDAC3 enzyme ', ' HDAC3 ', ' Address ', ' Data ', ' Deacetylation ', ' Histone Deacetylase Inhibitor ', ' Histone deacetylase inhibition ', ' HDAC inhibitor ', ' HDAC Agent ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Regulatory Element ', ' Supplementation ', ' Cell Growth and Maintenance ', ' Cell Maintenance ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Process ', ' Modification ', ' stem cell differentiation ', ' epigenomics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' desensitization ', ' Population ', ' chemotherapy ', ' progenitor ', ' stem cell biology ', ' large scale production ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' epigenetic marker ', ' epigenetic biomarker ', ' epigenome ', ' high dimensionality ', ' ']",NHLBI,NORTHWESTERN UNIVERSITY,F31,2017,38039,IL-07,0.052967714558916294
"Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations Abstract With the advent of new DNA sequencing technologies, genomic data has moved to the forefront in the quest for individualized medicine. However, the lack of new computational tools to interpret and exploit the deluge of genomic data has severely hampered its clinical benefit. A further complication is that clinical genomic data is often obtained from tissues containing a mixture of different cell types. For example, tumor samples are a mixture of tumor subclones and normal cell lineages. As a platform for understanding this heterogeneity in tumor cell populations, our studies will focus on DNA methylation changes in diffuse large B-cell lymphoma (DLBCL), the most prevalent, aggressive form of Non-Hodgkin Lymphoma (NHL). DNA methylation is cell type- specific, likely contributes to the phenotypic variation in tumor subclones, and plays key roles in gene regulation and lymphoma pathogenesis. Defining the methylation and transcriptional profiles of tumor subclones is necessary to identify potential drug targets, predict disease progression, and identify overall prognosis. Further, current computational approaches to understand epigenetic heterogeneity are not well- suited for tumor analysis and do not link epigenetic changes to expression. Here, we propose to develop a new computational approach that uses genomic methylation data from bulk samples to define DNA methylation- and expression-based subclonal populations and relate these populations to disease progression. Our approach exploits the fact that methylation levels are an accurate measure of the underlying distribution of allelic methylation states in the tumor (e.g. 30% methylation means 30% of the alleles are methylated). Our approach takes genome-wide methylation data as input, and outputs the number of subpopulations, their respective proportions, and each underlying subpopulations DNA methylation profile. After deconvolution, we will extend our previous work showing that DNA methylation profiles are predictive of expression levels, and apply tools from machine learning to estimate the relative expression profiles in each subpopulation. This approach will allow us to take advantage of the vast amount of data currently being collected in large-scale sequencing projects and obtain genome-wide methylation information from cellular subpopulations even when surface markers cannot be used to physically separate the different subpopulations. Lastly, we will assess the clinical relevance of these approaches by using them to understand the molecular changes found in tumor subpopulations from samples of relapsed DLBCL. We envision these methods can be applied as investigative tools first, and later as cost-effective clinical tools, to analyze the epigenetic and transcriptomic heterogeneity in different tumor types and diseased tissues. Public Narrative Tumors, including B-cell lymphomas, are comprised of heterogeneous populations of cells. Decoding the regulatory circuitry in these sub-populations is critical to understanding tumor metastasis, therapy resistance and relapse. We propose to develop a new computational approach to use genome-wide measurements of DNA methylation in primary tumors to understand the regulatory landscape of these subpopulations. All software will be made publically available to broadly advance cancer-research nationwide. Results from this work will improve our understanding of molecular mechanisms of B cell lymphoma development and relapse.",Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations,9317775,R21LM012395,"['Allelomorphs ', ' Alleles ', ' Antibodies ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cell Number ', ' Cell Count ', ' Cell Body ', ' Cells ', ' Complication ', ' Disorder ', ' Disease ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' lymph nodes ', ' lymph gland ', ' Lymph node proper ', ' Lymph Node Reticuloendothelial System ', ' Lymphoma ', ' Reticulolymphosarcoma ', ' Malignant Lymphoma ', ' Germinoblastoma ', ' Germinoblastic Sarcoma ', "" Non-Hodgkin's Lymphoma "", ' non-Hodgkins lymphoma ', ' non-Hodgkins disease ', ' Nonhodgkins Lymphoma ', ' Methods ', ' Methodology ', ' Methylation ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Research ', ' Computer software ', ' Software ', ' Technology ', ' Tissues ', ' Body Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' B lymphoma ', ' B-Cell Lymphomas ', ' Measures ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' prognostic ', ' Training ', ' Hematopoietic ', ' Measurement ', ' Disease Progression ', ' Germinal Center ', ' Structure of germinal center of lymph node ', ' Cell Lineage ', ' Therapeutic ', ' cancer cell ', ' Malignant Cell ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' programs ', ' cell type ', ' Techniques ', ' neoplastic cell ', ' Tumor Cell ', ' Primary Neoplasm ', ' Primary Tumor ', ' Pathogenesis ', ' Modeling ', ' Sampling ', ' Advanced Malignant Neoplasm ', ' Advanced Cancer ', ' Genomics ', ' Normal Cell ', ' Address ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Mixed Cellular Population ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Large-Scale Sequencing ', ' Molecular ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' cost ', ' cancer research ', ' anticancer research ', ' computational tools ', ' computerized tools ', ' cost effective ', ' cost-effective ', ' Population ', ' Resistance ', ' resistant ', ' transcriptomics ', ' clinically relevant ', ' clinical relevance ', ' chemotherapy ', ' tumor ', ' genome-wide ', ' genomewide ', ' genome scale ', ' genome wide methylation ', ' global methylation ', ' genomewide methylation ', ' Drug Targeting ', ' epigenome ', ' Genomic DNA ', ' gDNA ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' clinical sequencing ', ' tumor heterogeneity ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' genomic data ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2017,220064,MO-01,0.07073673625082477
"DNA Sequencing Using Single Molecule Electronics PROJECT SUMMARY / ABSTRACT  Progress in DNA sequencing has occurred through multiple stages of disruptive new technologies being introduced to the field, each of which has increased sequencing capabilities by lowering costs, improving throughput, and reducing errors. The goal of this research project is to investigate a new, all-electronic sequencing method that has the potential to become the next transformative step for DNA sequencing. This new method is based on single DNA polymerase molecules bound to nanoscale electronic transistors, a hybrid device that transduces the activity of a single polymerase molecule into an electronic signal.  The goal of this research project is to determine whether these hybrid polymerase-transistors are truly applicable to DNA sequencing and the competitive environment of advanced sequencing technologies. To answer this question, the project teams the scientists who have developed the devices with Illumina, Inc., a worldwide leader in the DNA sequencing market. The experiments proposed here build on encouraging preliminary results, first to demonstrate accurate DNA sequencing and second to evaluate whether the new technique could become a competitive challenge to other sequencing methods. The interdisciplinary team will combine state-of-the-art techniques from protein engineering, nanoscale fabrication, and machine learning to customize polymerase's activity and its interactions with the electronic transistors. If successful, nanoscale solid-state devices like transistors provide one of the best opportunities for increasing sequencing capabilities while decreasing sequencing costs, so that DNA sequencing can become a standard technique in health care and disease treatment. PROJECT NARRATIVE  Over the past two decades, DNA sequencing has transformed from a heroic, nearly impossible task to a routine component of modern laboratory research. The field of DNA sequencing has improved tremendously through a strategy of modifying and monitoring polymerases, a key enzyme at the heart of many DNA sequencing technologies. This proposal is motivated by developments in the field of single-molecule electronics, which provide an entirely new mode for listening to the activity of single polymerase molecules. This electronic method is very different from the biochemical, optical, or nanopore-based techniques currently in use, and it has inherent advantages that could provide exciting possibilities for DNA sequencing. The project will tailor single-molecule electronics for the specific purpose of DNA sequencing and determine whether this strategy could lead to a new generation of sequencing technology.",DNA Sequencing Using Single Molecule Electronics,9353854,R01HG009188,"['Affect ', ' Carbon ', ' Charge ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Dependent DNA Polymerases ', ' DNA Polymerases ', ' DNA-Directed DNA Polymerase ', ' Single-Stranded DNA ', ' electronic device ', ' Electronics ', ' Enzyme Gene ', ' Enzymes ', ' Foundations ', ' Goals ', ' Heart ', ' Hybrids ', ' Laboratory Research ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' Molecular Models ', ' Modernization ', ' Motion ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Noise ', ' Nucleotides ', ' Optics ', ' optical ', ' Protein Engineering ', ' protein design ', ' genetic protein engineering ', ' Proteins ', ' Publishing ', ' Reading ', ' Research ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Technology ', ' Temperature ', ' Transistors ', ' Work ', ' Generations ', ' health care ', ' Healthcare ', ' Custom ', ' base ', ' improved ', ' Site ', ' Surface ', ' Variation ', ' Variant ', ' Biochemical ', ' Individual ', ' enzyme activity ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Event ', ' Route ', ' Techniques ', ' System ', ' Performance ', ' solid state ', ' molecular modeling ', ' Molecular Modeling Protein/Amino Acid Biochemistry ', ' Molecular Modeling Nucleic Acid Biochemistry ', ' Base Pairing ', ' novel ', ' new technology ', ' novel technologies ', ' Modality ', ' Devices ', ' response ', ' Nanotechnology ', ' nanotechnological ', ' nanotech ', ' nano-technological ', ' nano technology ', ' nano tech ', ' single molecule ', ' Polymerase ', ' Data ', ' Reproducibility ', ' Resolution ', ' Enzyme Kinetics ', ' Monitor ', ' Modification ', ' developmental ', ' Development ', ' cost ', ' nano electronics ', ' nanoelectronics ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanoscale ', ' nano pore ', ' nanopore ', ' single walled carbon nano tube ', ' SWNT ', ' single walled carbon nanotube ', ' scale up ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' collaborative environment ', ' workplace environment ', ' workplace climate ', ' work environment ', ' supportive environment ', ' peer-group environment ', ' job environment ', ' interdisciplinary environment ', ' interactive environment ', ' informal environment ', ' enthusiastic environment ', ' competitive environment ', ' business-friendly environment ', ' experimental study ', ' experimental research ', ' experiment ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' ']",NHGRI,UNIVERSITY OF CALIFORNIA-IRVINE,R01,2017,438098,CA-45,0.06306426354659805
"Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data     DESCRIPTION (provided by applicant): This project involves the development of new statistical methodologies and computational tools for network-based integrative analysis of epigenetic risk factors of cardiovascular diseases (CVD). While the advent of omics data from new technologies has facilitated the study of epigenetic factors, existing methodologies often do not account for complexities of biological data  such as correlations due to interactions of genes/proteins as part of biological pathways  and fail to eciently integrate diverse omics data sets  for instance genetic variation, DNA methylation and gene expression. The methodologies proposed in this project, and the software tools that will be developed to implement them, address these shortcomings, and facilitate further research by the biomedical community to gain a better understanding of the underlying biology of CVD, and to develop new diagnostic biomarkers and potential targets for therapies. The proposed methodologies are motivated by the study of epigenetic data from the Multi-Ethnic Study of Atherosclerosis (MESA), and include (i) a network-based pathway enrichment analysis method that incorporates available knowledge of interactions among genes and proteins while complementing and rening such information (Aim 1A), as well as its extension for analysis of multiple types of omics data (Aim 1B), and (ii) an integrative analysis framework to identify associations among gene expression levels and DNA methylation (Aim 2A) and identify common epigenetic factors of multiple CVD phenotypes through integrated analysis of DNA methylation and mRNA expression data (Aim 2B). We will develop ecient and user-friendly software tools for the proposed methods (Aim 3), which will be made freely available to the public after extensive tests using both simulated data, as well as real data from MESA. PUBLIC HEALTH RELEVANCE: The proposed research addresses the need for development of new statistical machine learning methods for analysis of diverse epigenetic data from multiple cardiovascular disease outcomes. The proposed training activities are designed to enhance the applicant's knowledge of epigenetics and physiology of cardiovascular diseases (CVD), and to further his career as an independent investigator in the area of computational epigenetics for CVD.",Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data,9194309,K01HL124050,"['Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Biology ', ' Biomedical Research ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' cardiovascular function ', ' Cardiovascular Physiology ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Gene Expression ', ' Genes ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Information Networks ', ' Joints ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Methods ', ' Methodology ', ' Methylation ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Software Tools ', ' Computer Software Tools ', ' stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Testing ', ' training module ', ' Training Activity ', ' Genetic Diversity ', ' Genetic Variation ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' DNA analysis ', ' Area ', ' Biological ', ' Individual ', ' Dyslipidemias ', ' Measurement ', ' Genetic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Source ', ' System ', ' gene interaction ', ' user friendly software ', ' user friendly computer software ', ' Structure ', ' Disease Outcome ', ' novel ', ' member ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Gene Proteins ', ' Protein Gene Products ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Pathway Analysis ', ' Network Analysis ', ' response ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' histone modification ', ' Address ', ' Data ', ' Post-Transcriptional Regulation ', ' Post-Transcriptional Regulation Process ', ' Post-Transcriptional Control ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' mRNA Expression ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Exogenous Factors ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Outcome ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' therapeutic target ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' epigenetic marker ', ' epigenetic biomarker ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning network ', ' learning strategy ', ' learning method ', ' learning activity ', ' training opportunity ', ' multiple omics ', ' diagnostic biomarker ', ' diagnostic marker ', ' whole genome ', ' entire genome ', ' high dimensionality ', ' Multi-Ethnic Study of Atherosclerosis ', ' ']",NHLBI,UNIVERSITY OF WASHINGTON,K01,2017,137416,WA-07,0.16987156479436125
"DNA Sequencing Using Single Molecule Electronics PROJECT SUMMARY / ABSTRACT  Progress in DNA sequencing has occurred through multiple stages of disruptive new technologies being introduced to the field, each of which has increased sequencing capabilities by lowering costs, improving throughput, and reducing errors. The goal of this research project is to investigate a new, all-electronic sequencing method that has the potential to become the next transformative step for DNA sequencing. This new method is based on single DNA polymerase molecules bound to nanoscale electronic transistors, a hybrid device that transduces the activity of a single polymerase molecule into an electronic signal.  The goal of this research project is to determine whether these hybrid polymerase-transistors are truly applicable to DNA sequencing and the competitive environment of advanced sequencing technologies. To answer this question, the project teams the scientists who have developed the devices with Illumina, Inc., a worldwide leader in the DNA sequencing market. The experiments proposed here build on encouraging preliminary results, first to demonstrate accurate DNA sequencing and second to evaluate whether the new technique could become a competitive challenge to other sequencing methods. The interdisciplinary team will combine state-of-the-art techniques from protein engineering, nanoscale fabrication, and machine learning to customize polymerase's activity and its interactions with the electronic transistors. If successful, nanoscale solid-state devices like transistors provide one of the best opportunities for increasing sequencing capabilities while decreasing sequencing costs, so that DNA sequencing can become a standard technique in health care and disease treatment. PROJECT NARRATIVE  Over the past two decades, DNA sequencing has transformed from a heroic, nearly impossible task to a routine component of modern laboratory research. The field of DNA sequencing has improved tremendously through a strategy of modifying and monitoring polymerases, a key enzyme at the heart of many DNA sequencing technologies. This proposal is motivated by developments in the field of single-molecule electronics, which provide an entirely new mode for listening to the activity of single polymerase molecules. This electronic method is very different from the biochemical, optical, or nanopore-based techniques currently in use, and it has inherent advantages that could provide exciting possibilities for DNA sequencing. The project will tailor single-molecule electronics for the specific purpose of DNA sequencing and determine whether this strategy could lead to a new generation of sequencing technology.",DNA Sequencing Using Single Molecule Electronics,9531422,R01HG009188,"['Affect ', ' Carbon ', ' Charge ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA-Directed DNA Polymerase ', ' DNA-Dependent DNA Polymerases ', ' DNA Polymerases ', ' Single-Stranded DNA ', ' Electronics ', ' electronic device ', ' Enzymes ', ' Enzyme Gene ', ' Foundations ', ' Goals ', ' Heart ', ' Hybrids ', ' Laboratory Research ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' Modernization ', ' Motion ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Noise ', ' Nucleotides ', ' Optics ', ' optical ', ' Protein Engineering ', ' protein design ', ' genetic protein engineering ', ' Proteins ', ' Publishing ', ' Reading ', ' Research ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Technology ', ' Temperature ', ' Transistors ', ' Work ', ' Generations ', ' Healthcare ', ' health care ', ' Custom ', ' base ', ' improved ', ' Site ', ' Surface ', ' Variation ', ' Variant ', ' Biochemical ', ' Individual ', ' enzyme activity ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Collaborations ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Event ', ' Route ', ' Techniques ', ' System ', ' Performance ', ' solid state ', ' molecular modeling ', ' Molecular Models ', ' Molecular Modeling Protein/Amino Acid Biochemistry ', ' Molecular Modeling Nucleic Acid Biochemistry ', ' Base Pairing ', ' novel ', ' new technology ', ' novel technologies ', ' Modality ', ' Devices ', ' response ', ' Nanotechnology ', ' nanotechnological ', ' nanotech ', ' nano-technological ', ' nano technology ', ' nano tech ', ' single molecule ', ' Polymerase ', ' Data ', ' Reproducibility ', ' Resolution ', ' Enzyme Kinetics ', ' Monitor ', ' Modification ', ' developmental ', ' Development ', ' cost ', ' nano electronics ', ' nanoelectronics ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanoscale ', ' nano pore ', ' nanopore ', ' single walled carbon nano tube ', ' SWNT ', ' single walled carbon nanotube ', ' scale up ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Massive Parallel Sequencing ', ' workplace environment ', ' workplace climate ', ' work environment ', ' supportive environment ', ' peer-group environment ', ' job environment ', ' interdisciplinary environment ', ' interactive environment ', ' informal environment ', ' enthusiastic environment ', ' competitive environment ', ' business-friendly environment ', ' collaborative environment ', ' experimental research ', ' experiment ', ' experimental study ', ' DNAseq ', ' DNA seq ', ' DNA sequencing ', ' ']",NHGRI,UNIVERSITY OF CALIFORNIA-IRVINE,R01,2018,468098,CA-45,0.06306426354659805
"Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection Distal sensory polyneuropathy (DSPN) remains the most common neurological complication in HIV-infected population. Opiates and cocaine are often misused to manage neuropathic pain. These drugs, in turn, increase the risk of DSPN and exacerbate DSPN severity. The interplay of DSPN and substance use disorder (SUD) is associated with morbidity and mortality in HIV-infected individuals. Although neurotoxic effects of HIV-1 gp120 and antiretroviral medications contribute to DSPN through dysregulation of pro-inflammation genes, little is known about the mechanisms of DSPN and DSPN with comorbid SUD. A major barrier to advancing our understanding of DSPN is the inaccessibility of nerve tissues in living individuals and the absence of reliable biomarkers to inform the diagnosis of DSPN in the setting of SUD and HIV infection. Our overarching goal is to discover the DNA methylation signatures for DSPN, SUD, and their comorbidity. We focus on white blood cells (WBCs) because of their role in orchestrating and effecting immune responses and because they are highly accessible tissues. We hypothesize that DSPN emerges in the context of HIV infection as the result of HIV-1 enhanced expression of proinflammatory genes in many cell types, including WBCs. We also hypothesize that DSPN emerges as the result of SUD-enhanced expression of proinflammatory genes in WBCs. Thus, DNA methylation in WBCs is associated with DSPN that is influenced by SUD and contributes to HIV outcomes. To test the hypotheses, we will select methylation features in WBCs for DSPN, SUD, and their comorbidity using a combination of epigenome-wide association study (EWAS) and ensemble-based machine learning approaches. Leveraging two well-established independent cohorts, we will first identify methylation sites in WBCs for DSPN and SUD in four groups (DSPN+/SUD+, DSPN+/SUD-, DSPN-/SUD+, DSPN-/SUD-) in 2,000 HIV- infected samples using a 2-stage EWAS followed by a meta-EWAS. We will then select methylation features using machine learning methods and test the sensitivity and specificity to differentiate DSPN, SUD, and their comorbidity. We will apply our in-house developed bioinformatic package, smartFeatureSelection. The selected features will test associations with immune resilience (i.e. CD4+/CD8+) and HIV outcomes (i.e. frailty, mortality). Finally, we will explore the biological functions of the identified methylation sites in postmortem human brain and blood (N = 80) by RNA-seq and correlate methylation-regulated gene expression between WBCs and neural cells. We expect to discover a set of biologically meaningful methylation features as a marker for HIV- infected DSPN and SUD that can predict resilience and outcomes. Employing a rigorous design and a powerful computational approach, this application proposes the first epigenome-based prediction for DSPN, SUD, and their interaction. The identified features can serve as a biomarker for this complex condition and have potential clinical use. The results will enhance the knowledge of epigenetic mechanisms in blood and in brain for HIV-infected DSPN and SUD. Distal sensory polyneuropathy and substance use disorder are common in the HIV-infected population and can impact immune resilience and HIV outcomes. Applying a combination of epigenome-wide association and machine learning approaches, we aim to identify a panel of DNA methylation features in white blood cells for HIV-associated distal sensory polyneuropathy and substance misuse that link to immune resilience, HIV frailty and mortality. The selected features can serve as biomarker for neuropathy and enhance our understanding of the interplay between neuropathy and substance misuse in HIV-infected population.",Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection,9687814,R01DA047820,"['HIV-I ', ' Human ', ' Modern Man ', ' Infection ', ' Inflammation ', ' Leukocytes ', ' white blood corpuscle ', ' white blood cell ', ' White Cell ', ' White Blood Cells ', ' Marrow leukocyte ', ' Leukocytes Reticuloendothelial System ', ' Blood leukocyte ', ' Light ', ' Photoradiation ', ' Methods ', ' Methylation ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nerve Tissue ', ' Nervous Tissue ', ' Neurons ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Risk ', ' Role ', ' social role ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Substance Use Disorder ', ' Syndrome ', ' Testing ', ' Thalamic structure ', ' thalamic ', ' Thalamus ', ' Tissues ', ' Body Tissues ', ' Veterans ', ' Polyneuropathy ', ' base ', ' Distal ', ' Site ', ' Clinical ', ' Biological ', ' Neurological ', ' Neurologic ', ' Link ', ' Individual ', ' Opiates ', ' Opioid ', ' Biological Function ', ' Biological Process ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' frailty ', ' Immune ', ' Immunes ', ' Severities ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Neuropathy ', ' neuropathic ', ' Sensory ', ' cell type ', ' Pattern ', ' brain tissue ', ' Performance ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' cohort ', ' Genetic Fingerprintings ', ' DNA Typing ', ' DNA Profiling ', ' DNA Fingerprinting ', ' Disease Outcome ', ' novel ', ' Modeling ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' immune function ', ' Cellular Immune Function ', ' CD8B1 gene ', ' LYT3 ', ' CD8B1 ', ' CD8B ', ' CD8 ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' neuropathic pain ', ' painful neuropathy ', ' epigenomics ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Advanced Development ', ' designing ', ' design ', ' resilience ', ' Outcome ', ' Population ', ' Prevalence ', ' Impairment ', ' neurotoxic ', ' biosignature ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' cocaine use ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' epigenome ', ' model building ', ' learning method ', ' learning activity ', ' learning strategy ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid use ', ' medication misuse ', ' drug misuse ', ' substance misuse ', ' Womens Interagency HIV Study ', ' Aging ', ' Association Learning ', ' Autopsy ', ' postmortem ', ' necropsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cocaine ', ' Cohort Studies ', ' Concurrent Studies ', ' Comorbidity ', ' co-morbidity ', ' Complication ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Fingerprint ', ' Gene Expression ', ' Genes ', ' Goals ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Envelope Protein gp120 ', ' gp120(HIV) ', ' gp120 ENV Glycoprotein ', ' gp120 ', ' HTLV-III gp120 ', ' HIV env Protein gp120 ', ' HIV Envelope Glycoprotein gp120 ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' ']",NIDA,YALE UNIVERSITY,R01,2018,606847,CT-03,0.010419038064296244
"FASEB SRC on Transcription, Chromatin, & Epigenetics Summary The goal of this meeting is to cover the regulation and role of epigenetic mechanisms at the nexus between aging and cancer. Epigenetic mechanisms encompass post-translational modifications of chromatin and RNA as well as transcriptional regulation. This FASEB meeting will be unique in integrating the latest discoveries in epigenetics and their importance in aging and cancer. Indeed, exciting recent studies have revealed how organismal aging can be regulated by epigenetic mechanisms. As age is one of the largest risk factors for cancer, epigenetic dysfunction could provide a long sought after link between aging and cancer. There is a vital need for such a meeting. The field of epigenetic is rapidly expanding, and the aging and cancer fields need to benefit from the latest and greatest discoveries in this area. Conversely, challenges and questions about the role of epigenetics in aging and cancer abound, and it is critical for researchers in the chromatin and transcription fields to better grasp the implications of their work for health and disease. This FASEB meeting will discuss the most cutting-edge questions in field of chromatin, transcription, and epigenetics. A key topic will be the underlying molecular basis of epigenetic mechanisms. The question of how these mechanisms get dysregulated during disease or normal aging will also be discussed. The meeting will also cover new frontiers, including the contribution of non-coding RNA to epigenetic mechanisms and the exciting emerging field of RNA epigenetic. The meeting will particularly focus on transformative epigenomic technologies and machine learning approaches and how they can be used to interrogate changes in epigenetic landscapes in cells from individuals at different ages or in different types of cancers. This meeting should foster new fundamental knowledge and information, new methodology and technical capabilities, and interdisciplinary collaborations. The meeting will also provide a uniquely interactive forum for trainees and new investigators, highlighting their research through short talks, poster teasers and sessions and promoting several networking and meet-the-expert events. ! ! Narrative This application seeks funding to support the participation of junior investigators at the 2018 FASEB science research conference on Transcription, Chromatin, & Epigenetics, held in Florence, Italy on September 16th  21st, 2018. The main objective is to promote interdisciplinary discussion and collaboration among junior and senior physician- scientists and research scientists in fields related to chromatin, transcription, and epigenetics. Epigenetic mechanisms play central roles in cellular and organismal health. Dysregulation of epigenetic mechanisms is pivotal for aging and for several human diseases, notably cancer.","FASEB SRC on Transcription, Chromatin, & Epigenetics",9684684,R13AG060682,"['Age ', ' ages ', ' Aging ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Explosion ', ' Future ', ' Goals ', ' Health ', ' Italy ', ' Learning ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Physicians ', ' Play ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Role ', ' social role ', ' Science ', ' Technology ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Work ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' base ', ' Area ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' Link ', ' Grips ', ' grasp ', ' insight ', ' Discipline ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Fostering ', ' Funding ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' posters ', ' Scientist ', ' Event ', ' interest ', ' meetings ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' Regulation ', ' career development ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' chromatin modification ', ' histone modification ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' epigenomics ', ' frontier ', ' cancer type ', ' innovative ', ' innovate ', ' innovation ', ' human disease ', ' normal aging ', ' epigenetic regulation ', ' single cell technology ', ' ']",NIA,FEDERATION OF AMER SOC FOR EXPER BIOLOGY,R13,2018,51000,MD-08,0.07580475955477634
"Robust Control of the Stem Cell Niche Diana Arguijo has a unique background with a double major in biomedical engineering (BME) and electrical and computer engineering (ECE). Leveraging her strong mathematical background, she will develop computational techniques to identify patterns of epigenetic reprogramming during epithelial development and patterns of real- time electrical recoding of the GI tract reflective of sacral nerve modulation. Her work will provide insights into the robustness and plasticity of underlying biological control schemes. Diana Arguijo will develop machine-learning based computational techniques to analyze epigenetic reprogramming of epithelial development and electrical activities of the enteric nervous system. Her analyses will provide insights into the robustness and plasticity of tissue regulation.",Robust Control of the Stem Cell Niche,9731853,R35GM122465,"['Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Computers ', ' Engineering ', ' Gastrointestinal tract structure ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Mathematics ', ' Math ', ' Time ', ' Tissues ', ' Body Tissues ', ' Work ', ' base ', ' Biological ', ' Enteric Nervous System ', ' Epithelial ', ' Sacral nerve ', ' insight ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Pattern ', ' Regulation ', ' Computational Technique ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Scheme ', ' developmental ', ' Development ', ' stem cell niche ', ' ']",NIGMS,DUKE UNIVERSITY,R35,2018,42822,NC-04,0.08301238163669451
"Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes     DESCRIPTION (provided by applicant): Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal blood disorders characterized by ineffective hematopoiesis that can lead to bone marrow failure and progression to acute myeloid leukemia (AML). Aberrant DNA hypermethylation is characteristic of this disorder and, as such, DNA methyltransferase inhibitors (DMTis) are often used to treat MDS in lieu of conventional chemotherapies that have proven to be ineffective for this disease. However, even with DMTi therapy, only about one third of MDS patients achieve a clinical response leading to a survival benefit. Moreover, current DMTi-based regimens for MDS require a minimum of 6 months of treatment before a patient can be deemed resistant to this therapy. Given that only ~30-40% of patients respond to this treatment, the majority of patients will spend 6 months receiving a therapy to which they are unlikely to respond. Therefore, the identification of molecular differences that distinguish between sensitive and resistant patients at the time of diagnosis is critical in order to harness these differences for the development of molecular biomarkers predictive of DMTi response. These biomarkers would allow us to more accurately risk-stratify these patients and prevent unwarranted and ineffective therapy for resistant patients. Using next-generation sequencing technology we performed genome-wide DNA methylation, gene expression and mutational analysis on a cohort of patients with chronic myelomonocytic leukemia (CMML), an MDS/MPN overlap syndrome, including both sensitive and resistant patients to the DMTi Decitabine (DAC). We found that robust epigenetic and gene expression differences exist between DMTi responders and non-responders. From these differences, we were able to develop an epigenetic classifier that predicts response to decitabine therapy in these patients with 87% accuracy. Moreover, using RNA-seq we identified a gene expression signature associated with primary resistance to DAC in CMML. Based on these data, we hypothesize that comparable differences are likely to be found in MDS patients who are either sensitive or resistant to the DMTi Azacytidine (AZA), and that these too have the potential to be used as the basis of a molecular classifier of response as well as to identify mechanisms of primary resistance to the drug. We propose to perform genome-wide studies DNA methylation and expression studies in a cohort of 250 MDS patients treated with AZA in order to identify DNA methylation and expression biomarkers predictive of response to this agent in MDS. From these studies, we expect to be able to develop clinically useful biomarkers that can be translated to CLIA-compatible technologies that can be applied in molecular diagnostics labs. PUBLIC HEALTH RELEVANCE: Myelodysplastic syndromes (MDS) are the most common hematological disorder of the elderly. To date, the only effective therapies are the DNA methyltransferase inhibitors (Azacytidine and Decitabine), but even with this therapy, approximately 60% of patients do not respond. Currently there are no accurate molecular biomarkers that may help risk-stratify patients at the time of diagnosis, and therefore a vast majority of patients are forced to receive up to 6 months of Azacytidine before they can be offered alternative therapies. Moreover, it is unclear why some patients respond while others don't. Therefore, it is of the utmost urgency that we develop more accurate ways of risk-stratifying patients at the time of diagnosis in order to prevent the unwarranted treatment of a large fraction of patients who are unlikely to ever respond to these agents as well as to identify novel alternative therapeutic targets.",Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,9483343,R01HL126947,"['Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Algorithms ', ' Azacitidine ', ' ladakamycin ', ' Azacytidine ', ' AZC ', ' 5-Azacytidine ', ' 5-Aza-cytidine ', ' 5-AC ', ' 5 AZC ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Classification ', ' Systematics ', ' cytopenia ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Exons ', ' Gene Expression ', ' Genome ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematopoiesis ', ' Hematopoietic Cellular Control Mechanisms ', ' Introns ', ' Intervening Sequences ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Acute Myelocytic Leukemia ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Chronic Myelomonocytic Leukemia ', ' Dysmyelopoietic Syndromes ', ' myelodysplasia ', ' Smoldering Leukemia ', ' Refractory anaemia with excess blasts ', ' Refractory Anemia with an Excess of Blasts ', ' Myelodysplastic Syndromes ', ' Pancytopenia ', ' Bone marrow failure ', ' Patients ', ' Play ', ' Promoter Regions ', ' genetic promoter element ', ' Promotor Regions ', ' Nucleic Acid Regulatory Sequences ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Risk ', ' Role ', ' social role ', ' Syndrome ', ' Technology ', ' Time ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Translating ', ' Decitabine ', ' Dezocitidine ', ' Deoxyazacytidine ', ' 5-deoxyazacytidine ', ' 5-Azadeoxycytidine ', ' Enhancers ', ' base ', ' Distal ', ' Clinical ', ' Biological ', ' peripheral blood ', ' CpG-Rich Islands ', ' CpG Islands ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Disease Management ', ' Disorder Management ', ' Chemotherapy-Oncologic Procedure ', ' cancer chemotherapy ', ' Quimioterapia ', ' Combination Chemotherapy Regimen ', ' Chemotherapy, Cancer, General ', ' Chemotherapy Regimen ', ' Chemotherapy Protocol ', ' Gene Mutation ', ' Gene Alteration ', ' cohort ', ' novel ', ' Mutation Analysis ', ' response ', ' Genomics ', ' Alternative Therapies ', ' prevent ', ' preventing ', ' Hypercellular Bone Marrow ', ' Ineffective Hematopoiesis ', ' PPBP gene ', ' -Thromboglobulin ', ' -TG ', ' beta-Thromboglobulin ', ' Thromboglobulin, Beta-1 ', ' Thrombocidin 2 ', ' Thrombocidin 1 ', ' TGB1 ', ' TC2 ', ' TC1 ', ' Small Inducible Cytokine Subfamily B, Member 7 ', ' SCYB7 ', ' Pro-Platelet Basic Protein ', ' Platelet Basic Protein ', ' PPBP ', ' PBP protein ', ' PBP gene ', ' Neutrophil-Activating Peptide 2 ', ' NAP2 ', ' NAP-2 ', ' LA-PF4 ', ' Connective Tissue-Activating Peptide III ', ' CXCL7 ', ' CXC Chemokine Ligand 7 ', ' CTAPIII ', ' CTAP3 ', ' CTAP III ', ' Beta-TG ', ' ITGB3 gene ', ' Platelet Fibrinogen Receptor, Beta Subunit ', ' PTP gene ', ' NAIT ', ' Integrin Beta 3 ', ' ITGB3 ', ' GP3A ', ' GP IIIa ', ' CD61 ', ' DNA Methyltransferase Inhibitor ', ' Data ', ' Hypermethylation ', ' in vivo ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' Gene Expression Profile ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' next generation ', ' resistant ', ' Resistance ', ' chemotherapy ', ' therapeutic target ', ' genome-wide identification ', ' genome wide studies ', ' genome wide analysis ', ' genome-wide analysis ', ' overexpress ', ' over-expression ', ' overexpression ', ' public health relevance ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' effective treatment ', ' effective therapy ', ' molecular biomarker ', ' molecular marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' genomewide ', ' genome scale ', ' genome-wide ', ' Regimen ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Massive Parallel Sequencing ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' bisulfite sequencing ', ' transcriptional differences ', ' differentially expressed ', ' differential expression ', ' response prediction ', ' predictor of response ', ' predictive response ', ' prediction of response ', ' predicting response ', ' stratified patient ', ' patient stratification ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' response markers ', ' response biomarker ', ' responders vs non-responders ', ' responders versus non-responders ', ' responders or non-responders ', ' responders from non-responders ', ' responders and non-responders ', ' unnecessary treatment ', ' molecular diagnostics ', ' ineffective treatment ', ' ineffective therapies ', ' Expression Profiling ', ' ']",NHLBI,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2018,389800,FL-27,0.16249167426461603
"Molecular images and machine learning to extractplacental function from maternalcfDNA Abstract  Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. cfDNA is fragmented with sizes centered around 145bp and 166bp which is approximately the length of DNA wrapped around a nucleosome, and a nucleosome plus its linker, respectively. Shorter fragments (30-100bp) also exist and have a clear periodicity of 10bp, corresponding to a turn of the DNA helix wrapped around the core histone. Recent reports have shown that the fragmentation sizes of cfDNA are tissue specific, which is a product of distinct nucleosome spacing that is inherent in the function of individual tissues. When these individual fragments are compared with existing epigenetic data from tissues, they can be binned into cell of origin simply based on whether they reveal the nucleosome positioning information of the originating tissue. Identifying cfDNA fragments of placental origin from maternal circulation would provide a non-invasive means of assessing placental function during human pregnancy.  Several major barriers inhibit cfDNA as a non-invasive method for examining placental function: 1) the ability to accurately identify the placental origin of the short <160bp cfDNA fragments that constitute regulatory information (paternal SNPs occur at frequency of approximately 1/2000bp). 2) the ability to use these fragments to piece together precise epigenetic states of the placenta. 3) the cost of deep whole genome sequencing that has traditionally been required to deconvolute epigenetic profiles of admixed cellular origins. Our goal is to overcome each of these barriers by exploiting state-of-the-art genomics and machine learning techniques to extract precise information about human placental function from cfDNA. We will first compile robust and accurate nucleosome information, including epigenetic and transcription factor occupancy, from the human placenta and then we will establish machine-learning platforms to elucidate placental cfDNA from maternal circulation at low cost. Success in this project will enable earlier intervention for high-risk pregnancies and facilitate the longitudinal, non-invasive real-time monitoring of pregnancy progression, thereby informing adaptive treatment decision-making. Narrative Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. Out goal is to develop technology to utilize cfDNA as means to assess placental function non-invasively.",Molecular images and machine learning to extractplacental function from maternalcfDNA,9472569,R01HD094513,"['Algorithms ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Cell Extracts ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Chorionic Villi Sampling ', ' chorionic villous sampling ', ' Chorionic Villi Biopsy ', ' Decision Making ', ' DNA ', ' Deoxyribonucleic Acid ', ' Genome ', ' Goals ', ' Histones ', ' Human ', ' Modern Man ', ' Maps ', ' Methods ', ' Noise ', ' Nucleosomes ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placental Extracts ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Pregnancy ', ' Gestation ', ' Nucleic Acid Regulatory Sequences ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Technology ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Enhancers ', ' promoter ', ' promotor ', ' Cell Size ', ' base ', ' image processing ', ' Training ', ' Visual ', ' Individual ', ' Early Intervention ', ' High-Risk Pregnancy ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Fragmentation ', ' Frequencies ', ' Complex ', ' Pattern ', ' Techniques ', ' success ', ' Biological Neural Networks ', ' neural network ', ' prenatal ', ' unborn ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Genomics ', ' Binding ', ' Molecular Interaction ', ' computerized data processing ', ' data processing ', ' genome sequencing ', ' Length ', ' Data ', ' Detection ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Pathologic ', ' Molecular ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' cost ', ' Molecular Machines ', ' epigenome ', ' cell free circulating DNA ', ' cell free DNA ', ' ATACseq ', ' ATAC-seq ', ' full genome ', ' entire genome ', ' whole genome ', ' DNAseq ', ' DNA seq ', ' DNA sequencing ', ' real time monitoring ', ' deep learning ', ' ']",NICHD,STANFORD UNIVERSITY,R01,2018,737430,CA-18,0.14345383307317705
"Using epigenomic subtyping to understand the racial differences in lymphoma PROJECT SUMMARY Diffuse large B-cell lymphoma (DLBCL), the most common aggressive type of lymphomas, is characterized by marked clinical and pathological heterogeneity that is reflected at the molecular level. It is well known that although the incidence rates for DLBCL were lower for African Americans (AA) than for European Americans (EA), AA patients were diagnosed at a significantly younger age and have worse 5-year survival compared with EA patients. The reason for this apparent racial/ethnic difference is unclear and cannot be fully explained by social stressors or access to care. We speculate that epigenetic variations could underlie the racial/ethnic differences because the pathogenesis of DLBCL is strongly linked to perturbation of epigenetic mechanisms, and population-specific cytosine modifications are a fundamental feature between human populations. In addition, greater epigenetic heterogeneity is linked with more aggressive DLBCL and poorer survival outcomes. Most prior studies of DLBCL epigenetics have assessed 5-methylcytosines (5mC) in predominantly EA patients. No studies have evaluated 5-hydroxymethylcytosines (5hmC), an emerging stable and abundant modification with distinct gene regulatory and cellular functions, due mainly to technical limitations. Most importantly, no studies have assessed concurrently 5mC and 5hmC in both EA and AA DLBCL patients. Without an effective technique to obtain the complete landscape of modified cytosines, development of targeted epigenetic approaches to improve DLBCL disparities is unlikely. The objective of this Exploratory/Developmental study is to distinguish 5hmC from 5mC at the time of DLBCL diagnosis between AA and EA patients and evaluate their clinical significance. Our hypothesis is that the 5mC/5hmC signatures in tumor tissues differ between AA and EA patients and that these differences contribute to the well-known racial/ethnic differences in DLBCL risk and outcomes. The Specific Aims are to 1) distinguish 5hmC from 5mC in EA and AA patients and evaluate population-specific 5mC/5hmC loci; and 2) determine therapeutic response-associated 5hmC/5mC loci. Specifically, we will obtain tissues for 120 patients with DLBCL (60 AA and 60 EA) from the University of Chicago Lymphoma Biobank. We will combine an innovative technique, the Tet-assisted Bisulfite Sequencing (TAB-Seq) and the new Illumina EPIC array to accurately distinguish 5hmC from 5mC. We will perform an epigenome-wide scan to assess differences in 5hmC/5mC modification levels between AA and EA patients at presentation and also integrate both modifications to predict therapeutic response, defined as relapse within 24 months after treatment. This proposal addresses a critical research question in a highly innovative, cost-efficient, and timely manner, providing important data for the first time on the complete landscape of modified cytosines for racial/ethnic differences in DLBCL. The results are expected to have positive impact because it is possible that the identified epigenetic loci/biomarkers will provide new targets for individualized preventive and therapeutic interventions to decrease mortality and burden of DLBCL. PROJECT NARRATIVE PUBLIC HEALTH RELEVANCE: African Americans were diagnosed of diffuse large B-cell lymphoma (DLBCL), the most aggressive lymphoma in adults, at a significantly younger age (54 years vs. 65 years) and have worse 5-year survival (45% vs. 54%) compared with European American patients. This work seeks to understand the biological bases of the racial/ethnic differences by identifying complete DNA methylation and hydroxymethylation signatures at the time of diagnosis between African American and European American patients with DLBCL. Successful completion of this study will lead to a much better understanding of epigenetic factors that underlie the apparent racial/ethnic differences in DLBCL, which should accelerate the development of race-based individualized preventive and therapeutic interventions to substantially reduce the disparities observed in DLBCL among patients from different ethnic groups.",Using epigenomic subtyping to understand the racial differences in lymphoma,9572405,R21MD011439,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Age ', ' ages ', ' B-Lymphocytes ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Breast ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Chicago ', ' Colon ', ' Cytosine ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Endometrium ', ' Ethnic group ', ' ethnicity group ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Health Services Accessibility ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Incidence ', ' indexing ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Lymphoma ', ' Reticulolymphosarcoma ', ' Malignant Lymphoma ', ' Germinoblastoma ', ' Germinoblastic Sarcoma ', ' mortality ', ' Patients ', ' Prostate ', ' Prostatic Gland ', ' Prostate Gland ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Relapse ', ' Research ', ' Risk ', ' Specificity ', ' Time ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Work ', ' Treatment outcome ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Enhancers ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Link ', ' Individual ', ' African ', ' European ', ' Ethnicity ', ' Ethnic Origin ', ' Biological Function ', ' Biological Process ', ' Solid Tumor ', ' Solid Neoplasm ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Tumor Tissue ', ' American ', ' stressor ', ' tumor initiation ', ' novel ', ' member ', ' racial difference ', ' race differences ', ' ethnic difference ', ' ethnicity difference ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' social ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' health disparity ', ' disparity in health ', ' Address ', ' Data ', ' Prediction of Response to Therapy ', ' treatment response prediction ', ' treatment prediction ', ' therapy prediction ', ' predict treatment response ', ' predict therapy response ', ' predict therapeutic response ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Regulatory Element ', ' Tetanus Helper Peptide ', ' Tet ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' exploratory developmental study ', ' R21 Program ', ' R21 Mechanism ', ' Exploratory/Developmental Grant ', ' Pathologic ', ' Molecular ', ' Modification ', ' developmental ', ' Development ', ' epigenomics ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' cost efficient ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' clinical significance ', ' clinically significant ', ' racial and ethnic ', ' epigenetic variation ', ' tumor ', ' public health relevance ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' biorepository ', ' biobank ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' bisulfite sequencing ', ' survival outcome ', ' reduce disparity ', ' disparity reduction ', ' ']",NIMHD,UNIVERSITY OF CHICAGO,R21,2018,200434,IL-01,0.1061240681329216
"Identification of epigenetic subclones in lymphomas and leukemias Abstract Epigenetic modifications, such as DNA methylation, play a significant role in human disease. DNA methylation is altered in cancer, and DNA methylation-induced silencing of promoters of tumor-suppressors is thought to play a key role in tumorigenesis. Though there is an increasing number of methylation sequencing datasets generated from cancer, they are confounded by tumor heterogeneity. Understanding the subclonal architecture underlying heterogeneity is important because individual cancer subclones impact cancer growth, treatment resistance, and metastasis. Increased epigenetic heterogeneity, or variation in DNA methylation patterns, was determined to be correlated with worse prognosis in patients with diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML). However, these studies only profiled epigenetic heterogeneity at a global scale and did not analyze methylation of individual subclones. Many computational methods have been developed for this purpose in epigenome-wide association studies (EWAS), but these methods are not applicable for methylation sequencing data. As such, there is a need to develop new computational methods to study subclonal methylation profiles in cancer. I will develop a novel computational method (DXM) that deconvolves DNA methylation of heterogeneous clinical samples into their major subpopulations, their prevalence, and their respective DNA methylation profiles (Aim 1). DXM will be developed on simulations generated from data available from both the Roadmap Epigenomics Project and the Blueprint Epigenome Project and will be validated with methylation sequencing on DLBCL samples. I will then leverage DXM to study subclonal methylation profiles in AML (Aim 2). I hypothesize that methylation can confer fitness advantages in epigenetic subclones of AML, leading to clonal expansion following therapeutic intervention and subsequent relapse. Using DXM, I will first identify epigenetic subclones from whole genome bisulfite sequencing data from AML patients with well-characterized genetic subclonal architecture and compare the epigenetic subclonal architecture to that of the genetic subclones. In a second dataset containing methylation sequencing data from paired diagnosis-relapse samples, I will apply DXM, identify subclonal methylation profiles, and characterize all genes impacted by subclonal methylation to determine if they are expected to confer fitness advantages. Finally, I will test if mutations known to impact DNA methylation in AML (DNMT3A, IDH1/2) alter epigenetic subclonal expansion. Taken together, this proposal will result in a new computational approach to interpret epigenetic data from heterogeneous clinical samples as well as identification of DNA methylation changes in epigenetic subclones of AML that contribute to disease progression and correlate with prognosis. Project Narrative Studies that characterize which variations in cancer relate to worse outcome may do analysis on the entire tumor sample, which is composed of many different types of cells, each with distinct biology. The goal of this proposal is to develop a novel computational method to analyze variations in cancer at the level of cell-types. These results can be used to improve patient prognostics and care in multiple cancers.",Identification of epigenetic subclones in lymphomas and leukemias,9611428,F30CA224687,"['Algorithms ', ' Antibodies ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cells ', ' Cell Body ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Diagnosis ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Heterogeneity ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Acute Myelocytic Leukemia ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Mentorship ', ' Methods ', ' Methylation ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Pathology ', ' Patients ', ' Physicians ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Role ', ' social role ', ' statistics ', ' Testing ', ' Tumor Promoters ', ' United States ', ' X Inactivation ', ' X-Chromosome Inactivation ', ' Lyonization ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' bisulfite ', ' hydrosulfite ', ' hydrogen sulfite ', ' Fluorescence-Activated Cell Sorting ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' promoter ', ' promotor ', ' Data Set ', ' Dataset ', ' Caring ', ' career ', ' improved ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' prognostic ', ' Training ', ' Individual ', ' Parental Imprinting ', ' Genetic Imprinting ', ' Genomic Imprinting ', ' Disease Progression ', ' Genetic ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Complex ', ' cell type ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Retrotransposon ', ' simulation ', ' novel ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' tumorigenesis ', ' Oncogenesis ', ' genome sequencing ', ' Address ', ' fitness ', ' Data ', ' Cancer Biology ', ' Cancer Patient ', ' Clonal Expansion ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Newly Diagnosed ', ' Modification ', ' developmental ', ' Development ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' cancer research ', ' anti-cancer research ', ' anticancer research ', ' designing ', ' design ', ' Outcome ', ' lymphoma/leukemia ', ' leukemia/lymphoma ', ' Prevalence ', ' human disease ', ' tumor ', ' clinical care ', ' epigenome ', ' methylation pattern ', ' single cell sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' bisulfite sequencing ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' stratified patient ', ' patient stratification ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' tumor heterogeneity ', ' full genome ', ' entire genome ', ' whole genome ', ' ']",NCI,WASHINGTON UNIVERSITY,F30,2018,30434,MO-01,0.2528962600817255
"Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data     DESCRIPTION (provided by applicant): This project involves the development of new statistical methodologies and computational tools for network-based integrative analysis of epigenetic risk factors of cardiovascular diseases (CVD). While the advent of omics data from new technologies has facilitated the study of epigenetic factors, existing methodologies often do not account for complexities of biological data  such as correlations due to interactions of genes/proteins as part of biological pathways  and fail to eciently integrate diverse omics data sets  for instance genetic variation, DNA methylation and gene expression. The methodologies proposed in this project, and the software tools that will be developed to implement them, address these shortcomings, and facilitate further research by the biomedical community to gain a better understanding of the underlying biology of CVD, and to develop new diagnostic biomarkers and potential targets for therapies. The proposed methodologies are motivated by the study of epigenetic data from the Multi-Ethnic Study of Atherosclerosis (MESA), and include (i) a network-based pathway enrichment analysis method that incorporates available knowledge of interactions among genes and proteins while complementing and rening such information (Aim 1A), as well as its extension for analysis of multiple types of omics data (Aim 1B), and (ii) an integrative analysis framework to identify associations among gene expression levels and DNA methylation (Aim 2A) and identify common epigenetic factors of multiple CVD phenotypes through integrated analysis of DNA methylation and mRNA expression data (Aim 2B). We will develop ecient and user-friendly software tools for the proposed methods (Aim 3), which will be made freely available to the public after extensive tests using both simulated data, as well as real data from MESA. PUBLIC HEALTH RELEVANCE: The proposed research addresses the need for development of new statistical machine learning methods for analysis of diverse epigenetic data from multiple cardiovascular disease outcomes. The proposed training activities are designed to enhance the applicant's knowledge of epigenetics and physiology of cardiovascular diseases (CVD), and to further his career as an independent investigator in the area of computational epigenetics for CVD.",Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data,9392931,K01HL124050,"['Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biology ', ' Biomedical Research ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Cause of Death ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Gene Expression ', ' Genes ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Information Networks ', ' Joints ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Methods ', ' Methodology ', ' Methylation ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Software Tools ', ' Computer Software Tools ', ' Stroke ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Testing ', ' Training Activity ', ' training module ', ' Genetic Variation ', ' Genetic Diversity ', ' Data Set ', ' Dataset ', ' base ', ' career ', ' improved ', ' DNA analysis ', ' Area ', ' Biological ', ' Individual ', ' Dyslipidemias ', ' Measurement ', ' Genetic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Source ', ' System ', ' gene interaction ', ' user friendly software ', ' user friendly computer software ', ' Structure ', ' Disease Outcome ', ' novel ', ' member ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Gene Proteins ', ' Protein Gene Products ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Pathway Analysis ', ' Network Analysis ', ' response ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' histone modification ', ' Address ', ' Data ', ' Post-Transcriptional Regulation ', ' Post-Transcriptional Regulation Process ', ' Post-Transcriptional Control ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' mRNA Expression ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Exogenous Factors ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Outcome ', ' Network-based ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' therapeutic target ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' flexible ', ' flexibility ', ' epigenetic biomarker ', ' epigenetic marker ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' learning network ', ' learning method ', ' learning activity ', ' learning strategy ', ' training opportunity ', ' multi-omics ', ' multiple omics ', ' diagnostic marker ', ' diagnostic biomarker ', ' full genome ', ' entire genome ', ' whole genome ', ' high dimensionality ', ' Multi-Ethnic Study of Atherosclerosis ', ' ']",NHLBI,UNIVERSITY OF WASHINGTON,K01,2018,137512,WA-07,0.16987156479436125
"Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations Abstract With the advent of new DNA sequencing technologies, genomic data has moved to the forefront in the quest for individualized medicine. However, the lack of new computational tools to interpret and exploit the deluge of genomic data has severely hampered its clinical benefit. A further complication is that clinical genomic data is often obtained from tissues containing a mixture of different cell types. For example, tumor samples are a mixture of tumor subclones and normal cell lineages. As a platform for understanding this heterogeneity in tumor cell populations, our studies will focus on DNA methylation changes in diffuse large B-cell lymphoma (DLBCL), the most prevalent, aggressive form of Non-Hodgkin Lymphoma (NHL). DNA methylation is cell type- specific, likely contributes to the phenotypic variation in tumor subclones, and plays key roles in gene regulation and lymphoma pathogenesis. Defining the methylation and transcriptional profiles of tumor subclones is necessary to identify potential drug targets, predict disease progression, and identify overall prognosis. Further, current computational approaches to understand epigenetic heterogeneity are not well- suited for tumor analysis and do not link epigenetic changes to expression. Here, we propose to develop a new computational approach that uses genomic methylation data from bulk samples to define DNA methylation- and expression-based subclonal populations and relate these populations to disease progression. Our approach exploits the fact that methylation levels are an accurate measure of the underlying distribution of allelic methylation states in the tumor (e.g. 30% methylation means 30% of the alleles are methylated). Our approach takes genome-wide methylation data as input, and outputs the number of subpopulations, their respective proportions, and each underlying subpopulations DNA methylation profile. After deconvolution, we will extend our previous work showing that DNA methylation profiles are predictive of expression levels, and apply tools from machine learning to estimate the relative expression profiles in each subpopulation. This approach will allow us to take advantage of the vast amount of data currently being collected in large-scale sequencing projects and obtain genome-wide methylation information from cellular subpopulations even when surface markers cannot be used to physically separate the different subpopulations. Lastly, we will assess the clinical relevance of these approaches by using them to understand the molecular changes found in tumor subpopulations from samples of relapsed DLBCL. We envision these methods can be applied as investigative tools first, and later as cost-effective clinical tools, to analyze the epigenetic and transcriptomic heterogeneity in different tumor types and diseased tissues. Public Narrative Tumors, including B-cell lymphomas, are comprised of heterogeneous populations of cells. Decoding the regulatory circuitry in these sub-populations is critical to understanding tumor metastasis, therapy resistance and relapse. We propose to develop a new computational approach to use genome-wide measurements of DNA methylation in primary tumors to understand the regulatory landscape of these subpopulations. All software will be made publically available to broadly advance cancer-research nationwide. Results from this work will improve our understanding of molecular mechanisms of B cell lymphoma development and relapse.",Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations,9521585,R21LM012395,"['Alleles ', ' Allelomorphs ', ' Antibodies ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Count ', ' Cell Number ', ' Cells ', ' Cell Body ', ' Complication ', ' Disease ', ' Disorder ', ' Flow Cytometry ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Genes ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' lymph nodes ', ' lymph gland ', ' Lymph node proper ', ' Lymph Node Reticuloendothelial System ', ' Lymphoma ', ' Reticulolymphosarcoma ', ' Malignant Lymphoma ', ' Germinoblastoma ', ' Germinoblastic Sarcoma ', "" Non-Hodgkin's Lymphoma "", ' non-Hodgkins disease ', ' Nonhodgkins Lymphoma ', ' Methods ', ' Methodology ', ' Methylation ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Research ', ' Computer software ', ' Software ', ' Technology ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Work ', ' B-Cell Lymphomas ', ' B lymphoma ', ' Measures ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' prognostic ', ' Training ', ' Hematopoietic ', ' Measurement ', ' Disease Progression ', ' Germinal Center ', ' Structure of germinal center of lymph node ', ' Cell Lineage ', ' Therapeutic ', ' cancer cell ', ' Malignant Cell ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' programs ', ' cell type ', ' Techniques ', ' neoplastic cell ', ' Tumor Cell ', ' Primary Neoplasm ', ' Primary Tumor ', ' Pathogenesis ', ' Modeling ', ' Sampling ', ' Advanced Malignant Neoplasm ', ' Advanced Cancer ', ' Genomics ', ' Normal Cell ', ' Address ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Mixed Cellular Population ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Large-Scale Sequencing ', ' Molecular ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' cost ', ' cancer research ', ' anti-cancer research ', ' anticancer research ', ' computational tools ', ' computerized tools ', ' cost-effective ', ' cost effective ', ' Population ', ' resistant ', ' Resistance ', ' transcriptomics ', ' clinical relevance ', ' clinically relevant ', ' chemotherapy ', ' tumor ', ' genomewide ', ' genome scale ', ' genome-wide ', ' global methylation ', ' genomewide methylation ', ' genome wide methylation ', ' Drug Targeting ', ' epigenome ', ' gDNA ', ' Genomic DNA ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' clinical sequencing ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' tumor heterogeneity ', ' genomic data ', ' DNAseq ', ' DNA seq ', ' DNA sequencing ', ' Expression Profiling ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2018,193265,MO-01,0.07073673625082477
"Inferring gene regulatory circuitry from functional genomics data PROJECT SUMMARY It has long been known that methylation of genomic DNA correlates with gene expression. However, the structural mechanisms that underlie these observations remain obscure. In this project, we will pursue several innovative strategies for studying how methylation affects transcription factor (TF) binding. First, we will use Methyl-SELEX-seq  a novel experimental method developed in the previous cycle of this grant that uses barcoded mixtures of methylated and unmethylated DNA ligands  to create detailed maps of the effect of methylation on binding affinity for a broad panel of human transcription factors from various structural families. Second, we will perform detailed computational analyses and follow-up experiments to test the hypothesis that methylation causes local changes in DNA shape, which in turn modify TF binding affinity. We have shown that adding a methyl group in the major groove changes the geometry of the minor groove and enhances the electrostatic interaction between negative charges in the DNA minor groove and positively charged amino- acids in the TF. We will extend these analyses to other DNA modifications, as well as a wider range of DNA shape parameters and associated flexibility parameters. By building interpretable TF-DNA recognition models that integrate base, shape, and flexibility features using a powerful new machine learning framework developed in the previous funding cycle, we will make specific predictions regarding sequence and methylation readout mechanisms, and validate these using SELEX experiments with mutated TFs. To assess to what extent our quantitative models for binding to naked DNA built from SELEX data are predictive of binding to genomic DNA in the context of the living cell, we will perform detailed parallel analyses of SELEX and ChIP- seq data for Hox proteins and other TFs. Finally, to study the relationship between DNA binding and gene expression control in human cell lines, we will exploit Survey of Regulatory Elements (SuRE-seq), a novel massively parallel reporter assay that provides unique information about the autonomous transcriptional activity for each of >108 overlapping genomic fragments. PROJECT NARRATIVE Epigenetic modifications of the human genome are known to play a key role in development and disease, but the underlying molecular mechanisms are largely unknown. The main goal of this proposal is to develop and apply new experimental and computational tools for analyzing how the binding of regulatory proteins to DNA is influenced by cytosine methylation. This will help us better understand its impact on gene expression and disease.",Inferring gene regulatory circuitry from functional genomics data,9540035,R01HG003008,"['Affect ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Amino Acids ', ' aminoacid ', ' Base Sequence ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biophysics ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cells ', ' Cell Body ', ' Charge ', ' Communities ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Family ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Human Genome ', ' human whole genome ', ' Goals ', ' Grant ', ' Human ', ' Modern Man ', ' In Vitro ', ' Laboratories ', ' Ligands ', ' Maps ', ' Methods ', ' Methylation ', ' Names ', ' Play ', ' Proteins ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Measures ', ' Enhancers ', ' Mediating ', ' promoter ', ' promotor ', ' DNA Sequence ', ' base ', ' DNA analysis ', ' Variation ', ' Variant ', ' Biological ', ' Funding ', ' Shapes ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Electrostatics ', ' Hyperactive behavior ', ' Motor Hyperactivity ', ' Hyperkinetic Movements ', ' Hyperkinesis ', ' Hyperkinesia ', ' Hyperactivity ', ' Dependence ', ' Protocols documentation ', ' Protocol ', ' preference ', ' methyl group ', ' HOX protein ', ' Free Energy ', ' novel ', ' Human Cell Line ', ' Positioning Attribute ', ' Position ', ' genetic regulatory protein ', ' regulatory gene product ', ' Regulatory Protein ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' functional genomics ', ' Genomics ', ' DNA Binding ', ' DNA bound ', ' DNA Binding Interaction ', ' DNA Modification Process ', ' DNA Modification ', ' Binding ', ' Molecular Interaction ', ' Address ', ' Affinity ', ' Data ', ' Minor Groove ', ' Mutate ', ' Regulatory Element ', ' Chromatin Structure ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Computer Analysis ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Major Groove ', ' Molecular ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' deep sequencing ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' comparative ', ' genomewide ', ' genome scale ', ' genome-wide ', ' flexible ', ' flexibility ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-seq ', ' methylome ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' Geometry ', ' gDNA ', ' Genomic DNA ', ' genomic data ', ' genomic predictors ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NHGRI,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2018,560259,NY-13,0.11482425156446867
"Joint patterns of multi-genetic/epigenetic factors via non-parametric clustering and their association with allergic disease Ray PA-16-162 Project Summary Eczema is a chronic skin inflammatory disease infecting 10-30% of children and 2-10% of adults and increasing. Researchers have struggled to understand the genetic and environmental factors that appear to play a role in eczema's increasing prevalence. The majority of current studies focus on one or two specific types of Genome-wide data in association with eczema such as SNPS, DNA methylation levels, or gene expression levels. Current statistical methods have forced this limitation as none exist, to our knowledge that allow clustering of subjects across multi-dimensional and multi-faceted variables. Therefore, in this project we aim to introduce a novel clustering approach that will cluster subjects across genes which contain SNP information, DNA methylation levels, and gene expression levels. Summarized clusters will then tested for associated risk of eczema or any allergic disease. Genetic patterns associated with eczema will then be further explored to better identify the behavior genetic data and it's uniqueness. The method will be built in R Gui as a free downloadable package making it accessible and easy to use. We will apply the proposed method to the third generation Isle of Wight cohort data. The third generation cohort data consist of children born (2010-current time) from the original cohort of children born between 1989 and 1990 on the Isle of Wight in the UK and contains Genome-wide datasets, disease and exposure status, and allergy information across multiple follow-ups. The implications of this study not only impact the statistical field with a new clustering approach but the eczema and allergy field as well as no other studies have been able to analyze three Genome-wide datasets in concert associated with the risk of allergic diseases. Ray PA-16-162 Project Narrative The prevalence of eczema is increasing world-wide and infecting between 10-30% of children. The complete underlying cause of eczema is unknown but thought to be mixture of genetic and environmental factors. This project aims to incorporate genetic and epigenetic data in concert using a novel statistical approach in hopes of identifying patterns associated with eczema risk, allowing researchers to better understand the biological mechanisms.",Joint patterns of multi-genetic/epigenetic factors via non-parametric clustering and their association with allergic disease,9456064,R03AI128227,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Birth ', ' Parturition ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Eczema ', ' eczematous ', ' Eczematous Dermatitis ', ' Gene Expression ', ' Genes ', ' Behavioral Genetics ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Genome ', ' Health ', ' Hypersensitivity ', ' Allergy ', ' Joints ', ' Methods ', ' Methodology ', ' Methylation ', ' Play ', ' Public Health ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' Testing ', ' Time ', ' Work ', ' Generations ', ' Data Set ', ' Dataset ', ' fetal cord blood ', ' Cord Blood ', ' Umbilical Cord Blood ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Chronic ', ' Biological ', ' Link ', ' infantile ', ' infancy ', ' Biological Function ', ' Biological Process ', ' Genetic ', ' DNA Methylation ', ' Knowledge ', ' Complex ', ' Pattern ', ' Location ', ' cohort ', ' Disease Outcome ', ' novel ', ' Categories ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Statistical Methods ', ' Skin ', ' Address ', ' Data ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' vector ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Outcome ', ' Prevalence ', ' user-friendly ', ' genomewide ', ' genome scale ', ' genome-wide ', ' flexible ', ' flexibility ', ' Allergic Disease ', ' screening ', ' chronic inflammatory skin ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NIAID,UNIVERSITY OF MEMPHIS,R03,2018,69617,TN-09,0.021370771811506237
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9524748,R24DK106766,"['Back ', ' Dorsum ', ' Base Sequence ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Biology ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Chromosomes ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Engineering ', ' Evolution ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Health ', ' Heart ', ' Hematopoiesis ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoietic stem cells ', ' hematopoietic stem progenitor cell ', ' hematopoietic progenitor ', ' Hematopoietic Progenitor Cells ', ' Blood Precursor Cell ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Maps ', ' Methods ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Production ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Science ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Translating ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' falls ', ' Data Set ', ' Dataset ', ' DNA Sequence ', ' Custom ', ' improved ', ' Area ', ' Training ', ' Hematopoietic ', ' insight ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data base ', ' Data Bases ', ' Databases ', ' Measurement ', ' Gene Targeting ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' Monoclonal Antibody R24 ', ' Collaborations ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Catalogs ', ' Dimensions ', ' Frequencies ', ' cell type ', ' Pattern ', ' System ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' gene conservation ', ' cell injury ', ' cell damage ', ' Cellular injury ', ' novel ', ' Basic Science ', ' Basic Research ', ' Categories ', ' Human Resources ', ' personnel ', ' Manpower ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' response ', ' Erythroid Cells ', ' CISH gene ', ' Suppressor of Cytokine Signaling Gene ', ' Suppressor of Cytokine Signaling ', ' SOCS Gene ', ' G18 Gene ', ' G18 ', ' Cytokine-Inducible SH2-Containing Protein Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B ', ' Cytokine Inducible SH2-Containing Protein ', ' CISH Protein ', ' CIS-1 Protein ', ' CIS-1 Gene ', ' CIS protein ', ' CIS Gene ', ' Address ', ' Data ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Transcript ', ' Pathologic ', ' Monitor ', ' Knockout ', ' Knock-out ', ' Modification ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' data acquisition ', ' clinical significance ', ' clinically significant ', ' murine model ', ' mouse model ', ' loss of function ', ' prototype ', ' genomewide ', ' genome scale ', ' genome-wide ', ' epigenome ', ' precision-based medicine ', ' precision medicine ', ' genomic editing ', ' genome editing ', ' global transcription profile ', ' global gene expression ', ' transcriptome ', ' chromosome capture ', ' chromatin conformation capture ', ' 3C-based technology ', ' 3C-based technique ', ' 3C-based strategy ', ' 3C-based method ', ' 3C-based assay ', ' 3C-based approach ', ' chromosome conformation capture ', ' genome browser ', ' experimental research ', ' experiment ', ' experimental study ', ' annotation tool ', ' annotation framework ', ' annotation  system ', ' ']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2018,1219282,PA-12,0.05593076744399231
"Epigenetic Transgenerational Endocrine Disruptor Actions DESCRIPTION (provided by applicant): A number of environmental toxicants were shown in the previous grant period to promote the epigenetic transgenerational inheritance of adult onset disease including the fungicide vinclozolin, pesticides, plastics (BPA and phthalates), dioxin, hydrocarbons, and DDT. The ability of environmental compounds (e.g. endocrine disruptors) to promote transgenerational disease phenotypes is anticipated to be a critical aspect of adult onset disease etiology. The transgenerational inheritance phenotype requires the heritable epigenetic alterations of the germline. The current proposal is designed to further investigate the molecular and developmental aspects of the epigenetic transgenerational inheritance phenomenon and assess the potential use of epigenetic biomarkers for exposure and disease. The general hypothesis tested is that ""transient fetal exposure around the period of gonadal sex determination to environmental toxicants (i.e. vinclozolin) promotes the reprogramming of the epigenome (i.e. DNA methylation) of the male germline that then transmits an imprinted-like epigenome to subsequent generations to induce the epigenetic transgenerational inheritance of adult onset disease (e.g. male infertility)"". The previous grant period focused on the analysis of the epigenetic alteration in the F3 generation sperm using promoter associated differential DNA methylation regions (epimutations), as well as documented the epigenetic and transcriptome changes in the F3 generation vinclozolin lineage primordial germ cells. The molecular etiology of somatic cell changes associated with ovary and testis disease was established. The current proposal further investigates the molecular and developmental aspects of the germline mediated epigenetic transgenerational inheritance of disease. The experimental approach to test the above hypothesis consists of the following specific aims: Aim 1) Determine the developmental and generational aspects of the genome-wide germline epimutations. Aim 2) Determine the genomic features associated with the epimutations and potential genetic alterations involved in the epigenetic transgenerational inheritance phenomenon. Aim 3) Determine the optimal exposure parameters of the environmental induced transgenerational model and correlate epigenetic biomarkers with exposure and disease. Completion of the proposed research will determine the cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The proposed research will further elucidate the molecular and developmental aspects of environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease. PUBLIC HEALTH RELEVANCE: The current proposal further investigates the molecular and developmental aspects of germline mediated epigenetic transgenerational inheritance of disease. The cascade of epigenetic events involved in germ cell development that generates the sperm epimutations that transmit the epigenetic transgenerational inheritance of disease phenotypes will be determined. The protection of the sperm epimutations from DNA methylation erasure is anticipated in early embryonic development. The epimutations are anticipated to promote genetic alterations to contribute to the transgenerational disease phenotype. Completion of the research will elucidate the molecular etiology of the environmentally induced epigenetic transgenerational inheritance of disease and the potential use of epigenetic biomarkers for ancestral exposure and disease.",Epigenetic Transgenerational Endocrine Disruptor Actions,9459884,R01ES012974,"['Mediating ', ' promoter ', ' promotor ', ' phthalates ', ' Primordial Germ Cell ', ' Structure of primordial sex cell ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Industrial fungicide ', ' fungicide ', ' fungicidal ', ' Industrial Fungicides ', ' Event ', ' hazard ', ' Somatic Cell ', ' Modeling ', ' prenatal exposure ', ' prenatally exposed ', ' intrauterine environmental exposure ', ' intra-uterine environmental exposure ', ' in utero exposure ', ' fetal exposure ', ' exposed in utero ', ' Genomics ', ' Genomic Instability ', ' Genome Instability ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' sex determination ', ' Dose ', ' Copy Number Polymorphism ', ' copy number variation ', ' copy number variant ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Molecular ', ' developmental ', ' Development ', ' disease phenotype ', ' computerized ', ' designing ', ' design ', ' endocrine disrupting compound ', ' Endocrine disrupting agent ', ' Endocrine Disrupting Chemicals ', ' Endocrine Disrupter ', ' Endocrine Disruptors ', ' Heritability ', ' imprint ', ' public health relevance ', ' genomewide ', ' genome scale ', ' genome-wide ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' transgenerational inheritance ', ' transgenerational epigenetic inheritance ', ' global transcription profile ', ' global gene expression ', ' transcriptome ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Mental Depression ', ' depression ', ' Dioxins ', ' Dioxin Compound ', ' Disease ', ' Disorder ', ' Embryonic Development ', ' Embryogenesis ', ' Embryo Development ', ' Fertilization ', ' Fertility/Fertilization ', ' Genes ', ' Germ Cells ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Grant ', ' Human ', ' Modern Man ', ' Hydrocarbons ', ' Inbreeding ', ' Male Infertility ', ' male ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Ovary ', ' Pesticides ', ' Phenotype ', ' Plastics ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Research ', ' Safety ', ' Spermatogenesis ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Testing ', ' Testis ', ' Testicles ', ' Toxic Environmental Substances ', ' environmental toxicant ', ' Toxic Environmental Agents ', ' Environmental Toxin ', ' vinclozolin ', ' Generations ', ' ']",NIEHS,WASHINGTON STATE UNIVERSITY,R01,2018,339750,WA-05,0.1892151229488621
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns. PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.",Signals of Epigenetic Modification in Sjogrens Syndrome,9458167,F31DE025176,"['rheumatic arthritis ', ' Atrophic Arthritis ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmunity ', ' Autoimmune Status ', ' B-Lymphocytes ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Carbon ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Systemic Lupus Erythematosus ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Resources ', ' Research Resources ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Role ', ' social role ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Supervision ', ' T-Lymphocyte ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Trans-Activators ', ' Transactivators ', ' Trans-Acting Factors ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Woman ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Data Set ', ' Dataset ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Dimensions ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' Country ', ' Severity of illness ', ' disease severity ', ' Quantitative Trait Loci ', ' QTL ', ' novel ', ' Participant ', ' disorder risk ', ' disease risk ', ' Pathogenesis ', ' genetic risk factor ', ' inherited factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Binding ', ' Molecular Interaction ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' Individual National Research Service Award ', ' NIH National Research Service Award for Individual ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' epigenetic variation ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' genomewide ', ' genome scale ', ' genome-wide ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-seq ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' epigenome ', ' methylation pattern ', ' BeadChip ', ' bead chip ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' disease heterogeneity ', ' full genome ', ' entire genome ', ' whole genome ', ' genomic data ', ' recruit ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Rheumatoid Arthritis ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2018,21727,CA-13,0.25484849194085496
"Molecular images and machine learning to extractplacental function from maternalcfDNA Abstract  Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. cfDNA is fragmented with sizes centered around 145bp and 166bp which is approximately the length of DNA wrapped around a nucleosome, and a nucleosome plus its linker, respectively. Shorter fragments (30-100bp) also exist and have a clear periodicity of 10bp, corresponding to a turn of the DNA helix wrapped around the core histone. Recent reports have shown that the fragmentation sizes of cfDNA are tissue specific, which is a product of distinct nucleosome spacing that is inherent in the function of individual tissues. When these individual fragments are compared with existing epigenetic data from tissues, they can be binned into cell of origin simply based on whether they reveal the nucleosome positioning information of the originating tissue. Identifying cfDNA fragments of placental origin from maternal circulation would provide a non-invasive means of assessing placental function during human pregnancy.  Several major barriers inhibit cfDNA as a non-invasive method for examining placental function: 1) the ability to accurately identify the placental origin of the short <160bp cfDNA fragments that constitute regulatory information (paternal SNPs occur at frequency of approximately 1/2000bp). 2) the ability to use these fragments to piece together precise epigenetic states of the placenta. 3) the cost of deep whole genome sequencing that has traditionally been required to deconvolute epigenetic profiles of admixed cellular origins. Our goal is to overcome each of these barriers by exploiting state-of-the-art genomics and machine learning techniques to extract precise information about human placental function from cfDNA. We will first compile robust and accurate nucleosome information, including epigenetic and transcription factor occupancy, from the human placenta and then we will establish machine-learning platforms to elucidate placental cfDNA from maternal circulation at low cost. Success in this project will enable earlier intervention for high-risk pregnancies and facilitate the longitudinal, non-invasive real-time monitoring of pregnancy progression, thereby informing adaptive treatment decision-making. Narrative Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. Out goal is to develop technology to utilize cfDNA as means to assess placental function non-invasively.",Molecular images and machine learning to extractplacental function from maternalcfDNA,9670822,R01HD094513,"['Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Cell Extracts ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' chorionic villous sampling ', ' Chorionic Villi Biopsy ', ' Chorionic Villi Sampling ', ' Decision Making ', ' Deoxyribonucleic Acid ', ' DNA ', ' Genome ', ' Goals ', ' Histones ', ' Modern Man ', ' Human ', ' Maps ', ' Methods ', ' Nucleosomes ', ' Rhythmicity ', ' Cyclicity ', ' Periodicity ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Placental Extracts ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Gestation ', ' Pregnancy ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Enhancers ', ' promotor ', ' promoter ', ' Cell Size ', ' base ', ' image processing ', ' Training ', ' Visual ', ' Individual ', ' Early Intervention ', ' High-Risk Pregnancy ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Fragmentation ', ' Frequencies ', ' Complex ', ' Pattern ', ' Techniques ', ' success ', ' prenatal ', ' unborn ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Genomics ', ' Molecular Interaction ', ' Binding ', ' data processing ', ' computerized data processing ', ' genome sequencing ', ' Length ', ' Data ', ' Detection ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Genomic Segment ', ' genomic region ', ' Pathologic ', ' Molecular ', ' Development ', ' developmental ', ' molecular imaging ', ' molecule imaging ', ' Image ', ' imaging ', ' cost ', ' Molecular Machines ', ' epigenome ', ' cell free DNA ', ' cell free circulating DNA ', ' ATAC-seq ', ' ATACseq ', ' whole genome ', ' full genome ', ' entire genome ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' real time monitoring ', ' realtime monitoring ', ' denoising ', ' de-noising ', ' neural network algorithm ', ' deep learning algorithm ', ' ']",NICHD,STANFORD UNIVERSITY,R01,2019,603830,CA-18,0.14345383307317705
"Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection Distal sensory polyneuropathy (DSPN) remains the most common neurological complication in HIV-infected population. Opiates and cocaine are often misused to manage neuropathic pain. These drugs, in turn, increase the risk of DSPN and exacerbate DSPN severity. The interplay of DSPN and substance use disorder (SUD) is associated with morbidity and mortality in HIV-infected individuals. Although neurotoxic effects of HIV-1 gp120 and antiretroviral medications contribute to DSPN through dysregulation of pro-inflammation genes, little is known about the mechanisms of DSPN and DSPN with comorbid SUD. A major barrier to advancing our understanding of DSPN is the inaccessibility of nerve tissues in living individuals and the absence of reliable biomarkers to inform the diagnosis of DSPN in the setting of SUD and HIV infection. Our overarching goal is to discover the DNA methylation signatures for DSPN, SUD, and their comorbidity. We focus on white blood cells (WBCs) because of their role in orchestrating and effecting immune responses and because they are highly accessible tissues. We hypothesize that DSPN emerges in the context of HIV infection as the result of HIV-1 enhanced expression of proinflammatory genes in many cell types, including WBCs. We also hypothesize that DSPN emerges as the result of SUD-enhanced expression of proinflammatory genes in WBCs. Thus, DNA methylation in WBCs is associated with DSPN that is influenced by SUD and contributes to HIV outcomes. To test the hypotheses, we will select methylation features in WBCs for DSPN, SUD, and their comorbidity using a combination of epigenome-wide association study (EWAS) and ensemble-based machine learning approaches. Leveraging two well-established independent cohorts, we will first identify methylation sites in WBCs for DSPN and SUD in four groups (DSPN+/SUD+, DSPN+/SUD-, DSPN-/SUD+, DSPN-/SUD-) in 2,000 HIV- infected samples using a 2-stage EWAS followed by a meta-EWAS. We will then select methylation features using machine learning methods and test the sensitivity and specificity to differentiate DSPN, SUD, and their comorbidity. We will apply our in-house developed bioinformatic package, smartFeatureSelection. The selected features will test associations with immune resilience (i.e. CD4+/CD8+) and HIV outcomes (i.e. frailty, mortality). Finally, we will explore the biological functions of the identified methylation sites in postmortem human brain and blood (N = 80) by RNA-seq and correlate methylation-regulated gene expression between WBCs and neural cells. We expect to discover a set of biologically meaningful methylation features as a marker for HIV- infected DSPN and SUD that can predict resilience and outcomes. Employing a rigorous design and a powerful computational approach, this application proposes the first epigenome-based prediction for DSPN, SUD, and their interaction. The identified features can serve as a biomarker for this complex condition and have potential clinical use. The results will enhance the knowledge of epigenetic mechanisms in blood and in brain for HIV-infected DSPN and SUD. Distal sensory polyneuropathy and substance use disorder are common in the HIV-infected population and can impact immune resilience and HIV outcomes. Applying a combination of epigenome-wide association and machine learning approaches, we aim to identify a panel of DNA methylation features in white blood cells for HIV-associated distal sensory polyneuropathy and substance misuse that link to immune resilience, HIV frailty and mortality. The selected features can serve as biomarker for neuropathy and enhance our understanding of the interplay between neuropathy and substance misuse in HIV-infected population.",Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection,9776494,R01DA047820,"['Aging ', ' Association Learning ', ' Autopsy ', ' postmortem ', ' necropsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cocaine ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Complication ', ' Diagnosis ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fingerprint ', ' Gene Expression ', ' Genes ', ' Goals ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' gp120(HIV) ', ' gp120 ENV Glycoprotein ', ' gp120 ', ' HTLV-III gp120 ', ' HIV env Protein gp120 ', ' HIV Envelope Glycoprotein gp120 ', ' HIV Envelope Protein gp120 ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Modern Man ', ' Human ', ' Infection ', ' Inflammation ', ' white blood corpuscle ', ' white blood cell ', ' White Cell ', ' White Blood Cells ', ' Marrow leukocyte ', ' Leukocytes Reticuloendothelial System ', ' Blood leukocyte ', ' Leukocytes ', ' Photoradiation ', ' Light ', ' Methods ', ' Methylation ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Nervous Tissue ', ' Nerve Tissue ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Risk ', ' social role ', ' Role ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Substance Use Disorder ', ' Syndrome ', ' Testing ', ' thalamic ', ' Thalamus ', ' Thalamic structure ', ' Body Tissues ', ' Tissues ', ' Veterans ', ' Polyneuropathy ', ' base ', ' Distal ', ' Site ', ' Clinical ', ' Biological ', ' Neurologic ', ' Neurological ', ' Link ', ' Individual ', ' Opioid ', ' Opiates ', ' Biological Process ', ' Biological Function ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' frailty ', ' Immune ', ' Immunes ', ' Severities ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Neuropathy ', ' neuropathic ', ' Sensory ', ' cell type ', ' Pattern ', ' brain tissue ', ' Performance ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' cohort ', ' Genetic Fingerprintings ', ' DNA Typing ', ' DNA Profiling ', ' DNA Fingerprinting ', ' Disease Outcome ', ' novel ', ' Modeling ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' Cellular Immune Function ', ' immune function ', ' CD8B1 gene ', ' LYT3 ', ' CD8B1 ', ' CD8B ', ' CD8 ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Molecular ', ' painful neuropathy ', ' neuropathic pain ', ' epigenomics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Advanced Development ', ' design ', ' designing ', ' resilience ', ' Outcome ', ' Population ', ' Prevalence ', ' Impairment ', ' neurotoxic ', ' biosignature ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' epigenome ', ' model building ', ' learning strategy ', ' learning method ', ' learning activity ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' drug misuse ', ' medication misuse ', ' substance misuse ', ' Womens Interagency HIV Study ', ' ']",NIDA,YALE UNIVERSITY,R01,2019,599984,CT-03,0.010419038064296244
"DNA Sequencing Using Single Molecule Electronics PROJECT SUMMARY / ABSTRACT  Progress in DNA sequencing has occurred through multiple stages of disruptive new technologies being introduced to the field, each of which has increased sequencing capabilities by lowering costs, improving throughput, and reducing errors. The goal of this research project is to investigate a new, all-electronic sequencing method that has the potential to become the next transformative step for DNA sequencing. This new method is based on single DNA polymerase molecules bound to nanoscale electronic transistors, a hybrid device that transduces the activity of a single polymerase molecule into an electronic signal.  The goal of this research project is to determine whether these hybrid polymerase-transistors are truly applicable to DNA sequencing and the competitive environment of advanced sequencing technologies. To answer this question, the project teams the scientists who have developed the devices with Illumina, Inc., a worldwide leader in the DNA sequencing market. The experiments proposed here build on encouraging preliminary results, first to demonstrate accurate DNA sequencing and second to evaluate whether the new technique could become a competitive challenge to other sequencing methods. The interdisciplinary team will combine state-of-the-art techniques from protein engineering, nanoscale fabrication, and machine learning to customize polymerase's activity and its interactions with the electronic transistors. If successful, nanoscale solid-state devices like transistors provide one of the best opportunities for increasing sequencing capabilities while decreasing sequencing costs, so that DNA sequencing can become a standard technique in health care and disease treatment. PROJECT NARRATIVE  Over the past two decades, DNA sequencing has transformed from a heroic, nearly impossible task to a routine component of modern laboratory research. The field of DNA sequencing has improved tremendously through a strategy of modifying and monitoring polymerases, a key enzyme at the heart of many DNA sequencing technologies. This proposal is motivated by developments in the field of single-molecule electronics, which provide an entirely new mode for listening to the activity of single polymerase molecules. This electronic method is very different from the biochemical, optical, or nanopore-based techniques currently in use, and it has inherent advantages that could provide exciting possibilities for DNA sequencing. The project will tailor single-molecule electronics for the specific purpose of DNA sequencing and determine whether this strategy could lead to a new generation of sequencing technology.",DNA Sequencing Using Single Molecule Electronics,9766330,R01HG009188,"['Affect ', ' Carbon ', ' Charge ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Dependent DNA Polymerases ', ' DNA Polymerases ', ' DNA-Directed DNA Polymerase ', ' Single-Stranded DNA ', ' electronic device ', ' Electronics ', ' Enzyme Gene ', ' Enzymes ', ' Foundations ', ' Goals ', ' Heart ', ' Hybrids ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Modernization ', ' Motion ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Noise ', ' Nucleotides ', ' optical ', ' Optics ', ' protein design ', ' genetic protein engineering ', ' Protein Engineering ', ' Proteins ', ' Publishing ', ' Reading ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Technology ', ' Temperature ', ' Transistors ', ' Work ', ' Generations ', ' health care ', ' Healthcare ', ' Custom ', ' base ', ' improved ', ' Site ', ' Surface ', ' Variant ', ' Variation ', ' Biochemical ', ' Individual ', ' enzyme activity ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Collaborations ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Scientist ', ' Event ', ' Route ', ' Techniques ', ' System ', ' Performance ', ' solid state ', ' molecular modeling ', ' Molecular Models ', ' Molecular Modeling Protein/Amino Acid Biochemistry ', ' Molecular Modeling Nucleic Acid Biochemistry ', ' Base Pairing ', ' novel ', ' new technology ', ' novel technologies ', ' Modality ', ' Devices ', ' response ', ' Nanotechnology ', ' nanotechnological ', ' nanotech ', ' nano-technological ', ' nano technology ', ' nano tech ', ' single molecule ', ' Polymerase ', ' Data ', ' Reproducibility ', ' Resolution ', ' Enzyme Kinetics ', ' Monitor ', ' Modification ', ' Development ', ' developmental ', ' cost ', ' nanoelectronics ', ' nano electronics ', ' nanoscale ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanopore ', ' nano pore ', ' single walled carbon nanotube ', ' single walled carbon nano tube ', ' SWNT ', ' scale up ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' experimental study ', ' experimental research ', ' experiment ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' competitive environment ', ' competitive atmosphere ', ' ']",NHGRI,UNIVERSITY OF CALIFORNIA-IRVINE,R01,2019,468098,CA-45,0.06306426354659805
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9720892,R24DK106766,"['Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Catalogs ', ' Dimensions ', ' Frequencies ', ' cell type ', ' Pattern ', ' System ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' gene conservation ', ' cell injury ', ' cell damage ', ' Cellular injury ', ' novel ', ' Basic Science ', ' Basic Research ', ' Categories ', ' Human Resources ', ' personnel ', ' Manpower ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' response ', ' Erythroid Cells ', ' CISH gene ', ' Suppressor of Cytokine Signaling Gene ', ' Suppressor of Cytokine Signaling ', ' SOCS Gene ', ' G18 Gene ', ' G18 ', ' Cytokine-Inducible SH2-Containing Protein Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B Gene ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B ', ' Cytokine Inducible SH2-Containing Protein ', ' CISH Protein ', ' CIS-1 Protein ', ' CIS-1 Gene ', ' CIS protein ', ' CIS Gene ', ' Address ', ' Data ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Transcript ', ' Pathologic ', ' Monitor ', ' Knock-out ', ' Knockout ', ' Modification ', ' Development ', ' developmental ', ' Output ', ' epigenomics ', ' data acquisition ', ' clinically significant ', ' clinical significance ', ' mouse model ', ' murine model ', ' loss of function ', ' prototype ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epigenome ', ' precision medicine ', ' precision-based medicine ', ' genome editing ', ' genomic editing ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' chromosome conformation capture ', ' chromosome capture ', ' chromatin conformation capture ', ' 3C-based technology ', ' 3C-based technique ', ' 3C-based strategy ', ' 3C-based method ', ' 3C-based assay ', ' 3C-based approach ', ' genome browser ', ' experimental study ', ' experimental research ', ' experiment ', ' annotation  system ', ' annotation tool ', ' annotation framework ', ' blood formation ', ' hematopoietic differentiation ', ' Back ', ' Dorsum ', ' Base Sequence ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Biology ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Chromosomes ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Engineering ', ' Evolution ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Health ', ' Heart ', ' blood cell formation ', ' Hematopoietic Cellular Control Mechanisms ', ' Hematopoiesis ', ' hemopoietic stem cell ', ' hemopoietic progenitor ', ' hematopoietic stem progenitor cell ', ' hematopoietic progenitor ', ' blood stem cell ', ' Hematopoietic Progenitor Cells ', ' Blood Precursor Cell ', ' Hematopoietic stem cells ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Production ', ' Proteins ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Science ', ' Technology ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' falls ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Custom ', ' improved ', ' Area ', ' Training ', ' Hematopoietic ', ' hemopoietic ', ' insight ', ' Binding Proteins ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Monoclonal Antibody R24 ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' Collaborations ', ' Genetic ', ' tool ', ' ']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2019,1202598,PA-12,0.05593076744399231
"Identification of epigenetic subclones in lymphomas and leukemias Abstract Epigenetic modifications, such as DNA methylation, play a significant role in human disease. DNA methylation is altered in cancer, and DNA methylation-induced silencing of promoters of tumor-suppressors is thought to play a key role in tumorigenesis. Though there is an increasing number of methylation sequencing datasets generated from cancer, they are confounded by tumor heterogeneity. Understanding the subclonal architecture underlying heterogeneity is important because individual cancer subclones impact cancer growth, treatment resistance, and metastasis. Increased epigenetic heterogeneity, or variation in DNA methylation patterns, was determined to be correlated with worse prognosis in patients with diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML). However, these studies only profiled epigenetic heterogeneity at a global scale and did not analyze methylation of individual subclones. Many computational methods have been developed for this purpose in epigenome-wide association studies (EWAS), but these methods are not applicable for methylation sequencing data. As such, there is a need to develop new computational methods to study subclonal methylation profiles in cancer. I will develop a novel computational method (DXM) that deconvolves DNA methylation of heterogeneous clinical samples into their major subpopulations, their prevalence, and their respective DNA methylation profiles (Aim 1). DXM will be developed on simulations generated from data available from both the Roadmap Epigenomics Project and the Blueprint Epigenome Project and will be validated with methylation sequencing on DLBCL samples. I will then leverage DXM to study subclonal methylation profiles in AML (Aim 2). I hypothesize that methylation can confer fitness advantages in epigenetic subclones of AML, leading to clonal expansion following therapeutic intervention and subsequent relapse. Using DXM, I will first identify epigenetic subclones from whole genome bisulfite sequencing data from AML patients with well-characterized genetic subclonal architecture and compare the epigenetic subclonal architecture to that of the genetic subclones. In a second dataset containing methylation sequencing data from paired diagnosis-relapse samples, I will apply DXM, identify subclonal methylation profiles, and characterize all genes impacted by subclonal methylation to determine if they are expected to confer fitness advantages. Finally, I will test if mutations known to impact DNA methylation in AML (DNMT3A, IDH1/2) alter epigenetic subclonal expansion. Taken together, this proposal will result in a new computational approach to interpret epigenetic data from heterogeneous clinical samples as well as identification of DNA methylation changes in epigenetic subclones of AML that contribute to disease progression and correlate with prognosis. Project Narrative Studies that characterize which variations in cancer relate to worse outcome may do analysis on the entire tumor sample, which is composed of many different types of cells, each with distinct biology. The goal of this proposal is to develop a novel computational method to analyze variations in cancer at the level of cell-types. These results can be used to improve patient prognostics and care in multiple cancers.",Identification of epigenetic subclones in lymphomas and leukemias,9752227,F30CA224687,"['Algorithms ', ' Antibodies ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Body ', ' Cells ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Diagnosis ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Heterogeneity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myelocytic Leukemia ', ' Mentorship ', ' Methods ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Neoplasm Metastasis ', ' Pathology ', ' Patients ', ' Physicians ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Relapse ', ' social role ', ' Role ', ' statistics ', ' Testing ', ' Tumor Promoters ', ' United States ', ' X-Chromosome Inactivation ', ' Lyonization ', ' X Inactivation ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Fluorescence-Activated Cell Sorting ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' Caring ', ' career ', ' improved ', ' Surface ', ' Clinical ', ' Variant ', ' Variation ', ' Link ', ' prognostic ', ' Training ', ' Individual ', ' Genomic Imprinting ', ' Parental Imprinting ', ' Genetic Imprinting ', ' Disease Progression ', ' Genetic ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Complex ', ' cell type ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Retrotransposon ', ' simulation ', ' novel ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' Oncogenesis ', ' tumorigenesis ', ' genome sequencing ', ' Address ', ' fitness ', ' Data ', ' Cancer Biology ', ' Cancer Patient ', ' Clonal Expansion ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Newly Diagnosed ', ' Modification ', ' Development ', ' developmental ', ' therapy resistant ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' epigenomics ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' design ', ' designing ', ' Outcome ', ' leukemia/lymphoma ', ' lymphoma/leukemia ', ' Prevalence ', ' human disease ', ' tumor ', ' clinical care ', ' epigenome ', ' methylation pattern ', ' single cell sequencing ', ' bisulfite sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' patient stratification ', ' stratified patient ', ' tumor heterogeneity ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' whole genome ', ' full genome ', ' entire genome ', ' ']",NCI,WASHINGTON UNIVERSITY,F30,2019,30926,MO-01,0.2528962600817255
"Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint PROJECT SUMMARY/ABSTRACT Epigenetic memory is a phenomenon of trans-generational, altered trait inheritance without changes to DNA sequence. Our present ability to predict or direct epigenomic behavior is extremely limited, even though epigenetic factors participate in nearly all aspects of multicellular development, environmental stress response, and disease development. There are critical gaps in our current knowledge of DNA methylation patterning, stable epiallele formation, and the relationship of genome-wide epigenomic behavior to gene expression and phenotype in both plant and animal systems. We have developed a system that will directly address these questions. Our long-term goals are to decode the heritable epigenome, and its relationship to organismal phenotype, particularly in response to stress. What distinguishes our proposed research is the availability of robust biologicals in the model plant Arabidopsis to impose artificial stress, recurrent heritable epigenetic memory, and methylome repatterning. These resources emanate from discovery of the MSH1 gene, disruption of which leads to epigenomic reprogramming. Recent data from this system lead to the overarching hypothesis that stress-induced gene expression recruits methylation machinery to gene networks in a non-stochastic manner. To address this hypothesis, we have developed novel genome-wide methylome analysis procedures for high-resolution identification of gene-associated methylation repatterning. These analyses reveal gene networks that are strikingly consistent with phenotype changes, and display repatterning that is intragenic and often subtle, yet reproducible. We have also identified epigenetic components of the DNA methylation and RdDM pathways that are essential to reprogramming based on msh1 double mutant analysis. Building upon strong preliminary data, we propose to pursue three specific aims to characterize trans-generational epigenomic behavior: (1) To delineate stable, de novo epialleles in the Arabidopsis msh1 model system, exploiting a five-generation memory lineage, (2) to develop a mechanistic understanding of stable epiallele formation in response to stress, implementing machine learning and mutant screening, and (3) to test locus-specific mechanics of epiallele establishment, capitalizing on gene relocation to delimit germane local chromatin features. The proposed research will broadly impact the field by providing the first example of inducible epigenomic reprogramming in a non-stochastic pattern that permits machine learning-based predictive modeling and identification of cis-acting sequence features. The results will be pertinent to mammalian systems and, possibly, to diagnostic strategies for diseases with a strong GxE component. PROJECT NARRATIVE The proposed research has relevance to public health priorities as we see life style diseases, stress and environmental impacts on health, in utero and throughout development, pose greater challenges to conventional medicine. Environmental stress is a multifaceted influence on health, and epigenomic response is an important, under-investigated factor in cancer, neurodevelopmental, metabolic and toxin-related disorders with high GxE effects. Upon conclusion of the study, we will have defined the architectural features of stable, de novo epiallelic variation, assessed its influence on heritable phenotype, and refined a methodology for high resolution analysis of epigenomic data that is necessary to inform the development of early diagnostics and countermeasures.","Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint",9801992,R01GM134056,"['Affect ', ' Animals ', ' Architecture ', ' Engineering / Architecture ', ' Behavior ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Chromatin ', ' Complement Proteins ', ' Complement ', ' Cytosine ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Medicine ', ' Memory ', ' Methods ', ' Methodology ', ' Methylation ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' Nucleosomes ', ' living system ', ' Organism ', ' Phenotype ', ' Plants ', ' Recurrent ', ' Recurrence ', ' Reinforcement ', ' Psychological reinforcement ', ' Reproduction ', ' Research ', ' Research Resources ', ' Resources ', ' Splicing ', ' RNA Splicing ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Stress ', ' Testing ', ' Thermodynamic ', ' Thermodynamics ', ' Toxin ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' Generations ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Arabidopsis ', ' base ', ' density ', ' Procedures ', ' Site ', ' Variant ', ' Variation ', ' Biological ', ' Link ', ' insight ', ' Gene Targeting ', ' Environmental Impact ', ' Ecological impact ', ' Transgenes ', ' Liquid substance ', ' liquid ', ' fluid ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' programs ', ' Mechanics ', ' mechanical ', ' Pattern ', ' System ', ' mutant ', ' trait ', ' novel ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' response ', ' behavior influence ', ' behavioral influence ', ' Genomics ', ' histone modification ', ' Small RNA ', ' Address ', ' Chromatin Modeling ', ' Chromatin Assembly ', ' Data ', ' Detection ', ' Plant Model ', ' Reproducibility ', ' Resolution ', ' Cis-Acting Sequence ', ' Cis-Acting Locus ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pattern Recognition ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Process ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' in utero ', ' epigenomics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' genome-wide ', ' genomewide ', ' genome scale ', ' public health priorities ', ' flexibility ', ' flexible ', ' screening ', ' methylome ', ' epigenome ', ' biophysical properties ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' transgenerational epigenetic inheritance ', ' transgenerational inheritance ', ' methylation pattern ', ' epigenetic memory ', ' experimental study ', ' experimental research ', ' experiment ', ' recruit ', ' ']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2019,319720,PA-12,0.15742311235354714
"Critical role of TCF-1 on the epigenetic identity of memory T cells The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity of memory CD8+ T cells. Our adaptive immune system has evolved a unique capacity to remember a pathogen through the generation of memory T cells, which protect the host in the event of reinfection. A better understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in organ transplantation or enhance T cell responses during chronic infections. Although it is known that the transcription factor TCF-1 is required for memory CD8+ T cell function, the mechanisms through which this protein controls memory T cell fate remain unclear. Recently, we discovered that a mechanism through which TCF-1 controls the development of T cells relates to its unprecedented ability to create the chromatin accessibility landscape of nave T cells. We found that TCF-1 is selectively enriched at genomic regions that become accessible at the earliest stages of development and is required for the accessibility of these regulatory elements. At the single-cell level, TCF-1 can dictate a coordinate opening of chromatin in T cells. Moreover, ectopic TCF-1 can directly erase repressive chromatin marks in non-T cells, generating de novo open chromatin and inducing the expression of T cell genes. While our recent data determined the novel role of TCF-1 on the epigenome during T cell development, our findings also raised another critical question: what is the role of TCF-1 on the epigenetic identity of memory T cells? We hypothesize that TCF-1 in cooperation with transcription factor partners defines the epigenetic landscape of memory T cells. Our new preliminary data further indicate that TCF-1 expression post T cell activation in vitro can lead to gains in chromatin accessibility at pro-memory genes. However, it remains unclear if TCF-1 expression in T cells responding to an infection can create the epigenetic identity of memory T cells. The domains of TCF-1 required for targeting the chromatin and its potential cooperating factors also remain unknown. How TCF-1 dependent changes on the epigenome relate to pro-memory genes needs to be defined. To answer these questions, we will interrogate the effect of TCF-1 and its potential partners on the chromatin state and accessibility of CD8+ T cells in vitro. Using the state-of-the-art tools, we will generate the map of TCF-1 dependent 3D genome organization and define how changes on the epigenome relate to memory genes. We will further translate these findings in vivo exploiting single-cell epigenomic, transcriptomic, and flow cytometry assays. The expected outcome of this proposal is a detailed understanding of the fundamental interaction between TCF-1 and the chromatin in peripheral T cells which can be exploited to devise combination therapies including epigenetic editing to selectively alter T cell fate at will. Our adaptive immune system has evolved a unique capacity to remember a pathogen through the generation of memory T cells, which protect the host in the event of reinfection. A better understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in organ transplantation or enhance T cell responses during chronic infections. The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity of memory CD8+ T cells.",Critical role of TCF-1 on the epigenetic identity of memory T cells,9642390,R01HL145754,"['Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Chromatin ', ' multi-modal treatment ', ' multi-modal therapy ', ' combined treatment ', ' combined modality treatment ', ' combination therapy ', ' Multimodal Treatment ', ' Multimodal Therapy ', ' Combined Modality Therapy ', ' Disorder ', ' Disease ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Foundations ', ' Genes ', ' Genome ', ' Goals ', ' In Vitro ', ' Infection ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Memory ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Organ Transplants ', ' Grafting Procedure ', ' Organ Transplantation ', ' Proteins ', ' Research ', ' social role ', ' Role ', ' thymus derived lymphocyte ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Thymus Reticuloendothelial System ', ' Thymus Proper ', ' Thymus ', ' Thymus Gland ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Translating ', ' Generations ', ' Mediating ', ' Tertiary Protein Structure ', ' Protein Domains ', ' Peptide Domain ', ' base ', ' Peripheral ', ' Site ', ' Area ', ' CD8-Positive T-Lymphocytes ', ' T8 Lymphocytes ', ' T8 Cells ', ' CD8-Positive Lymphocytes ', ' CD8+ T-Lymphocyte ', ' CD8+ T cell ', ' CD8 lymphocyte ', ' CD8 T cells ', ' CD8 Cell ', ' Effector Cell ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Event ', ' cell type ', ' Techniques ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' mutant ', ' synergism ', ' immunoregulation ', ' immunoregulatory ', ' immunomodulatory ', ' immunologic reactivity control ', ' immune regulation ', ' immune modulation ', ' Immunomodulation ', ' novel ', ' T memory cell ', ' memory T lymphocyte ', ' T cell differentiation ', ' T-Cell Activation ', ' Molecular Interaction ', ' Binding ', ' FOXO1A gene ', ' Forkhead in Rhabdomyosarcoma ', ' Forkhead Box O1A ', ' FOXO1A ', ' FOXO1 ', ' FKHR ', ' Data ', ' Regulatory Element ', ' Resolution ', ' T-Cell Development ', ' T-Lymphocyte Development ', ' T-Cell Ontogeny ', ' in vivo ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Genomic Segment ', ' genomic region ', ' Monitor ', ' Molecular ', ' Development ', ' developmental ', ' TCF Transcription Factor ', ' T Cell Factor ', ' Lymphoid Enhancer Factor ', ' LEF Transcription Factor ', ' Gene Expression Profile ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' epigenomics ', ' Outcome ', ' pathogen ', ' transcriptomics ', ' novel therapeutic intervention ', ' novel therapy approach ', ' novel therapeutic approach ', ' new therapy approaches ', ' new therapeutic strategies ', ' new therapeutic intervention ', ' new therapeutic approach ', ' T cell response ', ' epigenome ', ' Adaptive Immune System ', ' chronic infection ', ' persistent infection ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,R01,2019,445194,PA-03,0.026065982851198908
"Inferring gene regulatory circuitry from functional genomics data PROJECT SUMMARY It has long been known that methylation of genomic DNA correlates with gene expression. However, the structural mechanisms that underlie these observations remain obscure. In this project, we will pursue several innovative strategies for studying how methylation affects transcription factor (TF) binding. First, we will use Methyl-SELEX-seq  a novel experimental method developed in the previous cycle of this grant that uses barcoded mixtures of methylated and unmethylated DNA ligands  to create detailed maps of the effect of methylation on binding affinity for a broad panel of human transcription factors from various structural families. Second, we will perform detailed computational analyses and follow-up experiments to test the hypothesis that methylation causes local changes in DNA shape, which in turn modify TF binding affinity. We have shown that adding a methyl group in the major groove changes the geometry of the minor groove and enhances the electrostatic interaction between negative charges in the DNA minor groove and positively charged amino- acids in the TF. We will extend these analyses to other DNA modifications, as well as a wider range of DNA shape parameters and associated flexibility parameters. By building interpretable TF-DNA recognition models that integrate base, shape, and flexibility features using a powerful new machine learning framework developed in the previous funding cycle, we will make specific predictions regarding sequence and methylation readout mechanisms, and validate these using SELEX experiments with mutated TFs. To assess to what extent our quantitative models for binding to naked DNA built from SELEX data are predictive of binding to genomic DNA in the context of the living cell, we will perform detailed parallel analyses of SELEX and ChIP- seq data for Hox proteins and other TFs. Finally, to study the relationship between DNA binding and gene expression control in human cell lines, we will exploit Survey of Regulatory Elements (SuRE-seq), a novel massively parallel reporter assay that provides unique information about the autonomous transcriptional activity for each of >108 overlapping genomic fragments. PROJECT NARRATIVE Epigenetic modifications of the human genome are known to play a key role in development and disease, but the underlying molecular mechanisms are largely unknown. The main goal of this proposal is to develop and apply new experimental and computational tools for analyzing how the binding of regulatory proteins to DNA is influenced by cytosine methylation. This will help us better understand its impact on gene expression and disease.",Inferring gene regulatory circuitry from functional genomics data,9745659,R01HG003008,"['Affect ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Amino Acids ', ' aminoacid ', ' Base Sequence ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biophysics ', ' biophysical sciences ', ' biophysical principles ', ' biophysical foundation ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' Charge ', ' Communities ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Gene Expression ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' human whole genome ', ' Human Genome ', ' Goals ', ' Grant ', ' Modern Man ', ' Human ', ' In Vitro ', ' Laboratories ', ' Ligands ', ' Maps ', ' Methods ', ' Methylation ', ' Names ', ' Play ', ' Proteins ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' DNA Sequence ', ' base ', ' DNA analysis ', ' Variant ', ' Variation ', ' Biological ', ' Funding ', ' Shapes ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Electrostatics ', ' Hyperactive behavior ', ' Motor Hyperactivity ', ' Hyperkinetic Movements ', ' Hyperkinesis ', ' Hyperkinesia ', ' Hyperactivity ', ' Dependence ', ' Protocols documentation ', ' Protocol ', ' preference ', ' methyl group ', ' HOX protein ', ' Free Energy ', ' Structure ', ' novel ', ' family structure ', ' Human Cell Line ', ' Positioning Attribute ', ' Position ', ' genetic regulatory protein ', ' regulatory gene product ', ' Regulatory Protein ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' functional genomics ', ' Genomics ', ' DNA Binding ', ' DNA bound ', ' DNA Binding Interaction ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Address ', ' Affinity ', ' Data ', ' Minor Groove ', ' Mutate ', ' Regulatory Element ', ' Chromatin Structure ', ' Computer Analysis ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Major Groove ', ' Molecular ', ' Modification ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' deep sequencing ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' comparative ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' methylome ', ' High-Throughput Nucleotide Sequencing ', ' High-Throughput Sequencing ', ' Geometry ', ' Genomic DNA ', ' gDNA ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' genomic predictors ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NHGRI,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2019,560259,NY-13,0.11482425156446867
"Neural-derived extracellular vesicles microRNAs in bipolar disorder: a peripheral window into the brain Project Summary/Abstract Bipolar disorder is a chronic and often severe psychiatric disorder with a strong genetic basis. However, even with significant progress made by molecular genetic studies, the few genetic variants associated with the disorder explain only a small portion of its heritability, which led to the hypothesis of the involvement of epigenetic alterations in BDs pathophysiology. While recent studies have attempted to identify epigenetic biomarkers in BD, most results are limited due to the tissue specificity of epigenetic alterations and the biased assessments of candidate genes or genome-wide investigations through microarrays. Since the search for biomarkers have repetitively focused on peripheral measures that do not necessarily reflect brain alterations, significant biologically- and clinically-relevant findings have been significantly hindered. This study will fill this important gap by measuring epigenetic markers in plasma-derived extracellular vesicles (EVs) released by the brain. Specifically, we will focus on microRNAs and other non-coding RNAs that have been recently proposed to mediate important mechanisms in BD and may integrate gene and environment stimuli. Of note, microRNAs- filled EVs are released by the neural tissue as a method of cell-to-cell communication and may be the key players in transferring epigenetic markers to germ cells, ultimately contributing to the inter- and transgenerational transmission of BD. Our working hypothesis is that patients with BD will show alterations in specific miRNAs and other non-coding RNA transcripts in plasma neural-derived EVs compared to controls. To test this, we will initially identify neural-specific EVs microRNAs in BD by analyzing blood samples from 60 healthy controls and 60 BD type I patients (already collected and stored in our Department) (Aim 1). After neural-derived EVs immunoprecipitation and characterization, RNA will be isolated and next generation sequencing libraries will be prepared and sequenced on an Illumina NextSeq instrument with 1x75 bp single-end reads at an approximate depth of 10-15 million reads per sample. Significantly altered miRNAs will be validated by real-time PCR and the putative biological relevance of the differentially expressed transcripts will be assessed by functional pathway analyses. In addition, a machine learning model will be built using the miRNA expression data in order to predict whether an individual sample belongs to the BD or control group, allowing for the establishment of a clinically useful predictive biosignature that can have immediate impact in the field. On a second step we will investigate the correlation between neuronal EVs transcriptome markers with clinical, neuroanatomical, and neurocognitive parameters available for each subject, with the ultimate goal of identifying the clinical relevance of the newly- identified EVs markers in endophenotypes of illness (Aim 2). The identification of such brain-specific markers will likely open new avenues for scientific investigation of BD. Public Health Relevance Statement The proposed research is relevant to public health because bipolar disorder is a chronic and highly disabling condition with a strong familial aggregation, yet non-genetic mechanisms (such as microRNAs) underlying the disorder are still fairly unknown. The investigation of plasma neural-derived extracellular vesicles in bipolar disorder patients and controls and the development of a machine learning algorithm for the identification of a microRNA biosignature can lead to the identification of clinically relevant peripherally measured brain-specific biomarkers that can improve our understanding of the disorder and inform the development of personalized treatments.",Neural-derived extracellular vesicles microRNAs in bipolar disorder: a peripheral window into the brain,9822873,R21MH117636,"['Affect ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Bipolar Disorder ', ' manic depressive illness ', ' manic depressive disorder ', ' bipolar disease ', ' bipolar affective disorder ', ' Manic-Depressive Psychosis ', ' Bipolar Affective Psychosis ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cell-to-Cell Interaction ', ' Cell Interaction ', ' Cell Communication ', ' Cell Body ', ' Cells ', ' Control Groups ', ' Disorder ', ' Disease ', ' Ethylenedinitrilotetraacetic Acid ', ' Ethylenediaminetetraacetic Acid ', ' Edathamil ', ' EDTA ', ' Edetic Acid ', ' Environment ', ' Gene Expression ', ' Genes ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Germ Cells ', ' Goals ', ' Immune Precipitation ', ' Immunoprecipitation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Methods ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Play ', ' Public Health ', ' Research ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Specificity ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Measures ', ' Molecular Genetics ', ' Mediating ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Peripheral ', ' Chronic ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Serum ', ' Blood Serum ', ' Multivesicular Body ', ' Stimulus ', ' Individual ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Genetic ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' milliliter ', ' Source ', ' Neurocognitive ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' interest ', ' Early Diagnosis ', ' early detection ', ' relating to nervous system ', ' neural ', ' Structure ', ' white matter ', ' substantia alba ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Pathogenesis ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Pathogenicity ', ' intercellular communication ', ' Cell-Cell Signaling ', ' Cell to Cell Communication and Signaling ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Data ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' First Degree Relative ', ' 1st degree relative ', ' Transcript ', ' Validation ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' clinically relevant ', ' clinical relevance ', ' endophenotype ', ' public health relevance ', ' candidate marker ', ' candidate biomarker ', ' biosignature ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' non-genetic ', ' nongenetic ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' epigenetic marker ', ' epigenetic biomarker ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' severe psychiatric disorder ', ' Genetic study ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' vesicular release ', ' vesicle release ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' specific biomarkers ', ' extracellular vesicles ', ' machine learning algorithm ', ' ']",NIMH,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R21,2019,192500,TX-09,0.031010700867564286
"An Integrative Computational Framework for DNA Hydroxymethylation Data Mining and Interpretation PROJECT SUMMARY/ABSTRACT Recent advances in next generationsequencing (NGS)-based molecular methods have illuminated the hierarchical organization of the genome and have shown that changes in the epigenome can promote or prevent the access of transcription factors (TFs) to specific DNA sequences, move genes between nuclear compartments, and build or remove the insulation between neighboring genomic regions. As changes in the epigenome and chromatin organization can derail precise transcriptional regulatory programs to change cell differentiation status or induce a pathological state, research in Dr. Lis laboratory seeks to improve our ability to define and understand the impact of such changes across multiple layers of transcriptional regulation in the cell. The laboratory has effectively addressed the regulatory roles of DNA methylation in its previous and ongoing work and now extends its focus to hydroxymethylation. 5-hydroxymethylcytosine (5hmC), is a key epigenetic modification linked to transcriptional activation; however, 5hmC data and its genome properties have thus far been evaluated with limited integration of different genomic data types. Moreover, there is no integrative computational framework designed to interpret the functional role of 5hmC in the context of 5-methycytosine (5mC), enhancer activities, chromatin interactions, gene expression data, and DNA sequence information. This proposal will fill the growing need for user-friendly, interpretable, and extendable tools for mining 5hmC data toward laying a foundation for basic mechanistic studies of the epigenome and facilitate discovery of potential therapeutic targets in disease. Building on the investigators progress in revealing the dynamics of 5hmC and its impact on gene regulation, the proposal will now develop innovative computational tools for 5hmC data mining and data integration with other NGS datasets, with a focus on applying these tools to B cell differentiation, cancer, and embryonic stem cell (ESC) differentiation. Key goals over the next five years include developing a computational framework to mine short- and long-read sequencing data to answer the following questions: (1) How does 5hmC contribute to epigenetic heterogeneity? (2) How does 5hmC epigenetic heterogeneity contribute to transcriptome heterogeneity? (3) How do 5hmC levels and epigenetic heterogeneity communicate with histone modifications, enhancer activities, chromatin interactions, and chromatin organization? We will combine machine learning and network mining algorithms to enable knowledge discovery and data integration from diverse genomic data types. We will then harness the 5hmC data-mining framework to identify 5hmC patterns that correlate with ESC differentiation, B cell differentiation, and that contribute to the fitness advantage of cancer cells. This work is significant because it will be the first dissection of 5hmCs contribution to local and long-range epigenetic heterogeneity and the first computational framework to uncover the cross-talk between DNA modifications and other transcriptional regulators via chromatin interaction data. Collectively, this work will yield a fuller picture of the molecular events that underlie fundamental changes in cell state and behavior. PROJECT NARRATIVE / RELEVANCE TO PUBLIC HEALTH Modifications of the genome that do not change the sequence of the DNA, called epigenetic modifications, can impact how genes are expressed and lead healthy cells into a disease state. Here we propose to develop computational tools to define how one type of epigenetic modification, called hydroxymethylation, impacts gene expression and ultimately cell behavior. These tools will be versatile and adaptable to any cell type of choice, enabling research into the molecular features of the genome that underlie both normal and pathological cell behaviors.",An Integrative Computational Framework for DNA Hydroxymethylation Data Mining and Interpretation,9798459,R35GM133562,"['Algorithms ', ' Behavior ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Differentiation ', ' Cell Differentiation process ', ' Cell Body ', ' Cells ', ' Chromatin ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Disorder ', ' Disease ', ' Dissection ', ' Deoxyribonucleic Acid ', ' DNA ', ' Foundations ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Mining ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' Enhancers ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Transcriptional Activation ', ' Transcription Activation ', ' base ', ' improved ', ' Link ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' programs ', ' Event ', ' cell type ', ' Pattern ', ' Nuclear ', ' embryonic stem cell ', ' stem cell of embryonic origin ', ' ES cell ', ' Property ', ' B cell differentiation ', ' B lymphocyte differentiation ', ' histone modification ', ' DNA Modification ', ' DNA Modification Process ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' preventing ', ' prevent ', ' datamining ', ' data mining ', ' Address ', ' fitness ', ' Data ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Genomic Segment ', ' genomic region ', ' Pathologic ', ' Molecular ', ' Modification ', ' stem cell differentiation ', ' computer framework ', ' computational framework ', ' computerized tools ', ' computational tools ', ' data integration ', ' design ', ' designing ', ' differentiated B cell ', ' differentiated B lymphocyte ', ' innovation ', ' innovative ', ' innovate ', ' user-friendly ', ' cell behavior ', ' cellular behavior ', ' therapeutic target ', ' Knowledge Discovery ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' epigenome ', ' learning network ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' ']",NIGMS,JACKSON LABORATORY,R35,2019,472500,ME-02,0.06851335211178686
"Computational modeling of DNA methylation-mediated gene regulation Abstract Large numbers of complete methylomes are being acquired through clinical sequencing projects, such as through The Cancer Genome Atlas, Blueprint Epigenome Project, and International Cancer Genome Consortium. Furthermore, third-generation nanopore sequencers, which detect DNA methylation and genetic variation in a single experiment, are nearly ready for routine clinical sequencing and will provide complete methylomes for all patients where whole-genome sequencing is indicated. Current analysis tools however only perform preliminary methylome processing and catalogue differentially methylated regions (DMRs). In order to transform methylome analysis into a clinically useful diagnostic/prognostic test, we need to develop predictive tools to interpret the functional and pathological consequences of identified methylation changes. Towards this goal, we have published a series of papers demonstrating that machine-learning based models utilizing high- resolution signatures of all methylation changes around a promoter vastly outperform conventional DMR methods. Our models accurately predict expression states at genes potentially regulated by methylation and reveal predictive methylation signatures that facilitate mechanistic interpretation. Nonetheless, several challenges remain before we can achieve our goals of translating genome-wide methylation data for routine clinical use: (1) To our knowledge, no current models integrate distal enhancers, whose activation is affected by DNA methylation. Such integrative analysis is necessary to understand consequences of methylation changes in cancers, whose genomes frequently undergo wide-spread methylation changes. In addition, such modelling will be essential to understand the role of 5-hydroxymethylcytosine (5hmC), which may play both repressive and activating roles in neurons depending on whether it is found at promoters or enhancers. (2) Our current models (and conventional approaches) represent methylation data independent of DNA sequence despite mechanistic studies demonstrating that methylation changes can have different functional effects depending on which sequences change and depending on the context of the local regulatory grammar. In this proposal, we will meet these challenges by first developing a predictive model that incorporates 5-methylcytosine and 5hmC at promoters and enhancers to determine how these marks act in concert. In particular, we will examine the hypothesized dual role of 5hmC as a repressor at promoters and as an activator at enhancers in cortical neurons. We will then use new advances in natural language processing to model DNA sequence and methylation to predict expression states. Our results will reveal which regulatory elements and transcription factors binding sites are affected by DNA methylation and how changes at different sites collaborate to affect expression changes. We will experimentally validate our in silico predictions using a combination of reporter assays and CRISPR- based epigenome-editing tools. Thus, the software tools we develop will form an important toolkit for the analysis and mechanistic interpretation of whole-genome methylation studies, both in the laboratory and clinic. Public Narrative DNA normally undergoes a variety of chemical modifications including the addition of methyl- and hydroxymethyl- groups to cytosines (DNA methylation). Though we are unsure how to interpret them, abnormal patterns of DNA methylation are often found in human diseases and will likely soon be routinely measured in the clinic. In this proposal, we will develop advanced computational approaches to predict the functional and pathological consequences of DNA methylation changes in disease. In the future, the approaches we develop will lead to software that suggests individualized therapies for patients based on clinical methylation data.",Computational modeling of DNA methylation-mediated gene regulation,9896942,R01LM013096,"['Affect ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cataloging ', ' Cell Body ', ' Cells ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Genome ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Glioma ', ' Goals ', ' Laboratories ', ' Maps ', ' Methods ', ' Methylation ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' natural language understanding ', ' Natural Language Processing ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Paper ', ' Patients ', ' Play ', ' Publishing ', ' Recurrent ', ' Recurrence ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Genetic Diversity ', ' Genetic Variation ', ' Generations ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' cofactor ', ' Label ', ' Distal ', ' Site ', ' Clinical ', ' Series ', ' Chemicals ', ' prognostic ', ' Training ', ' Individual ', ' Binding Proteins ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Reporter ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Catalogs ', ' Clinic ', ' Pattern ', ' embryonic stem cell ', ' stem cell of embryonic origin ', ' ES cell ', ' mutant ', ' success ', ' demethylation ', ' relating to nervous system ', ' neural ', ' Regulation ', ' Modeling ', ' Sampling ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genome sequencing ', ' Data ', ' International ', ' Regulatory Element ', ' Resolution ', ' Retrieval ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pathologic ', ' Characteristics ', ' Modification ', ' Development ', ' developmental ', ' epigenomics ', ' cancer genome ', ' tumor genome ', ' cancer cell genome ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' nanopore ', ' nano pore ', ' cancer type ', ' human disease ', ' genome-wide ', ' genomewide ', ' genome scale ', ' The Cancer Genome Atlas ', ' TCGA ', ' genome wide methylation ', ' global methylation ', ' genomewide methylation ', ' methylome ', ' epigenome ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' network architecture ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' methylation pattern ', ' clinical sequencing ', ' whole genome ', ' full genome ', ' entire genome ', ' predictive tools ', ' prognostic assays ', ' prognostic test ', ' experimental study ', ' experimental research ', ' experiment ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' recruit ', ' epigenetic therapy ', ' long short term memory network ', ' long short term memory neural network ', ' epigenome editing ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2019,362352,MO-01,0.17886449108789212
"Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data     DESCRIPTION (provided by applicant): This project involves the development of new statistical methodologies and computational tools for network-based integrative analysis of epigenetic risk factors of cardiovascular diseases (CVD). While the advent of omics data from new technologies has facilitated the study of epigenetic factors, existing methodologies often do not account for complexities of biological data  such as correlations due to interactions of genes/proteins as part of biological pathways  and fail to eciently integrate diverse omics data sets  for instance genetic variation, DNA methylation and gene expression. The methodologies proposed in this project, and the software tools that will be developed to implement them, address these shortcomings, and facilitate further research by the biomedical community to gain a better understanding of the underlying biology of CVD, and to develop new diagnostic biomarkers and potential targets for therapies. The proposed methodologies are motivated by the study of epigenetic data from the Multi-Ethnic Study of Atherosclerosis (MESA), and include (i) a network-based pathway enrichment analysis method that incorporates available knowledge of interactions among genes and proteins while complementing and rening such information (Aim 1A), as well as its extension for analysis of multiple types of omics data (Aim 1B), and (ii) an integrative analysis framework to identify associations among gene expression levels and DNA methylation (Aim 2A) and identify common epigenetic factors of multiple CVD phenotypes through integrated analysis of DNA methylation and mRNA expression data (Aim 2B). We will develop ecient and user-friendly software tools for the proposed methods (Aim 3), which will be made freely available to the public after extensive tests using both simulated data, as well as real data from MESA. PUBLIC HEALTH RELEVANCE: The proposed research addresses the need for development of new statistical machine learning methods for analysis of diverse epigenetic data from multiple cardiovascular disease outcomes. The proposed training activities are designed to enhance the applicant's knowledge of epigenetics and physiology of cardiovascular diseases (CVD), and to further his career as an independent investigator in the area of computational epigenetics for CVD.",Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data,9612567,K01HL124050,"['Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biology ', ' Biomedical Research ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' cardiovascular function ', ' Cardiovascular Physiology ', ' Cause of Death ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Communities ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Gene Expression ', ' Genes ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Information Networks ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Methodology ', ' Methylation ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk Factors ', ' Computer Software Tools ', ' Software Tools ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Testing ', ' training module ', ' Training Activity ', ' Genetic Diversity ', ' Genetic Variation ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' DNA analysis ', ' Area ', ' Biological ', ' Individual ', ' Dyslipidemias ', ' Measurement ', ' Genetic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Source ', ' System ', ' gene interaction ', ' user friendly software ', ' user friendly computer software ', ' Structure ', ' Disease Outcome ', ' novel ', ' member ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Gene Proteins ', ' Protein Gene Products ', ' genetic risk factor ', ' inherited factor ', ' Statistical Methods ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Pathway Analysis ', ' Network Analysis ', ' response ', ' Genomics ', ' cardiovascular disorder risk ', ' cardiovascular disease risk ', ' histone modification ', ' Address ', ' Data ', ' Post-Transcriptional Regulation ', ' posttranscriptional regulation ', ' posttranscriptional control ', ' Post-Transcriptional Control ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' mRNA Expression ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Exogenous Factors ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' disease phenotype ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' Outcome ', ' Network-based ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' therapeutic target ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' epigenetic marker ', ' epigenetic biomarker ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning network ', ' learning strategy ', ' learning method ', ' learning activity ', ' training opportunity ', ' diagnostic biomarker ', ' diagnostic marker ', ' whole genome ', ' full genome ', ' entire genome ', ' high dimensionality ', ' Multi-Ethnic Study of Atherosclerosis ', ' Multiomic Data ', ' multiple omic data ', ' ']",NHLBI,UNIVERSITY OF WASHINGTON,K01,2019,137611,WA-07,0.16987156479436125
"Joint patterns of multi-genetic/epigenetic factors via non-parametric clustering and their association with allergic disease Ray PA-16-162 Project Summary Eczema is a chronic skin inflammatory disease infecting 10-30% of children and 2-10% of adults and increasing. Researchers have struggled to understand the genetic and environmental factors that appear to play a role in eczema's increasing prevalence. The majority of current studies focus on one or two specific types of Genome-wide data in association with eczema such as SNPS, DNA methylation levels, or gene expression levels. Current statistical methods have forced this limitation as none exist, to our knowledge that allow clustering of subjects across multi-dimensional and multi-faceted variables. Therefore, in this project we aim to introduce a novel clustering approach that will cluster subjects across genes which contain SNP information, DNA methylation levels, and gene expression levels. Summarized clusters will then tested for associated risk of eczema or any allergic disease. Genetic patterns associated with eczema will then be further explored to better identify the behavior genetic data and it's uniqueness. The method will be built in R Gui as a free downloadable package making it accessible and easy to use. We will apply the proposed method to the third generation Isle of Wight cohort data. The third generation cohort data consist of children born (2010-current time) from the original cohort of children born between 1989 and 1990 on the Isle of Wight in the UK and contains Genome-wide datasets, disease and exposure status, and allergy information across multiple follow-ups. The implications of this study not only impact the statistical field with a new clustering approach but the eczema and allergy field as well as no other studies have been able to analyze three Genome-wide datasets in concert associated with the risk of allergic diseases. Ray PA-16-162 Project Narrative The prevalence of eczema is increasing world-wide and infecting between 10-30% of children. The complete underlying cause of eczema is unknown but thought to be mixture of genetic and environmental factors. This project aims to incorporate genetic and epigenetic data in concert using a novel statistical approach in hopes of identifying patterns associated with eczema risk, allowing researchers to better understand the biological mechanisms.",Joint patterns of multi-genetic/epigenetic factors via non-parametric clustering and their association with allergic disease,9629655,R03AI128227,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Birth ', ' Parturition ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' eczematous ', ' Eczematous Dermatitis ', ' Eczema ', ' Gene Expression ', ' Genes ', ' behavior genetics ', ' Genetic Determinants of Behavior ', ' Behavioral Genetics ', ' Genome ', ' Health ', ' Allergy ', ' Hypersensitivity ', ' Joints ', ' Methods ', ' Methodology ', ' Methylation ', ' Play ', ' Public Health ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' Testing ', ' Time ', ' Work ', ' Generations ', ' Dataset ', ' Data Set ', ' Umbilical Cord Blood ', ' fetal cord blood ', ' Cord Blood ', ' base ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Chronic ', ' Biological ', ' Link ', ' infancy ', ' infantile ', ' Biological Process ', ' Biological Function ', ' Genetic ', ' DNA Methylation ', ' Knowledge ', ' Complex ', ' Pattern ', ' Location ', ' cohort ', ' Disease Outcome ', ' novel ', ' Categories ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Statistical Methods ', ' Skin ', ' Address ', ' Data ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' vector ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' Outcome ', ' Prevalence ', ' user-friendly ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' Allergic Disease ', ' screening ', ' chronic inflammatory skin ', ' unsupervised learning ', ' unsupervised machine learning ', ' multidimensional data ', ' high dimensional data ', ' ']",NIAID,UNIVERSITY OF MEMPHIS,R03,2019,69485,TN-09,0.021370771811506237
"Predictable control of gene regulation through epigenetic engineering PROJECT SUMMARY/ ABSTRACT Recent landmark discoveries have revealed that in addition to DNA lesions, epigenetic mechanisms also play a major role in cancer. Epigenetics is mediated in part by interactions of proteins and DNA that confer heritable gene expression states. Drugging the cancer epigenome is a burgeoning medical technology that currently uses small molecule inhibitors and small RNAs to disrupt hyperactive epigenetic enzymes. The proposed work will test the hypothesis that a new modality, fusion proteins that interact with the chromatin fiber, will activate therapeutic genes at sites that bear a specific pattern of cancer-related biochemical marks. The specific aims are to (2) use bioinformatic analyses to discover chromosome features that support inducible changes in gene expression states and (2) to use protein engineering to identify determinants of nuclear protein engagement.  PROJECT NARRATIVE Current methods to reactivate dormant therapeutic genes in cancer cells are limited to inhibitors that bind epigenetic enzymes and other proteins. The proposed work will establish a new technology: customizable synthetic proteins that control anti-cancer genes near cancer-associated biochemical marks.",Predictable control of gene regulation through epigenetic engineering,9827157,R21CA232244,"['inhibitor/antagonist ', ' inhibitor ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' anti-cancer drug ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Chromosomes ', ' Systematics ', ' Classification ', ' Clinical Trials ', ' Cytoplasm ', ' Deoxyribonucleic Acid ', ' DNA ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' Enzyme Gene ', ' Enzymes ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Artificial Genes ', ' Synthetic Genes ', ' Histone H3 ', ' Histones ', ' In Vitro ', ' Libraries ', ' Methods ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Molecular Weight ', ' Nucleic Acids ', ' Transforming Genes ', ' Cancer-Promoting Gene ', ' Cancer Genes ', ' Oncogenes ', ' Play ', ' protein design ', ' genetic protein engineering ', ' Protein Engineering ', ' Proteins ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Technology ', ' Medical Technology ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translations ', ' Work ', ' trimethyllysine ', ' Generations ', ' Measures ', ' Polycomb ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' DNA Sequence ', ' Chimeric Proteins ', ' Fusion Protein ', ' Chimera Protein ', ' base ', ' Site ', ' Variant ', ' Variation ', ' Biological ', ' Biochemical ', ' Medical ', ' cancer cell ', ' Malignant Cell ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Hyperactive behavior ', ' Motor Hyperactivity ', ' Hyperkinetic Movements ', ' Hyperkinesis ', ' Hyperkinesia ', ' Hyperactivity ', ' Complex ', ' Pattern ', ' System ', ' synthetic protein ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Gene Silencing ', ' transcriptional silencing ', ' Gene Inactivation ', ' chromatin protein ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' Basic Science ', ' Basic Research ', ' new technology ', ' novel technologies ', ' Modality ', ' Reporting ', ' Gene Expression Profiling ', ' transcriptional profiling ', ' gene expression assay ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Regulation ', ' therapeutic protein ', ' protein drug agent ', ' pharmaceutical protein ', ' native protein drug ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' cancer recurrence ', ' Nuclear Protein ', ' Transcription Initiation Site ', ' Transcription Start Site ', ' Small Interfering RNA ', ' siRNA ', ' Short interfering RNA ', ' Protein Array ', ' Bioinformatics ', ' Bio-Informatics ', ' Transcription Initiation ', ' Molecular Interaction ', ' Binding ', ' Small RNA ', ' Address ', ' protein structure ', ' Affinity ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Chromatin Fiber ', ' 30 nm Fiber ', ' 30 nm Chromatin Fiber ', ' Chromatin Structure ', ' Emerging Technologies ', ' Emergent Technologies ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Molecular ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' design ', ' designing ', ' Heritability ', ' therapeutic gene ', ' genes therapeutics ', ' genes therapeutic ', ' gene-based therapeutics ', ' gene therapeutics ', ' C-terminal ', ' synthetic biology ', ' DNA lesion ', ' epigenome ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' small molecule inhibitor ', ' Structural Protein ', ' recruit ', ' epigenetic therapy ', ' anti-cancer ', ' anticancer ', ' ']",NCI,EMORY UNIVERSITY,R21,2019,179671,GA-05,0.12635429915769028
"Spatial Epigenomic Profiling of Immune Cell Signatures at Subcellular Resolution in Health and Disease SPATIAL EPIGENOMIC PROFILING OF IMMUNE CELL SIGNATURES AT SUBCELLULAR  RESOLUTION IN HEALTH AND DISEASE More than ten percent of childhood cancers are still incurable and need novel therapies. Epigenetic treatments deserve special attention with their specificity and reduced toxicity. Here I plan to explore epigenetic profiles of immune and cancer cells in normal development and blood cancer patients under the mentorship of Garry Nolan for single cell proteomics technology development, in collaboration with Howard Chang for implementation of epigenomic methods such as chromosome accessibility assays, and with Kara Davis for epigenetics studies of treatment resistant B cell subtypes in acute lymphoblastic leukemia (ALL). Epigenetic measurements have been limited to bulk level sequencing and ligation assays or limited number of imaging markers. To address these limitations, I will use an emerging three dimensional (3D) proteomic imaging technology in individual cells, termed as 3D Multiplexed ion beam imaging (MIBI) or 3D MIBI. Epigenetics research by 3D MIBI benefits from high degree multiplexing (up to 100 markers) and super resolution imaging capability (20 nm x-y; 5 nm z resolution), providing exciting opportunities to study genomic sites, methylated DNA, protein factors, and chromosome accessibility, all within the same experiments in single immune and aberrant (leukemic) cells. To systematically determine epigenetic states, I plan to utilize clonal B cell lines to decipher variability of epigenetic components including chromatin states, protein factors and modifiers by a fifty-marker 3D MIBI panel (Aim 1). These experiments will show distribution of epigenetic factors (linear or log-scale) in their expression levels and spatial variations (global or local) in the chromatin states. I will then perform experiments with primary B cells isolated from six different bone marrow aspirates of normal human subjects (Aim 2). I will correlate epigenetic signatures of each B cell subtype to corresponding development state (progenitor, pre, post, or mature). I will then perform an ex vivo co-culture of primary B cells on OP9 stromal cells over 1-6 weeks of culturing, which will be followed by fixation and profiling by 3D MIBI. These perturbation experiments will show how signaling events from neighboring cells drive necessary epigenetic conditions that are required for reaching a B cell subset. Finally, I will turn to primary B cells that are isolated from twenty newly diagnosed ALL patients (Aim 3). I will dissect differentiation and spatial epigenomic remodeling of responder B cell subsets and treatment resistant B cell subtypes from bone marrow aspirates using the OP9 co-culture. These will show how treatment resistance arises from a single epigenetic state or multiple distinct epigenetic signatures. I will then screen Histone deacetylase inhibitors (HDACi) on the same co-culture of B cell subtypes from ALL and stromal cells. By varying concentration and duration of inhibition conditions, I will dissect the role of epigenetic drugs in spatial chromatin remodeling toward development of epigenetic therapies in ALL. Together, these experiments will shed light on the role of epigenetic programming for cancer treatment applications from immune cell signatures in normal subjects and blood cancer patients. Public Health Relevance: Epigenetic alterations in immune and cancer cells regulate normal development and aberrant formation in humans. We reveal spatial heterogeneity and dynamic changes in epigenetic states of B cell subtypes from healthy and diseased subjects using a novel multiplex imaging mass cytometry. Deciphering the role of epigenetic perturbations in treatment resistant B cells will guide development of efficient and safe epigenetic therapies for pediatric blood cancers.",Spatial Epigenomic Profiling of Immune Cell Signatures at Subcellular Resolution in Health and Disease,9725907,K25AI140783,"['Attention ', ' B-Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Cell-to-Cell Interaction ', ' Cell Interaction ', ' Cell Communication ', ' cell culture ', ' Cell Culture Techniques ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Chromatin ', ' Chromosomes ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Exhibits ', ' Future ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' immuno therapy ', ' immune-based treatments ', ' immune-based therapies ', ' immune therapy ', ' immune therapeutic strategy ', ' immune therapeutic regimens ', ' immune therapeutic interventions ', ' immune therapeutic approach ', ' immune drugs ', ' Immunologically Directed Therapy ', ' Immunotherapy ', ' In Vitro ', ' acute lymphomatic leukemia ', ' acute lymphogenous leukemia ', ' acute lymphatic leukemia ', ' Precursor Lymphoblastic Leukemia ', ' Precursor Cell Lymphoblastic Leukemia ', ' Acute Lymphoid Leukemia ', ' Acute Lymphoblastic Leukemia ', ' Acute Lymphocytic Leukemia ', ' Libraries ', ' Closure by Ligation ', ' Ligation ', ' Photoradiation ', ' Light ', ' Maps ', ' Medicine ', ' Mentorship ', ' Methods ', ' Patients ', ' Proteins ', ' Relapse ', ' Research ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' B-Cell Subsets ', ' B-Lymphocyte Subsets ', ' Stromal Cells ', ' Imagery ', ' Visualization ', ' base ', ' human subject ', ' Site ', ' Variant ', ' Variation ', ' Biological ', ' lymphoblast ', ' Individual ', ' Measurement ', ' Malignant Childhood Neoplasm ', ' pediatric malignancy ', ' pediatric cancer ', ' children with cancer ', ' childhood malignancy ', ' child with cancer ', ' cancer in children ', ' cancer in a child ', ' Malignant childhood cancer ', ' Malignant Pediatric Tumor ', ' Malignant Pediatric Neoplasm ', ' Malignant Childhood Tumor ', ' Childhood Cancers ', ' Collaborations ', ' Coculture Techniques ', ' Coculture ', ' Cocultivation ', ' Co-culture ', ' cancer cell ', ' Malignant Cell ', ' Aspirate substance ', ' Aspirate ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Hematopoietic Neoplasms ', ' blood cancer ', ' Malignant Hematopoietic Neoplasm ', ' Hematopoietic and Lymphoid Neoplasms ', ' Hematopoietic and Lymphoid Cell Neoplasm ', ' Hematopoietic Tumor ', ' Hematopoietic Neoplasms including Lymphomas ', ' Hematopoietic Malignancies ', ' Hematopoietic Cell Tumor ', ' Catalogs ', ' nanometer ', ' nano meter ', ' Dimensions ', ' Immune ', ' Immunes ', ' Event ', ' Pattern ', ' System ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' single cell analysis ', ' success ', ' technology development ', ' tech development ', ' Toxic effect ', ' Toxicities ', ' novel ', ' Cytometry ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' cancer therapy ', ' anticancer therapy ', ' anti-cancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' chromatin remodeling ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' Childhood Hematopoietic Neoplasm ', ' Pediatric blood cancer ', ' Address ', ' Stem cell transplant ', ' Stem Cell Transplantation ', ' Progenitor Cell Transplantation ', ' B-Cell Development ', ' Data ', ' Histone Deacetylase Inhibitor ', ' Histone deacetylase inhibition ', ' HDAC inhibitor ', ' HDAC Agent ', ' Resolution ', ' Cancer Patient ', ' Computational Technique ', ' Computer Analysis ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Genomic Segment ', ' genomic region ', ' Leukemic Cell ', ' Newly Diagnosed ', ' sample fixation ', ' Fixation ', ' Development ', ' developmental ', ' therapy resistant ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' epigenomics ', ' shape analysis ', ' shape description ', ' design ', ' designing ', ' next generation ', ' Imaging technology ', ' Resistance ', ' resistant ', ' Four-dimensional ', ' 4-dimensional ', ' chemotherapy ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' progenitor ', ' epigenetic variation ', ' therapy design ', ' treatment design ', ' intervention design ', ' public health relevance ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' mathematical analysis ', ' mathematics analysis ', ' math analysis ', ' pediatric patients ', ' child patients ', ' imaging biomarker ', ' imaging-based marker ', ' imaging-based biomarker ', ' imaging-based biological marker ', ' imaging marker ', ' epigenetic drug ', ' epigenetic modifying drugs ', ' experimental study ', ' experimental research ', ' experiment ', ' imaging approach ', ' imaging based approach ', ' imaging capabilities ', ' Multiplexed Ion Beam Imaging ', ' epigenetic therapy ', ' acute lymphoblastic leukemia cell ', ' acute lymphoid leukemia cell ', ' acute lymphocytic leukemia cell ', ' multiplexed\xa0imaging ', ' ']",NIAID,STANFORD UNIVERSITY,K25,2019,26384,CA-18,0.1451058477593641
"Unbiased identification and characterization of mouse metastable epialleles PROJECT SUMMARY (Abstract) In addition to genetics and environment, interindividual variation in epigenetic regulation may determine risk of obesity. Exceptional genomic loci called metastable epialleles offer unprecedented opportunities to test this. Metastable epialleles  essentially epigenetic polymorphisms  exhibit interindividual variation in DNA methylation that is neither tissue-specific nor genetically mediated. Metastable epialleles were first discovered in mice when dramatic phenotypic variation was observed amongst inbred mice. Over the last 10 years we pioneered the discovery and characterization of human metastable epialleles. We have shown that DNA methylation profiling of multiple tissues in multiple individuals is an effective approach to identifying regions that exhibit systemic interindividual variation in DNA methylation, a hallmark of metastable epialleles. Now that we know epigenetic metastability is common to mice and humans, it is essential to identify and explore the full range of MEs in the mouse. We therefore propose to pursue the following Specific Aims: Aim 1 - Perform an unbiased screen for mouse metastable epialleles. Aim 2 - Test for effects of maternal dietary methyl donor supplementation on offspring DNA methylation at metastable epialleles. Aim 3: Use comparative genomics to identify sequence determinants of epigenetic metastability. Successful completion of these Aims will provide the foundation for development of mouse (and potentially other mammalian) models which will enable controlled experiments to help understand how interindividual variation in DNA methylation affects risk of disease in humans. PROJECT NARRATIVE (Relevance Statement) Just as individual genetic variation can affect risk of disease, so too can individual epigenetic variation. In particular, special genomic regions called metastable epialleles, which were first discovered in mice, offer the best opportunities to advance our understanding of epigenetic etiology of disease because their systemic nature means that  like genetic polymorphisms  they can be assessed in any easily obtainable tissue sample, such as peripheral blood. Now that we know that metastable epialleles also exist in humans, we urgently need to develop a more complete catalog of these genomic regions in the mouse, to enable well- controlled experiments to advance our understanding of the causes and consequences of interindividual epigenetic variation at these loci.",Unbiased identification and characterization of mouse metastable epialleles,10032890,R01DK125562,"['Affect ', ' Base Sequence ', ' Nucleotide Sequence ', ' nucleic acid sequence ', ' Beds ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cells ', ' Cell Body ', ' Cleft Palate ', ' Developmental Biology ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Embryo ', ' Embryonic ', ' Environment ', ' Exhibits ', ' Foundations ', ' Gene Expression ', ' Genes ', ' Human Genome ', ' human whole genome ', ' Germ Layers ', ' Human ', ' Modern Man ', ' Individuality ', ' Maps ', ' Methylation ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' nutrition ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Pancreas ', ' Pancreatic ', ' Paper ', ' Phenotype ', ' Genetic Polymorphism ', ' polymorphism ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Tail ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxicology ', ' Genetic Variation ', ' Genetic Diversity ', ' Mediating ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' catalyst ', ' base ', ' Label ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' peripheral blood ', ' Individual ', ' non-human primate ', ' nonhuman primate ', ' diet supplementation ', ' Dietary Supplementation ', ' Micronutrients ', ' Metabolic ', ' Genetic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Catalogs ', ' cell type ', ' Maternal Nutrition ', ' Maternal diet ', ' maternal nutrition during pregnancy ', ' mother nutrition ', ' IAP Elements ', ' Intracisternal A-Particle ', ' Intracisternal A-Particle Elements ', ' DNA Fingerprinting ', ' DNA Profiling ', ' DNA Typing ', ' Genetic Fingerprintings ', ' Retrotransposon ', ' offspring ', ' disease risk ', ' disorder risk ', ' Reporting ', ' Gene Expression Monitoring ', ' Gene Expression Pattern Analysis ', ' Transcript Expression Analyses ', ' Transcript Expression Analysis ', ' gene expression analysis ', ' gene expression assay ', ' transcriptional profiling ', ' Gene Expression Profiling ', ' Modeling ', ' Assisted Reproduction Technology ', ' assistive reproductive technology ', ' Assisted Reproductive Technology ', ' Genomics ', ' embryo culture ', ' Tissue Sample ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Data ', ' Inbred Mouse ', ' Supplementation ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Seminal ', ' Nutrition Research ', ' Nutritional Study ', ' nutritious ', ' Nutritional ', ' developmental ', ' Development ', ' Outcome ', ' risk for obesity ', ' risk of obesity ', ' obesity risk ', ' mouse genome ', ' murine model ', ' mouse model ', ' epigenetic variation ', ' critical period ', ' mouse development ', ' comparative genomics ', ' transgenerational inheritance ', ' transgenerational epigenetic inheritance ', ' genomic effort ', ' genomic strategy ', ' Genomic approach ', ' BS-seq ', ' Bisulfite-based sequencing ', ' bisulfite-seq ', ' bisulfite sequencing ', ' epigenetic regulation ', ' metabotype ', ' metabolic phenotype ', ' inter-individual variability ', ' interindividual variation ', ' inter-individual variation ', ' experiment ', ' experimental research ', ' experimental study ', ' early pregnancy ', ' gene locus ', ' genetic locus ', ' genomic locus ', ' ']",NIDDK,BAYLOR COLLEGE OF MEDICINE,R01,2020,500075,TX-09,0.19574880462100347
"Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint PROJECT SUMMARY/ABSTRACT Epigenetic memory is a phenomenon of trans-generational, altered trait inheritance without changes to DNA sequence. Our present ability to predict or direct epigenomic behavior is extremely limited, even though epigenetic factors participate in nearly all aspects of multicellular development, environmental stress response, and disease development. There are critical gaps in our current knowledge of DNA methylation patterning, stable epiallele formation, and the relationship of genome-wide epigenomic behavior to gene expression and phenotype in both plant and animal systems. We have developed a system that will directly address these questions. Our long-term goals are to decode the heritable epigenome, and its relationship to organismal phenotype, particularly in response to stress. What distinguishes our proposed research is the availability of robust biologicals in the model plant Arabidopsis to impose artificial stress, recurrent heritable epigenetic memory, and methylome repatterning. These resources emanate from discovery of the MSH1 gene, disruption of which leads to epigenomic reprogramming. Recent data from this system lead to the overarching hypothesis that stress-induced gene expression recruits methylation machinery to gene networks in a non-stochastic manner. To address this hypothesis, we have developed novel genome-wide methylome analysis procedures for high-resolution identification of gene-associated methylation repatterning. These analyses reveal gene networks that are strikingly consistent with phenotype changes, and display repatterning that is intragenic and often subtle, yet reproducible. We have also identified epigenetic components of the DNA methylation and RdDM pathways that are essential to reprogramming based on msh1 double mutant analysis. Building upon strong preliminary data, we propose to pursue three specific aims to characterize trans-generational epigenomic behavior: (1) To delineate stable, de novo epialleles in the Arabidopsis msh1 model system, exploiting a five-generation memory lineage, (2) to develop a mechanistic understanding of stable epiallele formation in response to stress, implementing machine learning and mutant screening, and (3) to test locus-specific mechanics of epiallele establishment, capitalizing on gene relocation to delimit germane local chromatin features. The proposed research will broadly impact the field by providing the first example of inducible epigenomic reprogramming in a non-stochastic pattern that permits machine learning-based predictive modeling and identification of cis-acting sequence features. The results will be pertinent to mammalian systems and, possibly, to diagnostic strategies for diseases with a strong GxE component. PROJECT NARRATIVE The proposed research has relevance to public health priorities as we see life style diseases, stress and environmental impacts on health, in utero and throughout development, pose greater challenges to conventional medicine. Environmental stress is a multifaceted influence on health, and epigenomic response is an important, under-investigated factor in cancer, neurodevelopmental, metabolic and toxin-related disorders with high GxE effects. Upon conclusion of the study, we will have defined the architectural features of stable, de novo epiallelic variation, assessed its influence on heritable phenotype, and refined a methodology for high resolution analysis of epigenomic data that is necessary to inform the development of early diagnostics and countermeasures.","Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint",9983094,R01GM134056,"['Affect ', ' Animals ', ' Architecture ', ' Engineering / Architecture ', ' Behavior ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Chromatin ', ' Complement ', ' Complement Proteins ', ' Cytosine ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Statistical Data Interpretation ', ' Statistical Data Analyses ', ' Statistical Data Analysis ', ' statistical analysis ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Information Systems ', ' Data Systems ', ' IT Systems ', ' Information Technology Systems ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Medicine ', ' Memory ', ' Methods ', ' Methodology ', ' Methylation ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Nucleosomes ', ' Organism ', ' living system ', ' Phenotype ', ' Plants ', ' Recurrence ', ' Recurrent ', ' Psychological reinforcement ', ' Reinforcement ', ' Reproduction ', ' Research ', ' Resources ', ' Research Resources ', ' RNA Splicing ', ' Splicing ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Stress ', ' Testing ', ' Thermodynamics ', ' Thermodynamic ', ' Toxin ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' bisulfite ', ' hydrogen sulfite ', ' hydrosulfite ', ' Generations ', ' reaction', ' crisis ', ' stress response ', ' stress', ' reaction ', ' biological adaptation to stress ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Arabidopsis ', ' base ', ' density ', ' Procedures ', ' Site ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' insight ', ' Gene Targeting ', ' Ecological impact ', ' Environmental Impact ', ' Transgenes ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' programs ', ' mechanical ', ' Mechanics ', ' Pattern ', ' System ', ' mutant ', ' trait ', ' novel ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' response ', ' behavioral influence ', ' behavior influence ', ' Genomics ', ' histone modification ', ' Small RNA ', ' Address ', ' Chromatin Assembly ', ' Chromatin Modeling ', ' Data ', ' Detection ', ' Plant Model ', ' Reproducibility ', ' Resolution ', ' Cis-Acting Locus ', ' Cis-Acting Sequence ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Pattern Recognition ', ' Differential Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' in utero ', ' epigenomics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' innovate ', ' innovative ', ' innovation ', ' Heritability ', ' genome scale ', ' genomewide ', ' genome-wide ', ' public health priorities ', ' flexible ', ' flexibility ', ' screening ', ' methylome ', ' epigenome ', ' biophysical characteristics ', ' biophysical characterization ', ' biophysical measurement ', ' biophysical parameters ', ' biophysical properties ', ' transgenerational inheritance ', ' transgenerational epigenetic inheritance ', ' methylation pattern ', ' epigenetic memory ', ' experiment ', ' experimental research ', ' experimental study ', ' recruit ', ' ']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2020,319720,PA-12,0.15742311235354714
"Role of Epigenetically Active  Environmental Compounds in Neurodevelopmental Disorders PROJECT SUMMARY Neurodevelopmental disorders (NDDs), are increasingly recognized as originating from dysregulation of early brain development, which represents a window of vulnerability to environmental compounds. Environmental compounds may alter neurodevelopment via epigenetic mechanisms, which may not induce massive cell death, but change the brain function through their epigenetic effect on stem cell fate and lineage development. However, tools to systematically examine the epigenetic impact of environment on neurodevelopment are lacking. Here we employ Microscopic Imaging of Epigenetic Landscape (MIEL) to screen ToxCast Phase III chemical library (4700 compounds) and to characterize hits that alter epigenetic landscape of human neural precursors without inducing cytotoxicity. Recognizing environmental insults and understanding their mechanism of action will enable the development of regulations and guidelines aimed at avoiding such insults and the development of antidotes and protective agents when exposure is unavoidable. PROJECT NARRATIVE We developed a novel technique rooted in analysis of the epigenome topography at the single-cell level. Here, we propose to employ our new approach to identify novel environmental inducers of NDD.",Role of Epigenetically Active  Environmental Compounds in Neurodevelopmental Disorders,9979666,R21ES030804,"['Affect ', ' Antidotes ', ' Theriacs ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cell Death ', ' necrocytosis ', ' cell growth ', ' Cellular Expansion ', ' Cellular Growth ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Cells ', ' Cell Body ', ' Decision Making ', ' Environment ', ' Fetal Development ', ' Developing fetus ', ' Flowcharts ', ' Future ', ' Genotype ', ' Goals ', ' Human ', ' Modern Man ', ' Human Development ', ' In Vitro ', ' Laboratories ', ' Libraries ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Patients ', ' Aromatic Polycyclic Hydrocarbons ', ' polyaromatic hydrocarbons ', ' polynuclear aromatic hydrocarbon ', ' Protective Agents ', ' Protective Drugs ', ' Risk ', ' Role ', ' social role ', ' Testing ', ' Thalidomide ', ' Sedalis ', ' Toxicology ', ' Valproic Acid ', ' Depakote ', ' Depakote ER ', ' Divalproex ', ' Vertebrates ', ' Vertebrate Animals ', ' vertebrata ', ' bisphenol A ', ' diphenylolpropane ', ' Neurites ', ' case report ', ' Case Study ', ' phthalates ', ' Dataset ', ' Data Set ', ' Guidelines ', ' base ', ' Phase ', ' Biological ', ' Link ', ' Chemicals ', ' insight ', ' Individual ', ' root ', ' Plant Roots ', ' Human Figure ', ' Human body ', ' Toxicity Testing ', ' Toxicity Tests ', ' Biological Function ', ' Biological Process ', ' Exposure to ', ' tool ', ' machine learned ', ' Machine Learning ', ' Frequencies ', ' Pattern ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Services ', ' Lytotoxicity ', ' cytotoxicity ', ' synapse formation ', ' synaptogenesis ', ' chemical library ', ' small molecule libraries ', ' neural ', ' relating to nervous system ', ' Neural Development ', ' neurodevelopment ', ' Toxicities ', ' Toxic effect ', ' novel ', ' Regulation ', ' High Throughput Assay ', ' high throughput screening ', ' Neural Stem Cell ', ' neural precursor ', ' neural precursor cell ', ' neural progenitor ', ' neural progenitor cells ', ' neuron progenitors ', ' neuronal progenitor ', ' neuronal progenitor cells ', ' neuronal stem cells ', ' neuroprogenitor ', ' nerve stem cell ', ' Bio-Informatics ', ' Bioinformatics ', ' histone modification ', ' Address ', ' Autism ', ' Autistic Disorder ', ' Early Infantile Autism ', ' Infantile Autism ', "" Kanner's Syndrome "", ' autistic spectrum disorder ', ' autism spectrum disorder ', ' Data ', ' in vivo ', ' Collection ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Neuronal Differentiation ', ' Validation ', ' Process ', ' developmental ', ' Development ', ' Neurological Development Disorder ', ' Neurodevelopmental Disorder ', ' stem cell fate ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' cost effective ', ' self-renew ', ' self-renewal ', ' progenitor ', ' stem ', ' environmental chemical ', ' iPS ', ' iPSC ', ' iPSCs ', ' induced pluripotent stem cell ', ' adverse consequence ', ' adverse outcome ', ' ChIP Sequencing ', ' chromatin immunoprecipitation-sequencing ', ' ChIP-seq ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' screening ', ' epigenome ', ' ATACseq ', ' ATAC-seq ', ' microscope imaging ', ' microscopy imaging ', ' microscopic imaging ', ' dashboard ', ' experiment ', ' experimental research ', ' experimental study ', ' model of human ', ' human model ', ' stem cell model ', ' ']",NIEHS,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,R21,2020,292500,CA-49,0.04914493409754201
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9976999,R24DK106766,"['Back ', ' Dorsum ', ' Base Sequence ', ' Nucleotide Sequence ', ' nucleic acid sequence ', ' Biology ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Chromosomes ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Engineering ', ' Evolution ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Regulator Genes ', ' Transcriptional Regulatory Elements ', ' regulatory gene ', ' trans acting element ', ' Genome ', ' Health ', ' Heart ', ' Hematopoiesis ', ' Hematopoietic Cellular Control Mechanisms ', ' blood cell formation ', ' Hematopoietic stem cells ', ' Blood Precursor Cell ', ' Hematopoietic Progenitor Cells ', ' blood stem cell ', ' hematopoietic progenitor ', ' hematopoietic stem progenitor cell ', ' hemopoietic progenitor ', ' hemopoietic stem cell ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Maps ', ' Methods ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Production ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Science ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Translating ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' falls ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Custom ', ' improved ', ' Area ', ' Training ', ' hemopoietic ', ' Hematopoietic ', ' insight ', ' Ligand Binding Protein ', ' Ligand Binding Protein Gene ', ' Protein Binding ', ' bound protein ', ' Binding Proteins ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' MoAb R24 ', ' R-24 Monoclonal Antibody ', ' R24 ', ' Monoclonal Antibody R24 ', ' Collaborations ', ' Genetic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Catalogs ', ' Frequencies ', ' cell type ', ' Pattern ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' transdisciplinary collaboration ', ' interdisciplinary collaboration ', ' gene conservation ', ' Cellular injury ', ' cell damage ', ' cellular damage ', ' damage to cells ', ' injury to cells ', ' cell injury ', ' novel ', ' Basic Research ', ' Basic Science ', ' Categories ', ' Manpower ', ' personnel ', ' Human Resources ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' response ', ' Erythroid Cells ', ' CIS Gene ', ' CIS protein ', ' CIS-1 Gene ', ' CIS-1 Protein ', ' CISH Protein ', ' Cytokine Inducible SH2-Containing Protein ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B Gene ', ' Cytokine-Inducible SH2-Containing Protein Gene ', ' G18 ', ' G18 Gene ', ' SOCS Gene ', ' Suppressor of Cytokine Signaling ', ' Suppressor of Cytokine Signaling Gene ', ' CISH gene ', ' Address ', ' Data ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Transcript ', ' Pathologic ', ' Monitor ', ' Knockout ', ' Knock-out ', ' Modification ', ' developmental ', ' Development ', ' Output ', ' epigenomics ', ' data acquisition ', ' clinical significance ', ' clinically significant ', ' murine model ', ' mouse model ', ' loss of function ', ' prototype ', ' genome scale ', ' genomewide ', ' genome-wide ', ' epigenome ', ' precision-based medicine ', ' precision medicine ', ' genomic editing ', ' genome editing ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' 3C-based approach ', ' 3C-based assay ', ' 3C-based method ', ' 3C-based strategy ', ' 3C-based technique ', ' 3C-based technology ', ' chromatin conformation capture ', ' chromosome capture ', ' chromosome conformation capture ', ' genome browser ', ' experiment ', ' experimental research ', ' experimental study ', ' annotation framework ', ' annotation tool ', ' annotation  system ', ' blood formation ', ' hematopoietic differentiation ', ' ']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2020,1183458,PA-12,0.05593076744399231
"Molecular images and machine learning to extractplacental function from maternalcfDNA Abstract  Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. cfDNA is fragmented with sizes centered around 145bp and 166bp which is approximately the length of DNA wrapped around a nucleosome, and a nucleosome plus its linker, respectively. Shorter fragments (30-100bp) also exist and have a clear periodicity of 10bp, corresponding to a turn of the DNA helix wrapped around the core histone. Recent reports have shown that the fragmentation sizes of cfDNA are tissue specific, which is a product of distinct nucleosome spacing that is inherent in the function of individual tissues. When these individual fragments are compared with existing epigenetic data from tissues, they can be binned into cell of origin simply based on whether they reveal the nucleosome positioning information of the originating tissue. Identifying cfDNA fragments of placental origin from maternal circulation would provide a non-invasive means of assessing placental function during human pregnancy.  Several major barriers inhibit cfDNA as a non-invasive method for examining placental function: 1) the ability to accurately identify the placental origin of the short <160bp cfDNA fragments that constitute regulatory information (paternal SNPs occur at frequency of approximately 1/2000bp). 2) the ability to use these fragments to piece together precise epigenetic states of the placenta. 3) the cost of deep whole genome sequencing that has traditionally been required to deconvolute epigenetic profiles of admixed cellular origins. Our goal is to overcome each of these barriers by exploiting state-of-the-art genomics and machine learning techniques to extract precise information about human placental function from cfDNA. We will first compile robust and accurate nucleosome information, including epigenetic and transcription factor occupancy, from the human placenta and then we will establish machine-learning platforms to elucidate placental cfDNA from maternal circulation at low cost. Success in this project will enable earlier intervention for high-risk pregnancies and facilitate the longitudinal, non-invasive real-time monitoring of pregnancy progression, thereby informing adaptive treatment decision-making. Narrative Circulating cell free DNA (cfDNA) has revolutionized prenatal diagnostics, but this is the tip of the iceberg, as cfDNA fragmentation patterns embed epigenetic footprints indicative of cell of origin, cellular function and pathological state. Out goal is to develop technology to utilize cfDNA as means to assess placental function non-invasively.",Molecular images and machine learning to extractplacental function from maternalcfDNA,9857489,R01HD094513,"['Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Cell Extracts ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Chorionic Villi Sampling ', ' Chorionic Villi Biopsy ', ' chorionic villous sampling ', ' Decision Making ', ' DNA ', ' Deoxyribonucleic Acid ', ' Genome ', ' Goals ', ' Histones ', ' Human ', ' Modern Man ', ' Maps ', ' Methods ', ' Nucleosomes ', ' Periodicity ', ' Cyclicity ', ' Rhythmicity ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Placental Extracts ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Pregnancy ', ' Gestation ', ' Nucleic Acid Regulatory Sequences ', ' Nucleic Acid Regulator Regions ', ' Regulatory Regions ', ' genetic regulatory element ', ' Technology ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Enhancers ', ' promotor ', ' promoter ', ' Cell Size ', ' base ', ' image processing ', ' Training ', ' Visual ', ' Individual ', ' Early Intervention ', ' High-Risk Pregnancy ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' DNA Fragmentation ', ' Frequencies ', ' Pattern ', ' Techniques ', ' success ', ' unborn ', ' prenatal ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Genomics ', ' Molecular Interaction ', ' Binding ', ' data processing ', ' computerized data processing ', ' genome sequencing ', ' Length ', ' Data ', ' Detection ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Pathologic ', ' Molecular ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' cost ', ' Molecular Machines ', ' epigenome ', ' cell free circulating DNA ', ' cell free DNA ', ' ATACseq ', ' ATAC-seq ', ' entire genome ', ' full genome ', ' whole genome ', ' DNA seq ', ' DNAseq ', ' DNA sequencing ', ' realtime monitoring ', ' real time monitoring ', ' de-noising ', ' denoising ', ' neural network algorithm ', ' deep learning algorithm ', ' complex data  ', ' ']",NICHD,STANFORD UNIVERSITY,R01,2020,603830,CA-18,0.14345383307317705
"Spatial Epigenomic Profiling of Immune Cell Signatures at Subcellular Resolution in Health and Disease SPATIAL EPIGENOMIC PROFILING OF IMMUNE CELL SIGNATURES AT SUBCELLULAR  RESOLUTION IN HEALTH AND DISEASE More than ten percent of childhood cancers are still incurable and need novel therapies. Epigenetic treatments deserve special attention with their specificity and reduced toxicity. Here I plan to explore epigenetic profiles of immune and cancer cells in normal development and blood cancer patients under the mentorship of Garry Nolan for single cell proteomics technology development, in collaboration with Howard Chang for implementation of epigenomic methods such as chromosome accessibility assays, and with Kara Davis for epigenetics studies of treatment resistant B cell subtypes in acute lymphoblastic leukemia (ALL). Epigenetic measurements have been limited to bulk level sequencing and ligation assays or limited number of imaging markers. To address these limitations, I will use an emerging three dimensional (3D) proteomic imaging technology in individual cells, termed as 3D Multiplexed ion beam imaging (MIBI) or 3D MIBI. Epigenetics research by 3D MIBI benefits from high degree multiplexing (up to 100 markers) and super resolution imaging capability (20 nm x-y; 5 nm z resolution), providing exciting opportunities to study genomic sites, methylated DNA, protein factors, and chromosome accessibility, all within the same experiments in single immune and aberrant (leukemic) cells. To systematically determine epigenetic states, I plan to utilize clonal B cell lines to decipher variability of epigenetic components including chromatin states, protein factors and modifiers by a fifty-marker 3D MIBI panel (Aim 1). These experiments will show distribution of epigenetic factors (linear or log-scale) in their expression levels and spatial variations (global or local) in the chromatin states. I will then perform experiments with primary B cells isolated from six different bone marrow aspirates of normal human subjects (Aim 2). I will correlate epigenetic signatures of each B cell subtype to corresponding development state (progenitor, pre, post, or mature). I will then perform an ex vivo co-culture of primary B cells on OP9 stromal cells over 1-6 weeks of culturing, which will be followed by fixation and profiling by 3D MIBI. These perturbation experiments will show how signaling events from neighboring cells drive necessary epigenetic conditions that are required for reaching a B cell subset. Finally, I will turn to primary B cells that are isolated from twenty newly diagnosed ALL patients (Aim 3). I will dissect differentiation and spatial epigenomic remodeling of responder B cell subsets and treatment resistant B cell subtypes from bone marrow aspirates using the OP9 co-culture. These will show how treatment resistance arises from a single epigenetic state or multiple distinct epigenetic signatures. I will then screen Histone deacetylase inhibitors (HDACi) on the same co-culture of B cell subtypes from ALL and stromal cells. By varying concentration and duration of inhibition conditions, I will dissect the role of epigenetic drugs in spatial chromatin remodeling toward development of epigenetic therapies in ALL. Together, these experiments will shed light on the role of epigenetic programming for cancer treatment applications from immune cell signatures in normal subjects and blood cancer patients. Public Health Relevance: Epigenetic alterations in immune and cancer cells regulate normal development and aberrant formation in humans. We reveal spatial heterogeneity and dynamic changes in epigenetic states of B cell subtypes from healthy and diseased subjects using a novel multiplex imaging mass cytometry. Deciphering the role of epigenetic perturbations in treatment resistant B cells will guide development of efficient and safe epigenetic therapies for pediatric blood cancers.",Spatial Epigenomic Profiling of Immune Cell Signatures at Subcellular Resolution in Health and Disease,9953964,K25AI140783,"['Attention ', ' B-Lymphocytes ', ' B blood cells ', ' B cell ', ' B cells ', ' B-Cells ', ' B-cell ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Cell Communication ', ' Cell Interaction ', ' Cell-to-Cell Interaction ', ' Cell Culture Techniques ', ' cell culture ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Cells ', ' Cell Body ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Chromatin ', ' Chromosomes ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Enzymes ', ' Enzyme Gene ', ' Exhibits ', ' Future ', ' Health ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Immunotherapy ', ' Immune mediated therapy ', ' Immunologically Directed Therapy ', ' immune therapeutic approach ', ' immune therapeutic interventions ', ' immune therapeutic regimens ', ' immune therapeutic strategy ', ' immune therapy ', ' immune-based therapies ', ' immune-based treatments ', ' immuno therapy ', ' In Vitro ', ' Acute Lymphocytic Leukemia ', ' Acute Lymphoblastic Leukemia ', ' Acute Lymphoid Leukemia ', ' Precursor Cell Lymphoblastic Leukemia ', ' Precursor Lymphoblastic Leukemia ', ' acute lymphatic leukemia ', ' acute lymphogenous leukemia ', ' acute lymphomatic leukemia ', ' Libraries ', ' Ligation ', ' Closure by Ligation ', ' Light ', ' Photoradiation ', ' Maps ', ' Medicine ', ' Mentorship ', ' Methods ', ' Patients ', ' Proteins ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Specificity ', ' Technology ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' B-Lymphocyte Subsets ', ' B-Cell Subsets ', ' Stromal Cells ', ' base ', ' human subject ', ' Site ', ' Variation ', ' Variant ', ' Biological ', ' lymphoblast ', ' Individual ', ' Measurement ', ' Childhood Cancers ', ' Malignant Childhood Tumor ', ' Malignant Pediatric Neoplasm ', ' Malignant Pediatric Tumor ', ' Malignant childhood cancer ', ' cancer in a child ', ' cancer in children ', ' child with cancer ', ' childhood malignancy ', ' children with cancer ', ' pediatric cancer ', ' pediatric malignancy ', ' Malignant Childhood Neoplasm ', ' Collaborations ', ' Co-culture ', ' Cocultivation ', ' Coculture ', ' Coculture Techniques ', ' Malignant Cell ', ' cancer cell ', ' Aspirate ', ' Aspirate substance ', ' machine learned ', ' Machine Learning ', ' Hematopoietic Cell Tumor ', ' Hematopoietic Malignancies ', ' Hematopoietic Neoplasms including Lymphomas ', ' Hematopoietic Tumor ', ' Hematopoietic and Lymphoid Cell Neoplasm ', ' Hematopoietic and Lymphoid Neoplasms ', ' Malignant Hematopoietic Neoplasm ', ' blood cancer ', ' Hematopoietic Neoplasms ', ' Catalogs ', ' nano meter ', ' nanometer ', ' Immunes ', ' Immune ', ' Event ', ' Pattern ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' single cell analysis ', ' success ', ' tech development ', ' technology development ', ' Toxicities ', ' Toxic effect ', ' novel ', ' Cytometry ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' Cancer Treatment ', ' Malignant Neoplasm Therapy ', ' Malignant Neoplasm Treatment ', ' anti-cancer therapy ', ' anticancer therapy ', ' cancer therapy ', ' chromatin remodeling ', ' Transcription Regulation ', ' Transcriptional Control ', ' Transcriptional Regulation ', ' Pediatric blood cancer ', ' Childhood Hematopoietic Neoplasm ', ' Address ', ' Progenitor Cell Transplantation ', ' Stem Cell Transplantation ', ' Stem cell transplant ', ' B-Cell Development ', ' Data ', ' HDAC Agent ', ' HDAC inhibitor ', ' Histone deacetylase inhibition ', ' Histone Deacetylase Inhibitor ', ' Resolution ', ' Cancer Patient ', ' Computational Technique ', ' computational analyses ', ' computational analysis ', ' computer analyses ', ' Computer Analysis ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Leukemic Cell ', ' Newly Diagnosed ', ' Fixation ', ' sample fixation ', ' developmental ', ' Development ', ' resistance to therapy ', ' resistant to therapy ', ' therapeutic resistance ', ' treatment resistance ', ' therapy resistant ', ' epigenomics ', ' shape description ', ' shape analysis ', ' designing ', ' design ', ' next generation ', ' Imaging technology ', ' resistant ', ' Resistance ', ' 4-dimensional ', ' Four-dimensional ', ' chemotherapy ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' progenitor ', ' epigenetic variation ', ' intervention design ', ' treatment design ', ' therapy design ', ' public health relevance ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' math analysis ', ' mathematics analysis ', ' mathematical analysis ', ' child patients ', ' pediatric patients ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' epigenetic modifying drugs ', ' epigenetic drug ', ' experiment ', ' experimental research ', ' experimental study ', ' imaging based approach ', ' imaging approach ', ' imaging capabilities ', ' Multiplexed Ion Beam Imaging ', ' epigenetic therapy ', ' acute lymphocytic leukemia cell ', ' acute lymphoid leukemia cell ', ' acute lymphoblastic leukemia cell ', ' multiplexed imaging ', ' Visualization ', ' ']",NIAID,GEORGIA INSTITUTE OF TECHNOLOGY,K25,2020,107880,GA-05,0.1451058477593641
"Uncovering the epitranscriptome regulatory codes using machine learning Project Summary N6-methyladenosine (m6A) is the most abundant methylation widely found in mRNAs of mammalian cells whose function is largely unknown. Recent research has accumulated increasingly strong evidence of m6A's involvement in different diseases such as leukemia, breast cancer, lung cancer, and AIDs. While m6A's close involvement in many diseases is apparent, mechanistic evidence linking m6A alterations to disease phenotypes is mostly missing. Most of the recent research is fueled by the high throughput sequencing technologies such as MeRIP-seq for transcriptome-wide profiling of m6A methylation. However, due to the innate limitations of such technologies, sophisticated machine learning based algorithms are urgently needed to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels and the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. Without bridging these knowledge gaps, it is impossible to made inroads to the problem of finding m6A's role in regulating diseases. To address these issues, our aims in this proposal are 1) Establish a deep learning algorithm for base-resolution m6A site prediction; 2) Establish base- resolution m6A differential site prediction using a hierarchical Bayesian approach; and 3) Determine m6A- mediated genes and functions by Bayesian Negative-Binomial regression. The proposed research will employ deep learning and adversarial learned inference methods and utilize both methylation quantification and sequence information for the first time. Also, it will employ Bayesian graphical model-based methods for combining sequence and methylation level information. It is expected that the developed algorithms will have broad applications in functional study, for which we plan to closely work with our collaborators in applying these algorithms in their research of Kaposi's sarcoma-associated herpesvirus (KSHV), which will lead to the fulfillment our long term goal in the eventual validation and practical medical application of m6A research in the future. Project Narrative  This project proposes to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels, the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. The overall goal is to elucidate m6A's role in regulating diseases.",Uncovering the epitranscriptome regulatory codes using machine learning,9937431,SC3GM136594,"['Affect ', ' Algorithms ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Disease ', ' Disorder ', ' Future ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Goals ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' leukemia ', ' Methods ', ' Methylation ', ' Play ', ' Problem Solving ', ' Proteins ', ' Research ', ' Messenger RNA ', ' mRNA ', ' Role ', ' social role ', ' Statistical Distributions ', ' Supervision ', ' Technology ', ' Time ', ' cell transformation ', ' transformed cells ', ' Work ', ' RNA-Binding Proteins ', ' Mediating ', ' base ', ' improved ', ' Site ', ' Area ', ' Medical ', ' Link ', ' Bayesian Methodology ', ' Bayesian Statistical Method ', ' Bayesian approaches ', ' Bayesian classification method ', ' Bayesian classification procedure ', ' Bayesian posterior distribution ', ' Bayesian Method ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Biological Function ', ' Biological Process ', ' gene function ', ' tool ', ' machine learned ', ' Machine Learning ', ' HHV-8 ', ' HHV8 ', ' KSHV ', ' Kaposi Sarcoma-Associated Herpes Virus ', ' Kaposi Sarcoma-Associated Herpesvirus ', ' Kaposi sarcoma associated virus ', ' Kaposi sarcoma herpes virus ', "" Kaposi's sarcoma (KS)-associated herpesvirus "", ' Virus-HHV8 ', "" kaposi's sarcoma-associated human herpesvirus "", ' Human Herpesvirus 8 ', ' Knowledge ', "" 5'UTR "", ' mRNA Leader Sequences ', "" 5' Untranslated Regions "", "" 3'UTR "", "" 3' Untranslated Regions "", ' novel ', ' Coding System ', ' Code ', ' Regulation ', ' Modeling ', ' Molecular Interaction ', ' Binding ', ' mRNA Stability ', ' preventing ', ' prevent ', ' Oncogenesis ', ' tumorigenesis ', ' Address ', ' Cellular Transformation ', ' metaplastic cell transformation ', ' Data ', ' Detection ', ' Hypermethylation ', ' Mammalian Cell ', ' Resolution ', ' Transcript ', ' Validation ', ' Modification ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' effective treatment ', ' effective therapy ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' epitranscriptome ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' machine learned algorithm ', ' machine learning algorithm ', ' deep learning algorithm ', ' ']",NIGMS,UNIVERSITY OF TEXAS SAN ANTONIO,SC3,2020,97500,TX-20,0.06396231908486048
"Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures PROJECT SUMMARY Recent advances in understanding the biology of aging have raised the prospect of drug interventions to promote healthy aging in humans. However, such interventions should have essentially no toxicity or side effects. In practice, the throughput of drug testing (currently conducted in animals) is one of the major limitations for identifying interventions to promote healthy aging. Hence, a challenge is to identify candidate drugs able to induce rejuvenation and/or healthy aging, with minimal side effects in a high throughput fashion. Here we propose to take advantage of a novel high content screening approach based on imaging of epigenetic landscape in single cells. To meet the challenge, we propose to take advantage of a novel technique we have developed that is rooted in the analysis of epigenome topography at the single cell level, automated microscopy, and machine learning. Microscopic Imaging of Epigenetic Landscapes (MIEL) captures patterns of nuclear staining of epigenetic marks (e.g. acetylated and methylated histones) and employs machine learning to accurately distinguish between such patterns. Pertinent to this application, we have tested whether MIEL approach is suitable for building a phenotypic cell-based assay for inducers of longevity at the cellular level. Our preliminary results validated MIEL assay for a high content screening application to identify novel candidate pro-longevity compounds. In sum, we have developed and validated a high content cell-based screening assay capable of identifying pro-longevity/healthy aging compounds based on their effect on epigenetic signature. Our specific Aims are as follows: Specific Aim 1. Screen for novel inducers of cellular rejuvenation. Specific Aim 2. Validation of novel inducers of cellular rejuvenation. PROJECT NARRATIVE Recent advances in understanding the biology of aging have raised the prospect of drug interventions to promote healthy aging in humans. We have developed and validated a high content cell-based screening assay capable of identifying pro-longevity/healthy aging compounds based on their effect on epigenetic signature.",Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures,10043841,R21AG068913,"['deep sequencing ', ' cost ', ' drug detection ', ' drug testing ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' healthy aging ', ' drug candidate ', ' screening ', ' Drug Targeting ', ' epigenome ', ' CRISPR ', ' CRISPR/Cas system ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' epigenetic profiling ', ' histone methylation ', ' microscope imaging ', ' microscopy imaging ', ' microscopic imaging ', ' Drug Screening ', ' side effect ', ' Age ', ' ages ', ' Aging ', ' Animals ', ' Antibodies ', ' Aspirin ', ' Acetylsalicylic Acid ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Cell Count ', ' Cell Number ', ' Cell Nucleus ', ' Nucleus ', ' Cells ', ' Cell Body ', ' Designer Drugs ', ' Customized Drugs ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Flowcharts ', ' Genome ', ' Glioblastoma ', ' Grade IV Astrocytic Neoplasm ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytoma ', ' glioblastoma multiforme ', ' spongioblastoma multiforme ', ' Heterochromatin ', ' Histones ', ' Human ', ' Modern Man ', ' In Vitro ', ' Inbreeding ', ' Incidence ', ' Libraries ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Microscopy ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Phenotype ', ' Powder dose form ', ' Powders ', ' Rejuvenation ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Specificity ', ' Stains ', ' Staining method ', ' Testing ', ' Yeasts ', ' Sirolimus ', ' Rapamune ', ' Rapamycin ', ' Mediating ', ' Custom ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' base ', ' Hepatic Cells ', ' Hepatic Parenchymal Cell ', ' Liver Cells ', ' Hepatocyte ', ' root ', ' Plant Roots ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Pattern ', ' Techniques ', ' Nuclear ', ' Tumor Cell ', ' neoplastic cell ', ' chemical library ', ' small molecule libraries ', ' Toxicities ', ' Toxic effect ', ' novel ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Drug Prospecting ', ' Normal Cell ', ' Dose ', ' Biology of Aging ', ' Sum ', ' in vivo ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Splenocyte ', ' Validation ', ' C57BL/6 Mouse ', ' Molecular ', ' imaging ', ' Image ', ' ']",NIA,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,R21,2020,292500,CA-49,0.0478059360131456
"Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection Distal sensory polyneuropathy (DSPN) remains the most common neurological complication in HIV-infected population. Opiates and cocaine are often misused to manage neuropathic pain. These drugs, in turn, increase the risk of DSPN and exacerbate DSPN severity. The interplay of DSPN and substance use disorder (SUD) is associated with morbidity and mortality in HIV-infected individuals. Although neurotoxic effects of HIV-1 gp120 and antiretroviral medications contribute to DSPN through dysregulation of pro-inflammation genes, little is known about the mechanisms of DSPN and DSPN with comorbid SUD. A major barrier to advancing our understanding of DSPN is the inaccessibility of nerve tissues in living individuals and the absence of reliable biomarkers to inform the diagnosis of DSPN in the setting of SUD and HIV infection. Our overarching goal is to discover the DNA methylation signatures for DSPN, SUD, and their comorbidity. We focus on white blood cells (WBCs) because of their role in orchestrating and effecting immune responses and because they are highly accessible tissues. We hypothesize that DSPN emerges in the context of HIV infection as the result of HIV-1 enhanced expression of proinflammatory genes in many cell types, including WBCs. We also hypothesize that DSPN emerges as the result of SUD-enhanced expression of proinflammatory genes in WBCs. Thus, DNA methylation in WBCs is associated with DSPN that is influenced by SUD and contributes to HIV outcomes. To test the hypotheses, we will select methylation features in WBCs for DSPN, SUD, and their comorbidity using a combination of epigenome-wide association study (EWAS) and ensemble-based machine learning approaches. Leveraging two well-established independent cohorts, we will first identify methylation sites in WBCs for DSPN and SUD in four groups (DSPN+/SUD+, DSPN+/SUD-, DSPN-/SUD+, DSPN-/SUD-) in 2,000 HIV- infected samples using a 2-stage EWAS followed by a meta-EWAS. We will then select methylation features using machine learning methods and test the sensitivity and specificity to differentiate DSPN, SUD, and their comorbidity. We will apply our in-house developed bioinformatic package, smartFeatureSelection. The selected features will test associations with immune resilience (i.e. CD4+/CD8+) and HIV outcomes (i.e. frailty, mortality). Finally, we will explore the biological functions of the identified methylation sites in postmortem human brain and blood (N = 80) by RNA-seq and correlate methylation-regulated gene expression between WBCs and neural cells. We expect to discover a set of biologically meaningful methylation features as a marker for HIV- infected DSPN and SUD that can predict resilience and outcomes. Employing a rigorous design and a powerful computational approach, this application proposes the first epigenome-based prediction for DSPN, SUD, and their interaction. The identified features can serve as a biomarker for this complex condition and have potential clinical use. The results will enhance the knowledge of epigenetic mechanisms in blood and in brain for HIV-infected DSPN and SUD. Distal sensory polyneuropathy and substance use disorder are common in the HIV-infected population and can impact immune resilience and HIV outcomes. Applying a combination of epigenome-wide association and machine learning approaches, we aim to identify a panel of DNA methylation features in white blood cells for HIV-associated distal sensory polyneuropathy and substance misuse that link to immune resilience, HIV frailty and mortality. The selected features can serve as biomarker for neuropathy and enhance our understanding of the interplay between neuropathy and substance misuse in HIV-infected population.",Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infection,9928910,R01DA047820,"['Aging ', ' Association Learning ', ' Autopsy ', ' necropsy ', ' postmortem ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cocaine ', ' Cohort Studies ', ' Concurrent Studies ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Complication ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Fingerprint ', ' Gene Expression ', ' Genes ', ' Goals ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Envelope Protein gp120 ', ' HIV Envelope Glycoprotein gp120 ', ' HIV env Protein gp120 ', ' HTLV-III gp120 ', ' gp120 ', ' gp120 ENV Glycoprotein ', ' gp120(HIV) ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV-1 ', ' HIV-I ', ' HIV1 ', ' Human Immunodeficiency Virus Type 1 ', ' Human immunodeficiency virus 1 ', ' Human ', ' Modern Man ', ' Infection ', ' Inflammation ', ' Leukocytes ', ' Blood leukocyte ', ' Leukocytes Reticuloendothelial System ', ' Marrow leukocyte ', ' White Blood Cells ', ' White Cell ', ' white blood cell ', ' white blood corpuscle ', ' Light ', ' Photoradiation ', ' Methods ', ' Methylation ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nerve Tissue ', ' Nervous Tissue ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Risk ', ' Role ', ' social role ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Substance Use Disorder ', ' Syndrome ', ' Testing ', ' Thalamic structure ', ' Thalamus ', ' thalamic ', ' Tissues ', ' Body Tissues ', ' Veterans ', ' Polyneuropathy ', ' base ', ' Distal ', ' Site ', ' Clinical ', ' Biological ', ' Neurological ', ' Neurologic ', ' Link ', ' Individual ', ' Opiates ', ' Opioid ', ' Biological Function ', ' Biological Process ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' frailty ', ' Immunes ', ' Immune ', ' Severities ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' neuropathic ', ' Neuropathy ', ' Sensory ', ' cell type ', ' Pattern ', ' brain tissue ', ' Performance ', ' Antiretroviral Agents ', ' anti-retroviral ', ' antiretroviral ', ' Anti-Retroviral Agents ', ' cohort ', ' DNA Fingerprinting ', ' DNA Profiling ', ' DNA Typing ', ' Genetic Fingerprintings ', ' Disease Outcome ', ' novel ', ' Modeling ', ' Sampling ', ' Bio-Informatics ', ' Bioinformatics ', ' Cellular Immune Function ', ' immune function ', ' CD8 ', ' CD8B ', ' CD8B1 ', ' LYT3 ', ' CD8B1 gene ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Molecular ', ' neuropathic pain ', ' painful neuropathy ', ' epigenomics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Advanced Development ', ' designing ', ' design ', ' resilience ', ' Outcome ', ' Population ', ' Prevalence ', ' Impairment ', ' neurotoxic ', ' biosignature ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' cocaine use ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' epigenome ', ' model building ', ' EWAS ', ' epigenome wide association analysis ', ' epigenome-wide association studies ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' medication misuse ', ' drug misuse ', ' substance misuse ', ' Womens Interagency HIV Study ', ' feature selection ', ' machine learning method ', ' ']",NIDA,YALE UNIVERSITY,R01,2020,595425,CT-03,0.010419038064296244
"Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data     DESCRIPTION (provided by applicant): This project involves the development of new statistical methodologies and computational tools for network-based integrative analysis of epigenetic risk factors of cardiovascular diseases (CVD). While the advent of omics data from new technologies has facilitated the study of epigenetic factors, existing methodologies often do not account for complexities of biological data  such as correlations due to interactions of genes/proteins as part of biological pathways  and fail to eciently integrate diverse omics data sets  for instance genetic variation, DNA methylation and gene expression. The methodologies proposed in this project, and the software tools that will be developed to implement them, address these shortcomings, and facilitate further research by the biomedical community to gain a better understanding of the underlying biology of CVD, and to develop new diagnostic biomarkers and potential targets for therapies. The proposed methodologies are motivated by the study of epigenetic data from the Multi-Ethnic Study of Atherosclerosis (MESA), and include (i) a network-based pathway enrichment analysis method that incorporates available knowledge of interactions among genes and proteins while complementing and rening such information (Aim 1A), as well as its extension for analysis of multiple types of omics data (Aim 1B), and (ii) an integrative analysis framework to identify associations among gene expression levels and DNA methylation (Aim 2A) and identify common epigenetic factors of multiple CVD phenotypes through integrated analysis of DNA methylation and mRNA expression data (Aim 2B). We will develop ecient and user-friendly software tools for the proposed methods (Aim 3), which will be made freely available to the public after extensive tests using both simulated data, as well as real data from MESA. PUBLIC HEALTH RELEVANCE: The proposed research addresses the need for development of new statistical machine learning methods for analysis of diverse epigenetic data from multiple cardiovascular disease outcomes. The proposed training activities are designed to enhance the applicant's knowledge of epigenetics and physiology of cardiovascular diseases (CVD), and to further his career as an independent investigator in the area of computational epigenetics for CVD.",Statistical Methods for Network-Based Integrative Analysis of CVD Epigenetic Data,9838771,K01HL124050,"['Biological Availability ', ' Bioavailability ', ' Biologic Availability ', ' Physiologic Availability ', ' Biology ', ' Biomedical Research ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Cause of Death ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Gene Expression ', ' Genes ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Information Networks ', ' Joints ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Maps ', ' Methods ', ' Methodology ', ' Methylation ', ' Myocardial Infarction ', ' Cardiac infarction ', ' Myocardial Infarct ', ' cardiac infarct ', ' coronary attack ', ' coronary infarct ', ' coronary infarction ', ' heart attack ', ' heart infarct ', ' heart infarction ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk Factors ', ' Software Tools ', ' Computer Software Tools ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Testing ', ' Training Activity ', ' training module ', ' Genetic Variation ', ' Genetic Diversity ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' DNA analysis ', ' Area ', ' Biological ', ' Individual ', ' Dyslipidemias ', ' Measurement ', ' Genetic ', ' Nature ', ' DNA Methylation ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Source ', ' System ', ' gene interaction ', ' user friendly computer software ', ' user friendly software ', ' Structure ', ' Disease Outcome ', ' novel ', ' member ', ' novel technologies ', ' new technology ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Protein Gene Products ', ' Gene Proteins ', ' inherited factor ', ' genetic risk factor ', ' Statistical Methods ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Network Analysis ', ' Pathway Analysis ', ' response ', ' Genomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' histone modification ', ' Address ', ' Data ', ' Post-Transcriptional Control ', ' post-transcriptional gene regulation ', ' posttranscriptional control ', ' posttranscriptional regulation ', ' Post-Transcriptional Regulation ', ' Molecular Marker of Prognosis ', ' Prognosis Marker ', ' prognostic biomarker ', ' prognostic indicator ', ' Prognostic Marker ', ' mRNA Expression ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Exogenous Factors ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Outcome ', ' Network-based ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' therapeutic target ', ' public health relevance ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' flexible ', ' flexibility ', ' epigenetic biomarker ', ' epigenetic marker ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' learning network ', ' training opportunity ', ' diagnostic marker ', ' diagnostic biomarker ', ' entire genome ', ' full genome ', ' whole genome ', ' high dimensionality ', ' Multi-Ethnic Study of Atherosclerosis ', ' multiple omic data ', ' Multiomic Data ', ' statistical and machine learning ', ' machine learning method ', ' ']",NHLBI,UNIVERSITY OF WASHINGTON,K01,2020,137714,WA-07,0.16987156479436125
"Critical role of TCF-1 on the epigenetic identity of memory T cells The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity of memory CD8+ T cells. Our adaptive immune system has evolved a unique capacity to remember a pathogen through the generation of memory T cells, which protect the host in the event of reinfection. A better understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in organ transplantation or enhance T cell responses during chronic infections. Although it is known that the transcription factor TCF-1 is required for memory CD8+ T cell function, the mechanisms through which this protein controls memory T cell fate remain unclear. Recently, we discovered that a mechanism through which TCF-1 controls the development of T cells relates to its unprecedented ability to create the chromatin accessibility landscape of nave T cells. We found that TCF-1 is selectively enriched at genomic regions that become accessible at the earliest stages of development and is required for the accessibility of these regulatory elements. At the single-cell level, TCF-1 can dictate a coordinate opening of chromatin in T cells. Moreover, ectopic TCF-1 can directly erase repressive chromatin marks in non-T cells, generating de novo open chromatin and inducing the expression of T cell genes. While our recent data determined the novel role of TCF-1 on the epigenome during T cell development, our findings also raised another critical question: what is the role of TCF-1 on the epigenetic identity of memory T cells? We hypothesize that TCF-1 in cooperation with transcription factor partners defines the epigenetic landscape of memory T cells. Our new preliminary data further indicate that TCF-1 expression post T cell activation in vitro can lead to gains in chromatin accessibility at pro-memory genes. However, it remains unclear if TCF-1 expression in T cells responding to an infection can create the epigenetic identity of memory T cells. The domains of TCF-1 required for targeting the chromatin and its potential cooperating factors also remain unknown. How TCF-1 dependent changes on the epigenome relate to pro-memory genes needs to be defined. To answer these questions, we will interrogate the effect of TCF-1 and its potential partners on the chromatin state and accessibility of CD8+ T cells in vitro. Using the state-of-the-art tools, we will generate the map of TCF-1 dependent 3D genome organization and define how changes on the epigenome relate to memory genes. We will further translate these findings in vivo exploiting single-cell epigenomic, transcriptomic, and flow cytometry assays. The expected outcome of this proposal is a detailed understanding of the fundamental interaction between TCF-1 and the chromatin in peripheral T cells which can be exploited to devise combination therapies including epigenetic editing to selectively alter T cell fate at will. Our adaptive immune system has evolved a unique capacity to remember a pathogen through the generation of memory T cells, which protect the host in the event of reinfection. A better understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in organ transplantation or enhance T cell responses during chronic infections. The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity of memory CD8+ T cells.",Critical role of TCF-1 on the epigenetic identity of memory T cells,9844985,R01HL145754,"['Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Combined Modality Therapy ', ' Multimodal Therapy ', ' Multimodal Treatment ', ' combination therapy ', ' combined modality treatment ', ' combined treatment ', ' multi-modal therapy ', ' multi-modal treatment ', ' Disease ', ' Disorder ', ' Flow Cytometry ', ' Flow Cytofluorometries ', ' Flow Cytofluorometry ', ' Flow Microfluorimetry ', ' Flow Microfluorometry ', ' flow cytophotometry ', ' Foundations ', ' Genes ', ' Genome ', ' Goals ', ' In Vitro ', ' Infection ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Maps ', ' Memory ', ' Organ Transplantation ', ' Grafting Procedure ', ' Organ Transplants ', ' organ allograft ', ' organ graft ', ' organ xenograft ', ' Proteins ', ' Research ', ' Role ', ' social role ', ' T-Lymphocyte ', ' T-Cells ', ' thymus derived lymphocyte ', ' Testing ', ' Thymus Gland ', ' Thymus ', ' Thymus Proper ', ' Thymus Reticuloendothelial System ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Translating ', ' Generations ', ' Mediating ', ' Peptide Domain ', ' Protein Domains ', ' Tertiary Protein Structure ', ' base ', ' Peripheral ', ' Site ', ' Area ', ' CD8 Cell ', ' CD8 T cells ', ' CD8 lymphocyte ', ' CD8+ T cell ', ' CD8+ T-Lymphocyte ', ' CD8-Positive Lymphocytes ', ' T8 Cells ', ' T8 Lymphocytes ', ' CD8-Positive T-Lymphocytes ', ' Effector Cell ', ' tool ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Event ', ' cell type ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' mutant ', ' synergism ', ' Immunomodulation ', ' immune modulation ', ' immune regulation ', ' immune regulator ', ' immunologic reactivity control ', ' immunomodulatory ', ' immunoregulatory ', ' immunoregulation ', ' novel ', ' memory T lymphocyte ', ' T memory cell ', ' T cell differentiation ', ' T-Cell Activation ', ' Molecular Interaction ', ' Binding ', ' FKHR ', ' FOXO1 ', ' FOXO1A ', ' Forkhead Box O1A ', ' Forkhead in Rhabdomyosarcoma ', ' FOXO1A gene ', ' Data ', ' Regulatory Element ', ' Resolution ', ' T-Cell Ontogeny ', ' T-Lymphocyte Development ', ' T-Cell Development ', ' in vivo ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Monitor ', ' Molecular ', ' developmental ', ' Development ', ' LEF Transcription Factor ', ' Lymphoid Enhancer Factor ', ' T Cell Factor ', ' TCF Transcription Factor ', ' Expression Signature ', ' gene expression pattern ', ' gene expression signature ', ' transcriptional signature ', ' Gene Expression Profile ', ' epigenomics ', ' Outcome ', ' pathogen ', ' transcriptomics ', ' new therapeutic approach ', ' new therapeutic intervention ', ' new therapeutic strategies ', ' new therapy approaches ', ' novel therapeutic approach ', ' novel therapy approach ', ' novel therapeutic intervention ', ' T cell response ', ' epigenome ', ' acquired immune system ', ' Adaptive Immune System ', ' persistent infection ', ' chronic infection ', ' ']",NHLBI,UNIVERSITY OF PENNSYLVANIA,R01,2020,462689,PA-03,0.026065982851198908
"Novel Therapeutics Targeting CARM1 Overexpression in AML PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is the 6th leading cause of cancer-related death in the United States. Although up to 40% of adult patients are responsive to standard chemotherapy, almost all relapse and progress to resistant disease. Most AML patients display no cytogenetic abnormalities or driver mutations, which poses a significant challenge for designing targeted therapy. Combination therapy may also be useful for preventing resistance and improving overall survival. Recent advances in epigenomics have shed light on cellular reprogramming in cancer. Epigenetic proteins can modulate gene expression to induce pathways that increase cell proliferation and decrease differentiation. Coactivator-associated arginine methyltransferase 1 (CARM1) is an epigenetic protein overexpressed in AML. CARM1 has been identified as a key regulator of myeloid differentiation and cancer progression; and is overexpressed in primary, resistant, and recurrent AML. CARM1s mechanistic role in AML induction and progression (including relevant substrates and regulation) is still unclear, which presents an additional challenge for clinicians to design new therapies. To address gaps in our current understanding of CARM1 function and the need for new AML therapies, I aim to (1) Identify compounds that target CARM1 expression and compounds that work in synergy with a known CARM1 inhibitor in AML and (2) Identify novel chemotypes that directly inhibit CARM1 using a hybrid approach of machine learning and simulations of small molecule-protein interactions. These aims support key goals of the National Cancer Institute (NCI) and Precision Medicine Initiative, including (1) understanding cancer progression, (2) genomic analysis, (3) advancing precision medicine, (4) bioinformatics and (5) translational research. PROJECT NARRATIVE Acute myeloid leukemia (AML) is a cancer of the bone marrow, where immature cells accumulate and disrupt the production of normal blood cells, disrupting normal blood formation and organ function. Despite advances in research, AML patients are typically treated with chemotherapy agents that often fail to cure them and frequently lead to relapse. We propose to create new therapies for repressing AML based on targeting the epigenome, or the pattern of chemical modification of DNA and histones, the proteins that package and order DNA to promote gene expression.",Novel Therapeutics Targeting CARM1 Overexpression in AML,9812180,F31CA228331,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' inhibitor/antagonist ', ' inhibitor ', ' Arginine ', ' L-Arginine ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Western Blotting ', ' Western Immunoblotting ', ' protein blotting ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Cell Survival ', ' Cell Viability ', ' Cells ', ' Cell Body ', ' Chromosome abnormality ', ' Aberrant Chromosome ', ' Chromosomal Aberrations ', ' Chromosomal Abnormalities ', ' Chromosomal Alterations ', ' Chromosome Aberrations ', ' Chromosome Alterations ', ' Chromosome Anomalies ', ' Cytogenetic Aberrations ', ' Cytogenetic Abnormalities ', ' chromosomal defect ', ' chromosome defect ', ' Combined Modality Therapy ', ' Multimodal Therapy ', ' Multimodal Treatment ', ' combination therapy ', ' combined modality treatment ', ' combined treatment ', ' multi-modal therapy ', ' multi-modal treatment ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Down-Regulation ', ' Downregulation ', ' Drug Combinations ', ' Drug Synergism ', ' Embryonic Development ', ' Embryo Development ', ' Embryogenesis ', ' Gene Expression ', ' Goals ', ' Histones ', ' Hybrids ', ' In Vitro ', ' indexing ', ' Institute of Medicine (U.S.) ', ' Institute of Medicine ', ' NAS/IOM ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Acute Myelocytic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myeloblastic Leukemia ', ' Acute Myelogenous Leukemia ', ' acute granulocytic leukemia ', ' acute myeloid leukemia ', ' Libraries ', ' Light ', ' Photoradiation ', ' Methylation ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Probability ', ' Production ', ' Protein Methyltransferases ', ' Protein Methylases ', ' Proteins ', ' Recurrence ', ' Recurrent ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Testing ', ' United States ', ' Work ', ' Dataset ', ' Data Set ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' base ', ' Organ ', ' cancer progression ', ' neoplasm progression ', ' neoplastic progression ', ' tumor progression ', ' improved ', ' Site ', ' Surface ', ' Biochemical ', ' Series ', ' Chemicals ', ' Chemical Structure ', ' Evaluation ', ' Individual ', ' analog ', ' Bone Cancer ', ' Malignant Osseous Neoplasm ', ' Malignant Osseous Tumor ', ' Malignant Tumor of the Bone ', ' Osseous Cancer ', ' Malignant Bone Neoplasm ', ' Therapeutic ', ' Normal Tissue ', ' Normal tissue morphology ', ' tool ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Catalogs ', ' programs ', ' Myeloid ', ' Myelogenous ', ' Pattern ', ' Cell Growth in Number ', ' Cell Multiplication ', ' Cellular Proliferation ', ' Cell Proliferation ', ' structural biology ', ' synergism ', ' complete response ', ' In complete remission ', ' Structure ', ' simulation ', ' novel ', ' Reporting ', ' CARM1 ', ' coactivator-associated arginine methyltransferase 1 ', ' Regulation ', ' Modeling ', ' Genomics ', ' resistance to disease ', ' resistant disease ', ' resistant to disease ', ' Disease Resistance ', ' Bio-Informatics ', ' Bioinformatics ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' preventing ', ' prevent ', ' small molecule ', ' Address ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Affinity ', ' Data ', ' NCI Organization ', ' National Cancer Institute ', ' Synthetic Chemistry ', ' Synthesis Chemistry ', ' in vivo ', ' Cancer Cause ', ' Cancer Etiology ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Differential Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Docking ', ' pathway ', ' Pathway interactions ', ' resistance to therapy ', ' resistant to therapy ', ' therapeutic resistance ', ' treatment resistance ', ' therapy resistant ', ' epigenomics ', ' virtual ', ' designing ', ' design ', ' resistant ', ' Resistance ', ' Network-based ', ' chemotherapy ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' overexpress ', ' overexpression ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' epigenome ', ' precision-based medicine ', ' precision medicine ', ' Precision Medicine Initiative ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' patient specific response ', ' responsive patient ', ' patient response ', ' acute granulocytic leukemia cell ', ' acute myeloblastic leukemia cell ', ' acute myelocytic leukemia cell ', ' acute myelogenous leukemia cell ', ' acute nonlymphocytic leukemia cell ', ' acute myeloid leukemia cell ', ' blood formation ', ' driver mutation ', ' ']",NCI,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,F31,2020,50520,FL-27,0.048139347929765576
"Computational modeling of DNA methylation-mediated gene regulation Abstract Large numbers of complete methylomes are being acquired through clinical sequencing projects, such as through The Cancer Genome Atlas, Blueprint Epigenome Project, and International Cancer Genome Consortium. Furthermore, third-generation nanopore sequencers, which detect DNA methylation and genetic variation in a single experiment, are nearly ready for routine clinical sequencing and will provide complete methylomes for all patients where whole-genome sequencing is indicated. Current analysis tools however only perform preliminary methylome processing and catalogue differentially methylated regions (DMRs). In order to transform methylome analysis into a clinically useful diagnostic/prognostic test, we need to develop predictive tools to interpret the functional and pathological consequences of identified methylation changes. Towards this goal, we have published a series of papers demonstrating that machine-learning based models utilizing high- resolution signatures of all methylation changes around a promoter vastly outperform conventional DMR methods. Our models accurately predict expression states at genes potentially regulated by methylation and reveal predictive methylation signatures that facilitate mechanistic interpretation. Nonetheless, several challenges remain before we can achieve our goals of translating genome-wide methylation data for routine clinical use: (1) To our knowledge, no current models integrate distal enhancers, whose activation is affected by DNA methylation. Such integrative analysis is necessary to understand consequences of methylation changes in cancers, whose genomes frequently undergo wide-spread methylation changes. In addition, such modelling will be essential to understand the role of 5-hydroxymethylcytosine (5hmC), which may play both repressive and activating roles in neurons depending on whether it is found at promoters or enhancers. (2) Our current models (and conventional approaches) represent methylation data independent of DNA sequence despite mechanistic studies demonstrating that methylation changes can have different functional effects depending on which sequences change and depending on the context of the local regulatory grammar. In this proposal, we will meet these challenges by first developing a predictive model that incorporates 5-methylcytosine and 5hmC at promoters and enhancers to determine how these marks act in concert. In particular, we will examine the hypothesized dual role of 5hmC as a repressor at promoters and as an activator at enhancers in cortical neurons. We will then use new advances in natural language processing to model DNA sequence and methylation to predict expression states. Our results will reveal which regulatory elements and transcription factors binding sites are affected by DNA methylation and how changes at different sites collaborate to affect expression changes. We will experimentally validate our in silico predictions using a combination of reporter assays and CRISPR- based epigenome-editing tools. Thus, the software tools we develop will form an important toolkit for the analysis and mechanistic interpretation of whole-genome methylation studies, both in the laboratory and clinic. Public Narrative DNA normally undergoes a variety of chemical modifications including the addition of methyl- and hydroxymethyl- groups to cytosines (DNA methylation). Though we are unsure how to interpret them, abnormal patterns of DNA methylation are often found in human diseases and will likely soon be routinely measured in the clinic. In this proposal, we will develop advanced computational approaches to predict the functional and pathological consequences of DNA methylation changes in disease. In the future, the approaches we develop will lead to software that suggests individualized therapies for patients based on clinical methylation data.",Computational modeling of DNA methylation-mediated gene regulation,10018936,R01LM013096,"['Affect ', ' Binding Sites ', ' Combining Site ', ' Reactive Site ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cataloging ', ' Cells ', ' Cell Body ', ' Communities ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Future ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Genome ', ' Glioma ', ' Glial Cell Tumors ', ' Glial Neoplasm ', ' Glial Tumor ', ' Neuroglial Neoplasm ', ' Neuroglial Tumor ', ' glial-derived tumor ', ' neuroglia neoplasm ', ' neuroglia tumor ', ' Goals ', ' Laboratories ', ' Maps ', ' Methods ', ' Methylation ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Natural Language Processing ', ' natural language understanding ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Paper ', ' Patients ', ' Play ', ' Publishing ', ' Recurrence ', ' Recurrent ', ' Nucleic Acid Regulatory Sequences ', ' Nucleic Acid Regulator Regions ', ' Regulatory Regions ', ' genetic regulatory element ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Testing ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Translating ', ' Genetic Variation ', ' Genetic Diversity ', ' Generations ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' cofactor ', ' Label ', ' Distal ', ' Site ', ' Clinical ', ' Series ', ' Chemicals ', ' prognostic ', ' Training ', ' Individual ', ' Ligand Binding Protein ', ' Ligand Binding Protein Gene ', ' Protein Binding ', ' bound protein ', ' Binding Proteins ', ' Reporter ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Catalogs ', ' Clinic ', ' Pattern ', ' ES cell ', ' stem cell of embryonic origin ', ' embryonic stem cell ', ' mutant ', ' success ', ' demethylation ', ' neural ', ' relating to nervous system ', ' Regulation ', ' Modeling ', ' Sampling ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genome sequencing ', ' Data ', ' International ', ' Regulatory Element ', ' Resolution ', ' Retrieval ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Pathologic ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' epigenomics ', ' cancer cell genome ', ' tumor genome ', ' cancer genome ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' nano pore ', ' nanopore ', ' cancer type ', ' human disease ', ' genome scale ', ' genomewide ', ' genome-wide ', ' TCGA ', ' The Cancer Genome Atlas ', ' genomewide methylation ', ' global methylation ', ' genome wide methylation ', ' methylome ', ' epigenome ', ' CRISPR ', ' CRISPR/Cas system ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' network architecture ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' methylation pattern ', ' clinical sequencing ', ' entire genome ', ' full genome ', ' whole genome ', ' predictive tools ', ' prognostic test ', ' prognostic assays ', ' experiment ', ' experimental research ', ' experimental study ', ' DNA seq ', ' DNAseq ', ' DNA sequencing ', ' recruit ', ' epigenetic therapy ', ' long short term memory neural network ', ' long short term memory network ', ' epigenome editing ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' in silico ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2020,350896,MO-01,0.17886449108789212
"Inferring gene regulatory circuitry from functional genomics data PROJECT SUMMARY It has long been known that methylation of genomic DNA correlates with gene expression. However, the structural mechanisms that underlie these observations remain obscure. In this project, we will pursue several innovative strategies for studying how methylation affects transcription factor (TF) binding. First, we will use Methyl-SELEX-seq  a novel experimental method developed in the previous cycle of this grant that uses barcoded mixtures of methylated and unmethylated DNA ligands  to create detailed maps of the effect of methylation on binding affinity for a broad panel of human transcription factors from various structural families. Second, we will perform detailed computational analyses and follow-up experiments to test the hypothesis that methylation causes local changes in DNA shape, which in turn modify TF binding affinity. We have shown that adding a methyl group in the major groove changes the geometry of the minor groove and enhances the electrostatic interaction between negative charges in the DNA minor groove and positively charged amino- acids in the TF. We will extend these analyses to other DNA modifications, as well as a wider range of DNA shape parameters and associated flexibility parameters. By building interpretable TF-DNA recognition models that integrate base, shape, and flexibility features using a powerful new machine learning framework developed in the previous funding cycle, we will make specific predictions regarding sequence and methylation readout mechanisms, and validate these using SELEX experiments with mutated TFs. To assess to what extent our quantitative models for binding to naked DNA built from SELEX data are predictive of binding to genomic DNA in the context of the living cell, we will perform detailed parallel analyses of SELEX and ChIP- seq data for Hox proteins and other TFs. Finally, to study the relationship between DNA binding and gene expression control in human cell lines, we will exploit Survey of Regulatory Elements (SuRE-seq), a novel massively parallel reporter assay that provides unique information about the autonomous transcriptional activity for each of >108 overlapping genomic fragments. PROJECT NARRATIVE Epigenetic modifications of the human genome are known to play a key role in development and disease, but the underlying molecular mechanisms are largely unknown. The main goal of this proposal is to develop and apply new experimental and computational tools for analyzing how the binding of regulatory proteins to DNA is influenced by cytosine methylation. This will help us better understand its impact on gene expression and disease.",Inferring gene regulatory circuitry from functional genomics data,9954130,R01HG003008,"['Affect ', ' Amino Acid Sequence ', ' Primary Protein Structure ', ' protein sequence ', ' Amino Acids ', ' aminoacid ', ' Bar Codes ', ' barcode ', ' Base Sequence ', ' Nucleotide Sequence ', ' nucleic acid sequence ', ' Binding Sites ', ' Combining Site ', ' Reactive Site ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biophysics ', ' biophysical foundation ', ' biophysical principles ', ' biophysical sciences ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Cells ', ' Cell Body ', ' Charge ', ' Communities ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' Transcriptional Regulatory Elements ', ' regulatory gene ', ' trans acting element ', ' Human Genome ', ' human whole genome ', ' Goals ', ' Grant ', ' Human ', ' Modern Man ', ' In Vitro ', ' Laboratories ', ' Ligands ', ' Maps ', ' Methods ', ' Methylation ', ' Names ', ' Play ', ' Promoter Regions ', ' Promotor Regions ', ' genetic promoter element ', ' genetic promoter sequence ', ' promoter sequence ', ' Proteins ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' DNA Sequence ', ' base ', ' DNA analysis ', ' Variation ', ' Variant ', ' Biological ', ' Funding ', ' Shapes ', ' Reporter ', ' tool ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Electrostatics ', ' Hyperactivity ', ' Hyperkinesia ', ' Hyperkinesis ', ' Hyperkinetic Movements ', ' Motor Hyperactivity ', ' Hyperactive behavior ', ' Dependence ', ' Protocol ', ' Protocols documentation ', ' preference ', ' methyl group ', ' HOX protein ', ' Free Energy ', ' Structure ', ' novel ', ' family structure ', ' Human Cell Line ', ' Position ', ' Positioning Attribute ', ' Regulatory Protein ', ' regulatory gene product ', ' genetic regulatory protein ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' functional genomics ', ' Genomics ', ' DNA Binding Interaction ', ' DNA bound ', ' DNA Binding ', ' DNA Modification ', ' DNA Modification Process ', ' Molecular Interaction ', ' Binding ', ' Address ', ' Affinity ', ' Data ', ' Minor Groove ', ' Mutate ', ' Regulatory Element ', ' Chromatin Structure ', ' computational analyses ', ' computational analysis ', ' computer analyses ', ' Computer Analysis ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Major Groove ', ' Molecular ', ' Modification ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' deep sequencing ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' innovate ', ' innovative ', ' innovation ', ' comparative ', ' genome scale ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ChIP Sequencing ', ' chromatin immunoprecipitation-sequencing ', ' ChIP-seq ', ' methylome ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' Geometry ', ' gDNA ', ' Genomic DNA ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' genomic predictors ', ' experiment ', ' experimental research ', ' experimental study ', ' ']",NHGRI,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2020,560259,NY-13,0.11482425156446867
"DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics Project Summary/Abstract  DNA synthesis has played a key role in the biotechnology revolution. The ready availability of synthetic DNA oligonucleotides and of genes assembled from them, has been invaluable for elucidating and unlocking biological function and enabling the new field of synthetic biology which can create novel cells, enzymes, therapeutics, diagnostics and other reagents of commercial value. Despite this impact, DNA synthesis uses chemical strategies developed over 30 years ago which are costly and limited to molecules of 200 nucleotides or less in length.  Next-generation enzymatic DNA synthesis technologies are being explored that use template- independent DNA polymerases (TIDPs) for controlled addition of nucleotides to a growing DNA strand. Although advances have been reported recently, enzymatic DNA synthesis is still limited by the low efficiency of available TIDPs, and specifically by the relative inability of these polymerases to incorporate 3'-blocked nucleotides.  In this Phase I Small Business Innovation Research (SBIR) project, Primordial Genetics Inc, a synthetic biology company with differentiated combinatorial genetic technology, and Denovium Inc., an artificial intelligence company pioneering novel Al methods for genetic discovery, are joining forces to develop novel and highly efficient TIDPs for enzymatic DNA synthesis in vitro.  Denovium will use their computational capabilities based on machine learning algorithms to discover novel TIDPs with the desired activities from proprietary and public databases. Denovium will also perform proprietary artificial intelligence (AI) scans to determine the functional impact of all possible mutations on the selected TIDPs. Primordial Genetics will synthesize and express the resulting collection of sequences, and test them in vitro to identify the most active enzymes. The best 2 enzymes will be diversified using Primordial Genetics' proprietary Function Generator technology and other randomized diversification methods. Populations of genes encoding enzyme variants will be screened with ultra-high-throughput screens to identify the most active enzymes. The dataset resulting from this work will be used to train Denovium's sequence prediction algorithm to accelerate further enzyme improvements in Phase II.  The proposed work is a feasibility study for isolating and developing novel enzymes suitable for enzymatic DNA synthesis, and also for creating a pipeline of enzyme optimization tools. The enzymes discovered and in this work will be directly useful for enzymatic DNA synthesis applications, and can be licensed or sold to leading DNA and gene manufaturers. Project Narrative The principal aim of this project is to develop novel and improved DNA polymerases for the industrial synthesis of DNA, which is currently performed by synthetic chemical methods and represents one of the cornerstone technologies of the biotechnology industry. To overcome limitations of the current chemical technology in cost, efficiency and the length of DNA molecules that can be synthesized, there have been widespread attempts to develop specific DNA polymerases as efficient molecular machines for synthesizing DNA. This project will develop novel and more efficient polymerases than are currently available, which will impact the diagnosis, prevention and treatment of human diseases such as cancer, heart disease, HIV and genetic diseases such as cystic fibrosis.",DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics,10010243,R43HG010995,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biotechnology ', ' Biotech ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Capital ', ' Cells ', ' Cell Body ', ' Chemistry ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Cystic Fibrosis ', ' Mucoviscidosis ', ' Diagnosis ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Nucleotidylexotransferase ', ' Deoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Desoxynucleotidyltransferase ', ' Terminal Addition Enzyme ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxyribonucleotidyltransferase ', ' DNA-Directed DNA Polymerase ', ' DNA Polymerases ', ' DNA-Dependent DNA Polymerases ', ' Single-Stranded DNA ', ' Enzymes ', ' Enzyme Gene ', ' Equipment ', ' Evolution ', ' Feasibility Studies ', ' Genes ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' In Vitro ', ' Industrialization ', ' Industry ', ' Libraries ', ' Methods ', ' Modernization ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Nucleotides ', ' Oligonucleotides ', ' Oligo ', ' oligos ', ' Play ', ' Proteins ', ' Reagent ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Technology ', ' Testing ', ' Work ', ' Generations ', ' Molecular Genetics ', ' TimeLine ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Licensing ', ' data retrieval ', ' data storage ', ' Data Storage and Retrieval ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Therapeutic ', ' Genetic ', ' tool ', ' Diagnostic ', ' Scanning ', ' Performance ', ' synthetic DNA ', ' synthetic construct ', ' DNA Replication ', ' DNA Synthesis ', ' DNA biosynthesis ', ' novel ', ' Prevention ', ' Reporting ', ' genetic technology ', ' Modeling ', ' High Throughput Assay ', ' high throughput screening ', ' model development ', ' phosphoramidite ', ' Bio-Informatics ', ' Bioinformatics ', ' Polymerase ', ' Length ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Collection ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' cost ', ' next generation ', ' Population ', ' Microbe ', ' Molecular Machines ', ' synthetic biology ', ' combinatorial ', ' human disease ', ' in vitro testing ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' Cost efficiency ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' predictive assay ', ' predictive test ', ' deep learning ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NHGRI,"PRIMORDIAL GENETICS, INC",R43,2020,374524,CA-49,0.07758052918862275
"An Integrative Computational Framework for DNA Hydroxymethylation Data Mining and Interpretation PROJECT SUMMARY/ABSTRACT Recent advances in next generationsequencing (NGS)-based molecular methods have illuminated the hierarchical organization of the genome and have shown that changes in the epigenome can promote or prevent the access of transcription factors (TFs) to specific DNA sequences, move genes between nuclear compartments, and build or remove the insulation between neighboring genomic regions. As changes in the epigenome and chromatin organization can derail precise transcriptional regulatory programs to change cell differentiation status or induce a pathological state, research in Dr. Lis laboratory seeks to improve our ability to define and understand the impact of such changes across multiple layers of transcriptional regulation in the cell. The laboratory has effectively addressed the regulatory roles of DNA methylation in its previous and ongoing work and now extends its focus to hydroxymethylation. 5-hydroxymethylcytosine (5hmC), is a key epigenetic modification linked to transcriptional activation; however, 5hmC data and its genome properties have thus far been evaluated with limited integration of different genomic data types. Moreover, there is no integrative computational framework designed to interpret the functional role of 5hmC in the context of 5-methycytosine (5mC), enhancer activities, chromatin interactions, gene expression data, and DNA sequence information. This proposal will fill the growing need for user-friendly, interpretable, and extendable tools for mining 5hmC data toward laying a foundation for basic mechanistic studies of the epigenome and facilitate discovery of potential therapeutic targets in disease. Building on the investigators progress in revealing the dynamics of 5hmC and its impact on gene regulation, the proposal will now develop innovative computational tools for 5hmC data mining and data integration with other NGS datasets, with a focus on applying these tools to B cell differentiation, cancer, and embryonic stem cell (ESC) differentiation. Key goals over the next five years include developing a computational framework to mine short- and long-read sequencing data to answer the following questions: (1) How does 5hmC contribute to epigenetic heterogeneity? (2) How does 5hmC epigenetic heterogeneity contribute to transcriptome heterogeneity? (3) How do 5hmC levels and epigenetic heterogeneity communicate with histone modifications, enhancer activities, chromatin interactions, and chromatin organization? We will combine machine learning and network mining algorithms to enable knowledge discovery and data integration from diverse genomic data types. We will then harness the 5hmC data-mining framework to identify 5hmC patterns that correlate with ESC differentiation, B cell differentiation, and that contribute to the fitness advantage of cancer cells. This work is significant because it will be the first dissection of 5hmCs contribution to local and long-range epigenetic heterogeneity and the first computational framework to uncover the cross-talk between DNA modifications and other transcriptional regulators via chromatin interaction data. Collectively, this work will yield a fuller picture of the molecular events that underlie fundamental changes in cell state and behavior. PROJECT NARRATIVE / RELEVANCE TO PUBLIC HEALTH Modifications of the genome that do not change the sequence of the DNA, called epigenetic modifications, can impact how genes are expressed and lead healthy cells into a disease state. Here we propose to develop computational tools to define how one type of epigenetic modification, called hydroxymethylation, impacts gene expression and ultimately cell behavior. These tools will be versatile and adaptable to any cell type of choice, enabling research into the molecular features of the genome that underlie both normal and pathological cell behaviors.",An Integrative Computational Framework for DNA Hydroxymethylation Data Mining and Interpretation,9986833,R35GM133562,"['Algorithms ', ' Behavior ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell Differentiation process ', ' Cell Differentiation ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Disease ', ' Disorder ', ' Dissection ', ' DNA ', ' Deoxyribonucleic Acid ', ' Foundations ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Genome ', ' Goals ', ' Heterogeneity ', ' Laboratories ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Methods ', ' Mining ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Work ', ' Enhancers ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Transcription Activation ', ' Transcriptional Activation ', ' base ', ' improved ', ' Link ', ' Malignant Cell ', ' cancer cell ', ' tool ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' programs ', ' Event ', ' cell type ', ' Pattern ', ' Nuclear ', ' ES cell ', ' stem cell of embryonic origin ', ' embryonic stem cell ', ' Property ', ' B lymphocyte differentiation ', ' B cell differentiation ', ' histone modification ', ' DNA Modification ', ' DNA Modification Process ', ' Transcription Regulation ', ' Transcriptional Control ', ' Transcriptional Regulation ', ' preventing ', ' prevent ', ' datamining ', ' data mining ', ' Address ', ' fitness ', ' Data ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Pathologic ', ' Molecular ', ' Modification ', ' stem cell differentiation ', ' computational framework ', ' computer framework ', ' computational tools ', ' computerized tools ', ' data integration ', ' designing ', ' design ', ' innovate ', ' innovative ', ' innovation ', ' user-friendly ', ' cellular behavior ', ' cell behavior ', ' therapeutic target ', ' Knowledge Discovery ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' epigenome ', ' learning network ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' ']",NIGMS,JACKSON LABORATORY,R35,2020,472500,ME-02,0.06851335211178686
"Mathematical Models of Vulnerability and Cell-Type Specific Analysis of DNA Modifications in Aging Project Summary Understanding the biochemical processes underlying aging that give rise to age-related pathologies is the central concept of geroscience research. A focus in geroscience is to identify interventions that slow/prevent aging. These could both alter the trajectory of aging and have beneficial effects across a number of diseases, delaying onset or slowing progression. However, evaluating anti-aging interventions requires years-long studies in mammalian model organisms and is almost impossible in clinical trials that would require of multi-year studies to evaluate lifespan and healthspan extensions. The solution to this problem lies in developing endpoints that indicate biological age and the health-related changes that go with it with sufficient sensitivity. The recent development of epigenetic clocks, chronological age-predictive machine learning models that use DNA cytosine methylation data, are leading the field in age estimation accuracy and precision. The difference between a persons chronological age and the estimated methylation age has been proposed as a measure of aging acceleration or deceleration  a biological age. Age acceleration predicted by methylation has shown robust correlations to all-cause mortality risk, but weak correlations in age-related diseases. Age-related biological outcomes such as cognitive decline have found little to no association with methylation age acceleration. Put simply, epigenetic clocks have been developed to predict chronological age but have so far demonstrated marginal utility to predict disease states. However, our preliminary results indicate that as many as 20% of genomic cytosines have age-related methylation changes which may be leveraged to understand biological aging and its outcomes simultaneously. Using the largest collection of methylation data with disease, age, tissue, and sex labels from our previous work in natural language processing, we will create the first model of epigenetic aging to identify healthy aging loci and disease-predictive loci. These loci will give us insight into the molecular pathways disturbed by age-related methylation changes, providing targets for therapeutic intervention and a predictor for patient disease risk. However, it is still unknown how epigenetic clocks tick, especially considering their performance across tissues. We will test how epigenetic changes with age are distributed throughout specific cell types in the central nervous system and cell types common across all tissues  such as vascular endothelium and immune cells. Using single-cell bisulfite sequencing and cell-type specific promoter-driven labelling, we can detect if the epigenetic clock changes are truly occurring in all cells or if they are restricted to some cell types common across tissues. This information is critical for predicting the downstream effects of changes identified by epigenetic clocks and interpreting the effects of reversing epigenetic aging. These experiments will further our understanding of the role epigenetics play in the aging process and in neurological diseases of age such as Alzheimers and Parkinsons Disease. Project Narrative Epigenetic clocks, models of DNA methylation changes with age, have been shown as robust biomarkers for aging and all-cause mortality risk, but weakly predict disease risk and thus biological aging. This proposed research plan will generate a new epigenetic model by identifying loci predictive of both age and disease to create an Epigenetic Vulnerability Estimator (EVE), granting insights into disease-associated pathways affected by DNA methylation aging. We will also determine how epigenetic clocks tick in the brain using cell-type specific single-cell bisulfite sequencing to understand what cellular populations are reflecting both age-related epigenetic dysregulation and potentially responding to anti-aging interventions.",Mathematical Models of Vulnerability and Cell-Type Specific Analysis of DNA Modifications in Aging,10067953,F31AG063493,"['Acceleration ', ' Affect ', ' Age ', ' ages ', ' Aging ', ' Alleles ', ' Allelomorphs ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Animals ', ' Astrocytes ', ' Astrocytus ', ' Astroglia ', ' astrocytic glia ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cell Nucleus ', ' Nucleus ', ' Cells ', ' Cell Body ', ' Chronology ', ' Clinical Trials ', ' Cytosine ', ' Deceleration ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Vascular Endothelium ', ' Genes ', ' Genome ', ' Grant ', ' Health ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Joints ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Methylation ', ' Genetic Models ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Persons ', ' Natural Language Processing ', ' natural language understanding ', ' nervous system disorder ', ' Nervous System Diseases ', ' Neurologic Disorders ', ' Neurological Disorders ', ' neurological disease ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Parkinson Disease ', ' Paralysis Agitans ', ' Parkinson ', "" Parkinson's disease "", ' Parkinsons disease ', ' Primary Parkinsonism ', ' Pathology ', ' Patients ', ' Phagocytes ', ' Phagocytic Cell ', ' amebocyte ', ' Play ', ' Research ', ' Ribosomes ', ' Risk Factors ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Testing ', ' Ticks ', ' Ixodida ', ' Tissues ', ' Body Tissues ', ' Work ', ' Euchromatin ', ' Measures ', ' Biological Aging ', ' Enhancers ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' base ', ' Organ ', ' Label ', ' DNA analysis ', ' Site ', ' Biological ', ' Hortega cell ', ' gitter cell ', ' mesoglia ', ' microglial cell ', ' microgliocyte ', ' perivascular glial cell ', ' Microglia ', ' Link ', ' insight ', ' Individual ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Age-associated cognitive decline ', ' Age-related cognitive decline ', ' Benign senescent forgetfulness ', ' age associated memory decline ', ' age related cognitive deficit ', ' age related cognitive impairment ', ' age related memory dysfunction ', ' Age-associated memory impairment ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Entropy ', ' Immunes ', ' Immune ', ' Source ', ' cell type ', ' Nuclear ', ' Degenerative Neurologic Diseases ', ' Degenerative Neurologic Disorders ', ' Nervous System Degenerative Diseases ', ' Neural Degenerative Diseases ', ' Neural degenerative Disorders ', ' Neurodegenerative Diseases ', ' Neurologic Degenerative Conditions ', ' degenerative diseases of motor and sensory neurons ', ' degenerative neurological diseases ', ' neurodegenerative illness ', ' Neurodegenerative Disorders ', ' Performance ', ' animal data ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Disease Outcome ', ' novel ', ' disease risk ', ' disorder risk ', ' intervention therapy ', ' Therapeutic Intervention ', ' Modeling ', ' Sampling ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Genomics ', ' CNS Nervous System ', ' Central Nervous System ', ' Neuraxis ', ' Neural Stem Cell ', ' neural precursor ', ' neural precursor cell ', ' neural progenitor ', ' neural progenitor cells ', ' neuron progenitors ', ' neuronal progenitor ', ' neuronal progenitor cells ', ' neuronal stem cells ', ' neuroprogenitor ', ' nerve stem cell ', ' DNA Modification ', ' DNA Modification Process ', ' Vascular Endothelial Cell ', ' preventing ', ' prevent ', ' Biochemical Process ', ' Data ', ' Research Training ', ' Collection ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' sex ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' meta data ', ' Metadata ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' anti aging drug ', ' anti aging medicine ', ' antiaging ', ' antiaging drug ', ' antiaging medicine ', ' anti aging ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Outcome ', ' Population ', ' aged brain ', ' aging brain ', ' normal aging ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' healthy aging ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' Geroscience ', ' Cre-Lox ', ' Cre/LoxP ', ' Cre-LoxP ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' single cell sequencing ', ' BS-seq ', ' Bisulfite-based sequencing ', ' bisulfite-seq ', ' bisulfite sequencing ', ' lab assignment ', ' lab experiment ', ' laboratory activity ', ' laboratory assignment ', ' laboratory exercise ', ' laboratory experiment ', ' experiment ', ' experimental research ', ' experimental study ', ' health-span ', ' healthspan ', ' death risk ', ' mortality risk ', ' ']",NIA,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,F31,2020,34001,OK-05,0.19923675688565137
"Predictable control of gene regulation through epigenetic engineering PROJECT SUMMARY/ ABSTRACT Recent landmark discoveries have revealed that in addition to DNA lesions, epigenetic mechanisms also play a major role in cancer. Epigenetics is mediated in part by interactions of proteins and DNA that confer heritable gene expression states. Drugging the cancer epigenome is a burgeoning medical technology that currently uses small molecule inhibitors and small RNAs to disrupt hyperactive epigenetic enzymes. The proposed work will test the hypothesis that a new modality, fusion proteins that interact with the chromatin fiber, will activate therapeutic genes at sites that bear a specific pattern of cancer-related biochemical marks. The specific aims are to (2) use bioinformatic analyses to discover chromosome features that support inducible changes in gene expression states and (2) to use protein engineering to identify determinants of nuclear protein engagement.  PROJECT NARRATIVE Current methods to reactivate dormant therapeutic genes in cancer cells are limited to inhibitors that bind epigenetic enzymes and other proteins. The proposed work will establish a new technology: customizable synthetic proteins that control anti-cancer genes near cancer-associated biochemical marks.",Predictable control of gene regulation through epigenetic engineering,10021602,R21CA232244,"['inhibitor/antagonist ', ' inhibitor ', ' Antineoplastic Agents ', ' Anti-Cancer Agents ', ' Antineoplastic Drugs ', ' Antineoplastics ', ' Cancer Drug ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Tumor-Specific Treatment Agents ', ' anti-cancer drug ', ' anticancer agent ', ' anticancer drug ', ' Ursidae Family ', ' Bears ', ' Ursidae ', ' bear ', ' Binding Sites ', ' Combining Site ', ' Reactive Site ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Chromosomes ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Cytoplasm ', ' DNA ', ' Deoxyribonucleic Acid ', ' Drug resistance ', ' drug resistant ', ' resistance to Drug ', ' resistant to Drug ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Engineering ', ' Enzymes ', ' Enzyme Gene ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Synthetic Genes ', ' Artificial Genes ', ' Histone H3 ', ' Histones ', ' In Vitro ', ' Libraries ', ' Methods ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Molecular Weight ', ' Nucleic Acids ', ' Oncogenes ', ' Cancer Genes ', ' Cancer-Promoting Gene ', ' Transforming Genes ', ' Play ', ' Protein Engineering ', ' genetic protein engineering ', ' protein design ', ' Proteins ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Technology ', ' Medical Technology ', ' Testing ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Translations ', ' Work ', ' trimethyllysine ', ' Generations ', ' Measures ', ' Polycomb ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' DNA Sequence ', ' Chimera Protein ', ' Fusion Protein ', ' Chimeric Proteins ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Biological ', ' Biochemical ', ' Medical ', ' Malignant Cell ', ' cancer cell ', ' machine learned ', ' Machine Learning ', ' programs ', ' Hyperactivity ', ' Hyperkinesia ', ' Hyperkinesis ', ' Hyperkinetic Movements ', ' Motor Hyperactivity ', ' Hyperactive behavior ', ' Complex ', ' Pattern ', ' System ', ' synthetic protein ', ' tumor suppressor ', ' Tumor Suppressor Proteins ', ' Gene Inactivation ', ' transcriptional silencing ', ' Gene Silencing ', ' chromatin protein ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' novel ', ' Basic Research ', ' Basic Science ', ' novel technologies ', ' new technology ', ' Modality ', ' Reporting ', ' Gene Expression Monitoring ', ' Gene Expression Pattern Analysis ', ' Transcript Expression Analyses ', ' Transcript Expression Analysis ', ' gene expression analysis ', ' gene expression assay ', ' transcriptional profiling ', ' Gene Expression Profiling ', ' Regulation ', ' native protein drug ', ' pharmaceutical protein ', ' protein drug agent ', ' therapeutic protein ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' cancer recurrence ', ' Nuclear Protein ', ' Transcription Start Site ', ' Transcription Initiation Site ', ' Short interfering RNA ', ' siRNA ', ' Small Interfering RNA ', ' Protein Array ', ' Bio-Informatics ', ' Bioinformatics ', ' Transcription Initiation ', ' Molecular Interaction ', ' Binding ', ' Small RNA ', ' Address ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Affinity ', ' K01 Award ', ' K01 Mechanism ', ' K01 Program ', ' Mentored Training Award ', ' Research Scientist Development Award ', ' Mentored Research Scientist Development Award ', ' 30 nm Chromatin Fiber ', ' 30 nm Fiber ', ' Chromatin Fiber ', ' Chromatin Structure ', ' Emergent Technologies ', ' Emerging Technologies ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' designing ', ' design ', ' Heritability ', ' gene therapeutics ', ' gene-based therapeutic ', ' gene-based therapeutics ', ' genes therapeutic ', ' genes therapeutics ', ' therapeutic gene ', ' C-terminal ', ' synthetic biology ', ' DNA lesion ', ' epigenome ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' small molecule inhibitor ', ' recruit ', ' epigenetic therapy ', ' anticancer ', ' anti-cancer ', ' ']",NCI,EMORY UNIVERSITY,R21,2020,196085,GA-05,0.12635429915769028
"Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression. Project Summary / Abstract The objective of the proposed research is to better understand how peripheral blood epigenetic patterns are associated with knee osteoarthritis (OA). A great deal of work has already been demonstrated widespread epigenetic changes within articular tissues in both knee and hip OA. Others have described serum and urine protein biomarkers as predictors of future knee OA progression. Our first Aim is to evaluate peripheral blood cell DNA epigenetic patterns in baseline blood samples from patients who will go on to have rapid radiographc and/or pain progression in the subsequent 24 months. We will then use these data to develop develop and evaluate the performance of epigenetic algorithmic models to discriminate these groups. Patient samples will parallel the National Institutes of Health OA Biomarkers Consortium (OABC-FNIH) study. DNA methylation will be evaluated using a next-generation bisulfite sequencing approach (methylSeq), and algorithms developed using cutting-edge machine learning techniques. We will then translate our findings into a more high- throughput, inexpensive, and clinically relevant form by developing and validating a targeted capture sequencing system to interrogate these specific epigenetic locations. Our second Aim is to evaluate the peripheral blood DNA methylation patterns that precede the development of OA, using samples from 48-, 24-, 12-, and 0-months before incident OA. We will again develop algorithms to predict future OA development using similar techniques as Aim 1 and translate this to a targeted capture sequencing system. This unique longitudinal approach which will allow us not only to determine whether and when epigenetic patterns develop preceding OA development, but also track longitudinal epigenetic changes as OA develops. The proposed work is important, as there are no FDA approved biomarkers for OA diagnosis or prognosis. Our work is quite innovative both in its combination of ""big data"" epigenetic analysis and cutting-edge machine learning techniques applied to a specific clinical problem, as well as in its examination of PBMC epigenetics in OA, which has not yet been described. Moreover, we tackle the problem of translation of big-data research by aiming specifically to develop high-throughput methods to translate our findings into a clinically-relevant and accessible form. Success in our proposal will produce both algorithmic models with direct clinical impact to predict future OA development and progression, as well as broaden our understanding of epigenetic changes in peripheral blood cells from OA patients. Project Narrative The proposed research is relevant to public health because a better understanding of blood epigenetic patterns in osteoarthritis (OA) is likely not only to give insights into the causes of OA, but also to give rise to new biomarkers to assist physicians and researchers diagnose OA patients and predict how rapidly they will worsen over time. Thus, this proposal is relevant to the part of the NIH's mission that pertains to fostering fundamental creative discoveries, innovative research strategies, and their applications as a basis for ultimately improving health.",Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression.,9861881,R01AR076440,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Cartilage ', ' Cartilaginous Tissue ', ' Classification ', ' Systematics ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Foundations ', ' Future ', ' Genes ', ' Health ', ' Inflammation ', ' Joints ', ' Libraries ', ' Methods ', ' Methylation ', ' Mission ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Musculoskeletal Diseases ', ' musculoskeletal disorder ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Degenerative polyarthritis ', ' Degenerative Arthritis ', ' Osteoarthritis ', ' Osteoarthrosis ', ' degenerative joint disease ', ' hypertrophic arthritis ', ' osteoarthritic ', ' Hip Osteoarthritis ', ' Coxarthrosis ', ' hip OA ', ' Pain ', ' Painful ', ' Patients ', ' Phenotype ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' outcome forecast ', ' Prognosis ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Translating ', ' Translations ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Diagnostic radiologic examination ', ' Conventional X-Ray ', ' Diagnostic Radiology ', ' Diagnostic X-Ray ', ' Diagnostic X-Ray Radiology ', ' Radiography ', ' Roentgenography ', ' X-Ray Imaging ', ' X-Ray Medical Imaging ', ' Xray imaging ', ' Xray medical imaging ', ' conventional Xray ', ' diagnostic Xray ', ' diagnostic Xray radiology ', ' bisulfite ', ' hydrogen sulfite ', ' hydrosulfite ', ' sodium bisulfite ', ' TimeLine ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Chronic ', ' Clinical ', ' peripheral blood ', ' Blood Serum ', ' Serum ', ' disability ', ' insight ', ' Individual ', ' Fostering ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' knee OA ', ' knee joint OA ', ' knee joint osteoarthritis ', ' Knee Osteoarthritis ', ' Pattern ', ' Techniques ', ' System ', ' Location ', ' Performance ', ' success ', ' cohort ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' novel ', ' economic impact ', ' Pathogenesis ', ' Modeling ', ' Sampling ', ' Genomics ', ' model development ', ' Pathogenicity ', ' Age-Years ', ' Data ', ' Clinical Data ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Validation ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Modification ', ' developmental ', ' Development ', ' joint function ', ' pathway ', ' Pathway interactions ', ' deep sequencing ', ' next generation ', ' innovate ', ' innovative ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' clinical applicability ', ' clinical application ', ' genome wide analysis ', ' genome wide studies ', ' genome-wide identification ', ' genome-wide analysis ', ' FDA approved ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' epigenetic biomarker ', ' epigenetic marker ', ' epigenome ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' BigData ', ' Big Data ', ' methylation pattern ', ' BS-seq ', ' Bisulfite-based sequencing ', ' bisulfite-seq ', ' bisulfite sequencing ', ' targeted sequencing ', ' biomarker development ', ' protein markers ', ' protein biomarkers ', ' subchondral bone ', ' algorithm development ', ' ']",NIAMS,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,R01,2020,21455,OK-05,0.16980579488389788
"Epigenetic Age Measures to Predict COVID-19 Symptom Progression and Severity PROJECT SUMMARY  The risk of fatality and/or severe complications due to COVID-19 infection is strongly age dependent. Data from the CDC suggests that those ages 85 and older have predicted mortality rates that is 100-fold higher than for those under the age of 50 and currently, 8 out of 10 COVID-19 deaths in the United States were in adults age 65 or older. While the exact etiology underlying this age disparity is unknown, evidence suggests that vulnerability may be due to changes that occur as a function of the aging process. This is further evidenced by the pattern of increased vulnerability among persons with pre-existing diseases of agingcardiovascular disease, diabetes, COPD, chronic kidney disease, liver diseasesuggesting that it isn't just chronological age that determines risk, but rather, biological age.  In recent years, our group has helped develop some of the most robust biomarkers available, namely the epigenetic clocks. These measures estimate biological age in a sample based on DNA methylation levels at hundreds to thousands of CpG sites across the genome. Not only do epigenetic clocks track with age in diverse tissues and cell types, but discrepancies between epigenetic age and actual age have also been shown to predict risk of mortality and incidence of major chronic disease, including those which appear to be major risk factors for COVID-19. However, in order for these measures to be informative for assessing COVID-19 risk clinically, or in the general population, 1) they need to be re-optimized to capture the aspects of biological aging specific to COVID-19 susceptibility, and 2) advances in technology need to be made to ensure lower costs and rapid turnaround.  This proposal aims to build on our team's multidisciplinary strengths to develop and validate a targeted, lab-developed, readily-available test to predict COVID-19 symptomology and mortality risk. If successful, this test will have widespread applicationsfrom informing triage and treatment decisions in the clinic, to guiding social and pollical decisions when it comes to lifting stay-at-home orders for certain individuals. PROJECT NARRATIVE The risks associated with COVID-19 infection are highly age and health dependent, suggesting that biological aging may be a major determinant for symptom severity and mortality risk. Based on our previous work in developing biomarkers of aging, we propose to develop and validate a novel, rapid, and affordable COVID-19 test to predict long-term response to infection, based on DNA methylation.",Epigenetic Age Measures to Predict COVID-19 Symptom Progression and Severity,10158592,R00AG052604,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Aging ', ' Alleles ', ' Allelomorphs ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cells ', ' Cell Body ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Chronology ', ' Communities ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Future ', ' Genome ', ' Grant ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Hybrids ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Immunocompetence ', ' Immunologic Competence ', ' Immunological Competence ', ' Incidence ', ' Infection ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Methods ', ' Methylation ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' Organism ', ' living system ', ' Patients ', ' Risk ', ' Risk Factors ', ' Running ', ' Sensitivity and Specificity ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Triage ', ' United States ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' Virus ', ' Work ', ' bisulfite ', ' hydrogen sulfite ', ' hydrosulfite ', ' Measures ', ' Biological Aging ', ' Ventilator ', ' base ', ' 85+ years old ', ' age 85 and greater ', ' age 85 and older ', ' aged 85 and greater ', ' aged 85 and older ', ' human very old age (85+) ', ' Site ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' Lifting ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Individual ', ' Measurement ', ' Nature ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Severities ', ' Home ', ' Home environment ', ' Clinic ', ' cell type ', ' Pattern ', ' Techniques ', ' Proxy ', ' Speed ', ' novel ', ' General Public ', ' General Population ', ' social ', ' Social Support System ', ' Support System ', ' Admission ', ' Admission activity ', ' Sampling ', ' response ', ' Pathogenicity ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Symptoms ', ' Data ', ' High Prevalence ', ' Population-based research ', ' Population-level research ', ' Population Research ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Transmission ', ' transmission process ', ' trend ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' age dependent ', ' age related ', ' cost ', ' resilience ', ' elderly patient ', ' older patient ', ' cost effective ', ' Population ', ' Individual Differences ', ' multidisciplinary ', ' clinical applicability ', ' clinical application ', ' molecular biomarker ', ' molecular marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' genome scale ', ' genomewide ', ' genome-wide ', ' Geroscience ', ' clinical risk ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' Risk stratification ', ' preservation ', ' death risk ', ' mortality risk ', ' COVID19 ', ' corona virus disease 2019 ', ' coronavirus disease 2019 ', ' COVID-19 ', ' COVID-19 epidemic ', ' COVID19 epidemic ', ' COVID19 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 pandemic ', ' COVID-19 pandemic ', ' COVID ', ' CoV disease ', ' corona virus disease ', ' coronavirus disease ', ' ']",NIA,YALE UNIVERSITY,R00,2020,139448,CT-03,0.08265078524788755
"Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort ABSTRACT  Sjgren's Syndrome (SS) is a systemic autoimmune disease affecting the exocrine system, with hallmark symptoms of dry mouth and/or dry eyes caused by the dysfunction of salivary and/or lacrimal glands, respectively. While Genome-Wide Association Studies (GWAS) and other studies have increased our knowledge of genetic risk factors for SS, the disease etiology remains not well understood, and such risk factors have not been translatable to any immunological treatment options for SS. The NIH-NIDCR-funded Sjgren's International Collaborative Clinical Alliance (SICCA) was established to improve the understanding, diagnosis and treatment of patients with SS by developing/validating standardized classification criteria for SS; and developing a rich biospecimen repository with clinical data to be used for future epidemiologic, pathogenesis, and genetic studies of SS.[1, 2] For this project, we will focus on genomic data and measures of the 2016 ACR-EULAR classification criteria, involving ocular, oral, and autoantibody manifestations. As shown in our previous work, the genetics of SS varies with ancestry; thus, we will cluster patients by both the criteria subphenotypes and genetic ancestry. We believe that accounting for disease heterogeneity in this way will enable us to more precisely identify disease pathways and mechanisms. Using previously secured funding, we are completing DNA methylation typing on LSGs in 373 SICCA patients and single-cell RNA sequencing (scRNAseq) on PBMCs of 86 SICCA patients who also have DNA methylation profiling. This data provides a unique opportunity for multi-omics analysis to determine correlates between LSG tissue epigenetics, peripheral blood cell-type distributions and cell-specific gene expression by SS subsets. First, using GWAS data and DNA methylation data from LSG biopsies, we will identify genetic and epigenetic modifications associated with subtypes of SS in SICCA patients. We will then examine the relationships between them by testing for genotype-specific methylation and expression, and utilizing mendelian randomization and causal inference testing to investigate causality between these measures. Second, we will analyze scRNAseq data to identify how cell types, states and cell- specific gene expression correlate with SS subtypes. Finally, we will integrate genetics, epigenetics, and transcriptomics to determine multi-omics profiles associated with SS subtypes. We will jointly model associated features from the genomic data to investigate causal pathways via correlation networks, conditional analysis, and machine learning. We anticipate that SS subtypes will exhibit specific relationships within the multi- omics data and that this will advance our understanding of SS disease processes, leading to better treatment targets. PROJECT NARRATIVE Our proposal leverages unique NIDCR-funded resources by utilizing existing infrastructure and data with high level expertise to better understand the pathogenesis of Sjgren's syndrome and identify new therapeutic pathways. We propose to analyze genetic, epigenetic, and transcriptomic data recently generated on patients of the Sjgren's International Collaborative Clinical Alliance (SICCA) biorepository/registry. We will identify genomic determinants of subtypes of SS derived from subphenotypes and genetic ancestry, which we believe will be more indicative of underlying biologic pathways and will lead to more appropriate genomic candidates for SS treatments.",Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort,10041649,R03DE029800,"['Accounting ', ' Affect ', ' Arthralgia ', ' Joint Pain ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Biopsy ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Exanthema ', ' Exanthem ', ' Rash ', ' Skin Rash ', ' Exhibits ', ' Fatigue ', ' Lack of Energy ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Hereditary Disease ', ' Inborn Genetic Diseases ', ' Inherited disorder ', ' hereditary disorder ', ' heritable disorder ', ' inborn error ', ' inherited diseases ', ' inherited genetic disease ', ' inherited genetic disorder ', ' Laboratories ', ' Lacrimal gland structure ', ' Lacrimal Glands ', ' Systemic Lupus Erythematosus ', ' Lupus Erythematosus Disseminatus ', ' SLE ', ' Systemic Lupus Erythematous ', ' Systemic Lupus Erythmatosus ', ' disseminated lupus erythematosus ', ' systemic lupus erythematosis ', ' Lymphoma ', ' Germinoblastic Sarcoma ', ' Germinoblastoma ', ' Malignant Lymphoma ', ' Reticulolymphosarcoma ', ' Methylation ', ' monocyte ', ' Blood monocyte ', ' Marrow monocyte ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Phenotype ', ' Registries ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Rheumatism ', ' Musculoskeletal Pain Disorder ', ' Rheumatic Diseases ', ' Rheumatologic Disorder ', ' Rheumatology ', ' Risk ', ' Risk Factors ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Standardization ', ' Testing ', ' Work ', ' Xerostomia ', ' Asialia ', ' Hyposalivation ', ' Mouth Dryness ', ' aptyalism ', ' dry mouth ', ' Measures ', ' Mediating ', ' Caring ', ' improved ', ' Site ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Biological Substance Banks ', ' biological specimen repository ', ' biosample repository ', ' biospecimen repository ', ' specimen bank ', ' specimen repository ', ' Biological Specimen Banks ', ' European ', ' Genetic Heterogeneity ', ' Funding ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Genetic ', ' dry eye ', ' eye dryness ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' Oral ', ' cell type ', ' collegiate ', ' college ', ' American ', ' QTL ', ' Quantitative Trait Loci ', ' success ', ' cohort ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' Pathogenesis ', ' Position ', ' Positioning Attribute ', ' inherited factor ', ' genetic risk factor ', ' Modeling ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' depository ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genetic association ', ' Symptoms ', ' Data ', ' Disease Pathway ', ' International ', ' NIDCR ', ' NIDR ', ' National Institute of Dental Research ', ' National Institute of Dental and Craniofacial Research ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Clinical Data ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Exocrine System ', ' Salivary Gland Tissue ', ' Validation ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Molecular ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' Sjogrens ', ' Sjgren Syndrome ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' transcriptomics ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' systemic autoimmune disorder ', ' systemic autoimmune disease ', ' biorepository ', ' biobank ', ' Secure ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' epigenome ', ' Genetic study ', ' methylation testing ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' multiomics ', ' multiple omics ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' disease heterogeneity ', ' entire genome ', ' full genome ', ' whole genome ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' Infrastructure ', ' multiple omic data ', ' Multiomic Data ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2020,161500,CA-12,0.1012413865911764
"Neural-derived extracellular vesicles microRNAs in bipolar disorder: a peripheral window into the brain Project Summary/Abstract Bipolar disorder is a chronic and often severe psychiatric disorder with a strong genetic basis. However, even with significant progress made by molecular genetic studies, the few genetic variants associated with the disorder explain only a small portion of its heritability, which led to the hypothesis of the involvement of epigenetic alterations in BDs pathophysiology. While recent studies have attempted to identify epigenetic biomarkers in BD, most results are limited due to the tissue specificity of epigenetic alterations and the biased assessments of candidate genes or genome-wide investigations through microarrays. Since the search for biomarkers have repetitively focused on peripheral measures that do not necessarily reflect brain alterations, significant biologically- and clinically-relevant findings have been significantly hindered. This study will fill this important gap by measuring epigenetic markers in plasma-derived extracellular vesicles (EVs) released by the brain. Specifically, we will focus on microRNAs and other non-coding RNAs that have been recently proposed to mediate important mechanisms in BD and may integrate gene and environment stimuli. Of note, microRNAs- filled EVs are released by the neural tissue as a method of cell-to-cell communication and may be the key players in transferring epigenetic markers to germ cells, ultimately contributing to the inter- and transgenerational transmission of BD. Our working hypothesis is that patients with BD will show alterations in specific miRNAs and other non-coding RNA transcripts in plasma neural-derived EVs compared to controls. To test this, we will initially identify neural-specific EVs microRNAs in BD by analyzing blood samples from 60 healthy controls and 60 BD type I patients (already collected and stored in our Department) (Aim 1). After neural-derived EVs immunoprecipitation and characterization, RNA will be isolated and next generation sequencing libraries will be prepared and sequenced on an Illumina NextSeq instrument with 1x75 bp single-end reads at an approximate depth of 10-15 million reads per sample. Significantly altered miRNAs will be validated by real-time PCR and the putative biological relevance of the differentially expressed transcripts will be assessed by functional pathway analyses. In addition, a machine learning model will be built using the miRNA expression data in order to predict whether an individual sample belongs to the BD or control group, allowing for the establishment of a clinically useful predictive biosignature that can have immediate impact in the field. On a second step we will investigate the correlation between neuronal EVs transcriptome markers with clinical, neuroanatomical, and neurocognitive parameters available for each subject, with the ultimate goal of identifying the clinical relevance of the newly- identified EVs markers in endophenotypes of illness (Aim 2). The identification of such brain-specific markers will likely open new avenues for scientific investigation of BD. Public Health Relevance Statement The proposed research is relevant to public health because bipolar disorder is a chronic and highly disabling condition with a strong familial aggregation, yet non-genetic mechanisms (such as microRNAs) underlying the disorder are still fairly unknown. The investigation of plasma neural-derived extracellular vesicles in bipolar disorder patients and controls and the development of a machine learning algorithm for the identification of a microRNA biosignature can lead to the identification of clinically relevant peripherally measured brain-specific biomarkers that can improve our understanding of the disorder and inform the development of personalized treatments.",Neural-derived extracellular vesicles microRNAs in bipolar disorder: a peripheral window into the brain,9973236,R21MH117636,"['Affect ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Bipolar Disorder ', ' Bipolar Affective Psychosis ', ' Manic-Depressive Psychosis ', ' bipolar affective disorder ', ' bipolar disease ', ' bipolar illness ', ' manic depressive disorder ', ' manic depressive illness ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cell Communication ', ' Cell Interaction ', ' Cell-to-Cell Interaction ', ' Cells ', ' Cell Body ', ' Control Groups ', ' Disease ', ' Disorder ', ' Edetic Acid ', ' EDTA ', ' Edathamil ', ' Ethylenediaminetetraacetic Acid ', ' Ethylenedinitrilotetraacetic Acid ', ' Environment ', ' Gene Expression ', ' Genes ', ' Germ Cells ', ' Gametes ', ' Germ-Line Cells ', ' Reproductive Cells ', ' Sex Cell ', ' initial cell ', ' sexual cell ', ' Goals ', ' Immunoprecipitation ', ' Immune Precipitation ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Libraries ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Patients ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Play ', ' Public Health ', ' Research ', ' Risk ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Role ', ' social role ', ' Specificity ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Measures ', ' Molecular Genetics ', ' Mediating ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Peripheral ', ' Chronic ', ' Clinical ', ' Biological ', ' peripheral blood ', ' Blood Serum ', ' Serum ', ' Multivesicular Body ', ' Stimulus ', ' Individual ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Genetic ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Investigation ', ' milliliter ', ' Source ', ' Neurocognitive ', ' Degenerative Neurologic Diseases ', ' Degenerative Neurologic Disorders ', ' Nervous System Degenerative Diseases ', ' Neural Degenerative Diseases ', ' Neural degenerative Disorders ', ' Neurodegenerative Diseases ', ' Neurologic Degenerative Conditions ', ' degenerative diseases of motor and sensory neurons ', ' degenerative neurological diseases ', ' neurodegenerative illness ', ' Neurodegenerative Disorders ', ' interest ', ' early detection ', ' Early Diagnosis ', ' neural ', ' relating to nervous system ', ' Structure ', ' substantia alba ', ' white matter ', ' disease risk ', ' disorder risk ', ' General Public ', ' General Population ', ' Pathogenesis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' Functional RNA ', ' Non-Coding ', ' Non-Coding RNA ', ' Non-translated RNA ', ' Noncoding RNA ', ' Nontranslated RNA ', ' noncoding ', ' Untranslated RNA ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' Pathogenicity ', ' Cell to Cell Communication and Signaling ', ' Cell-Cell Signaling ', ' intercellular communication ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Data ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' 1st degree relative ', ' First Degree Relative ', ' Transcript ', ' Validation ', ' Transmission ', ' transmission process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Heritability ', ' clinical relevance ', ' clinically relevant ', ' endophenotype ', ' public health relevance ', ' candidate biomarker ', ' candidate marker ', ' biosignature ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' genome scale ', ' genomewide ', ' genome-wide ', ' nongenetic ', ' non-genetic ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' epigenetic biomarker ', ' epigenetic marker ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' severe psychiatric disorder ', ' Genetic study ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' vesicle release ', ' vesicular release ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' specific biomarkers ', ' extracellular vesicles ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIMH,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R21,2020,194584,TX-09,0.031010700867564286
